drug1	drug2	strength	RR	severity	patients.fem.mal	description	color	onethousand	fdr
Digoxin	Furosemide	0.314	1.174	Moderate	10444 (6548/3896)	The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin.	#F9BCBC	1932.17410287292	0
Acetaminophen	Acenocoumarol	0.245	-1.054	None	31980 (18420/13560)	Acetaminophen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	5916.40442453809	1
Omeprazole	Alprazolam	0.309	2.068	Moderate	20365 (15223/5142)	The metabolism of Alprazolam can be decreased when combined with Omeprazole.	#F5B2B2	3767.59149798994	1
Amiodarone	Acenocoumarol	0.331	-1.287	None	5336 (2810/2526)	The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Amiodarone.	#B2D0E5	987.177423681528	0
Omeprazole	Diazepam	0.208	1.623	Moderate	16608 (11610/4998)	The metabolism of Diazepam can be decreased when combined with Omeprazole.	#F7B7B7	3072.53423022916	1
Rivastigmine	Quetiapine	0.317	1.024	Moderate	2385 (1418/967)		#F9BCBC	441.232787758704	0
Acetylsalicylic acid	Ibuprofen	0.131	-1.161	Major	21064 (11632/9432)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Ibuprofen.	#B4D1E6	3896.90878043997	1
Digoxin	Spironolactone	0.331	1.243	Minor	2760 (1767/993)	The serum concentration of Digoxin can be increased when it is combined with Spironolactone.	#F8BABA	510.609012249066	0
Donepezil	Quetiapine	0.349	1.334	Moderate	2025 (1329/696)		#F8BABA	374.631612247956	0
Risperidone	Donepezil	0.281	1.463	Moderate	1683 (1139/544)		#F7B9B9	311.360495512746	0
Acetylsalicylic acid	Gliclazide	0.371	-1.548	None	7724 (3711/4013)	Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.	#AFCEE4	1428.96522123615	1
Trazodone	Donepezil	0.304	1.655	Moderate	1526 (1073/453)		#F7B7B7	282.314982859447	0
Alendronic acid	Ibuprofen	0.172	6.719	Moderate	5426 (4915/511)	The risk or severity of adverse effects can be increased when Ibuprofen is combined with Alendronic acid.	#E28989	1003.82771755921	1
Omeprazole	Clonazepam	0.247	1.403	Moderate	5291 (3532/1759)		#F7B9B9	978.852276742684	1
Trazodone	Rivastigmine	0.281	1.102	Moderate	1446 (885/561)		#F9BCBC	267.514721634837	0
Allopurinol	Acenocoumarol	0.298	-3.303	None	6313 (1909/4404)	Allopurinol may increase the anticoagulant activities of Acenocoumarol.	#A0C3DD	1167.92561388709	2.57115252900376e-60
Galantamine	Risperidone	0.296	1.198	Moderate	888 (561/327)		#F8BABA	164.282899593178	8.81221336693631e-300
Acetylsalicylic acid	Glyburide	0.338	-1.568	Moderate	4763 (2273/2490)	Acetylsalicylic acid may increase the hypoglycemic activities of Glyburide.	#AFCEE4	881.170552660254	1
Prednisone	Acetylsalicylic acid	0.163	-1.715	Moderate	9483 (4314/5169)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisone.	#AECDE3	1754.38596491228	1
Galantamine	Quetiapine	0.343	1.008	Moderate	982 (580/402)	Galantamine may increase the QTc-prolonging activities of Quetiapine.	#F9BCBC	181.673206532095	1.84018686443422e-312
Levothyroxine	Acenocoumarol	0.296	2.019	None	3478 (2584/894)	Levothyroxine may increase the anticoagulant activities of Acenocoumarol.	#F5B4B4	643.441356739947	1
Furosemide	Ibuprofen	0.182	1.227	Moderate	8712 (5551/3161)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Ibuprofen.	#F8BABA	1611.7484473601	1
Digoxin	Carvedilol	0.302	-1.187	Moderate	1617 (884/733)	Digoxin may increase the bradycardic activities of Carvedilol.	#B2D0E5	299.150280002442	2.56139522608365e-138
Citalopram	Acenocoumarol	0.321	1.39	None	3283 (2185/1098)	The metabolism of Acenocoumarol can be decreased when combined with Citalopram.	#F7B9B9	607.365720004958	1
Acetylsalicylic acid	Insulin aspart	0.297	-1.256	Moderate	2670 (1422/1248)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Aspart.	#B2D0E5	493.958718371379	1
Acetylsalicylic acid	Insulin detemir	0.338	-1.171	Moderate	2322 (1277/1045)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Detemir.	#B4D1E6	429.577582044323	0.097807747324462
Haloperidol	Biperiden	0.443	1.907	Moderate	235 (172/63)		#F5B4B4	43.4757673472937	1.0854577813771e-124
Omeprazole	Methotrexate	0.31	1.433	Major	1941 (1305/636)	The serum concentration of Methotrexate can be increased when it is combined with Omeprazole.	#F7B9B9	359.091337962115	1
Trazodone	Galantamine	0.293	1.111	Moderate	728 (447/281)		#F9BCBC	134.682377143957	2.14756230521162e-174
Spironolactone	Enalapril	0.311	-1.207	Major	3764 (2042/1722)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Enalapril.	#B2D0E5	696.352290617929	1
Prednisone	Acenocoumarol	0.166	-1.614	None	4212 (1980/2232)		#AFCEE4	779.233753475749	1
Diclofenac	Alendronic acid	0.163	6.481	Moderate	2220 (2004/216)	The risk or severity of adverse effects can be increased when Diclofenac is combined with Alendronic acid.	#E38B8B	410.707248982945	1
Torasemide	Ibuprofen	0.173	1.374	Moderate	3925 (2602/1323)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Ibuprofen.	#F7B9B9	726.137816332458	1
Tramadol	Citalopram	0.223	2.963	Major	3119 (2524/595)	Citalopram may increase the neuroexcitatory activities of Tramadol.	#F1ABAB	577.025184494506	1
Bisoprolol	Ibuprofen	0.125	1.088	Moderate	5318 (3239/2079)	Ibuprofen may decrease the antihypertensive activities of Bisoprolol.	#F9BCBC	983.847364905991	1
Diltiazem	Simvastatin	0.432	-1.314	Major	3222 (1680/1542)	The serum concentration of Simvastatin can be increased when it is combined with Diltiazem.	#B2D0E5	596.080520821193	1
Donepezil	Sertraline	0.422	2.052	Minor	1004 (749/255)	The metabolism of Donepezil can be decreased when combined with Sertraline.	#F5B4B4	185.743278368863	2.72497912340178e-31
Levofloxacin	Acenocoumarol	0.101	-1.807	None	3484 (1540/1944)	Levofloxacin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	644.551376331792	1
Bisoprolol	Gliclazide	0.344	-1.338	None	2414 (1248/1166)	Bisoprolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	446.597882452625	1
Mirtazapine	Rivastigmine	0.312	1.669	Moderate	644 (454/190)		#F7B7B7	119.142102858115	4.44089318205737e-64
Bisoprolol	Salbutamol	0.17	-1.568	Moderate	3568 (1703/1865)	Bisoprolol may decrease the bronchodilatory activities of Salbutamol.	#AFCEE4	660.091650617633	1
Ciprofloxacin	Acenocoumarol	0.104	-1.699	None	3901 (1784/2117)		#AFCEE4	721.697737965075	1
Acetaminophen	Warfarin	0.23	-1.067	Minor	2311 (1324/987)	Acetaminophen may increase the anticoagulant activities of Warfarin.	#B4D1E6	427.542546125939	1
Ibuprofen	Acenocoumarol	0.126	-1.146	None	5043 (2801/2242)	Ibuprofen may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	932.971466946392	1
Digoxin	Levothyroxine	0.322	2.466	Moderate	1377 (1073/304)		#F3AFAF	254.74949632861	1
Paroxetine	Acenocoumarol	0.323	1.66	None	1786 (1257/529)	Paroxetine may increase the anticoagulant activities of Acenocoumarol.	#F7B7B7	330.415831839432	1
Indomethacin	Methotrexate	0.292	1.456	Major	182 (123/59)	The serum concentration of Methotrexate can be increased when it is combined with Indomethacin.	#F7B9B9	33.6705942859891	3.90074249265819e-71
Digoxin	Amiodarone	0.322	-1.175	Major	1016 (558/458)	The serum concentration of Digoxin can be increased when it is combined with Amiodarone.	#B4D1E6	187.963317552555	3.45461480912427e-22
Tramadol	Paroxetine	0.203	4.586	Major	1861 (1615/246)	Paroxetine may increase the neuroexcitatory activities of Tramadol.	#EB9C9C	344.291076737504	1
Acetylsalicylic acid	Ginkgo biloba	0.256	1.022	Moderate	1773 (1053/720)	Ginkgo biloba may increase the anticoagulant activities of Acetylsalicylic acid.	#F9BCBC	328.010789390433	1
Diltiazem	Atorvastatin	0.459	-1.744	Moderate	1930 (870/1060)	The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin.	#AECDE3	357.056302043731	1
Mirtazapine	Donepezil	0.391	2.671	Moderate	574 (455/119)		#F2AEAE	106.191874286581	3.50022689449696e-26
Bisoprolol	Formoterol	0.248	-1.774	Moderate	2369 (1058/1311)	Bisoprolol may decrease the bronchodilatory activities of Formoterol.	#AECDE3	438.272735513782	1
Propafenone	Acenocoumarol	0.338	1.633	None	484 (339/145)	The serum concentration of Acenocoumarol can be increased when it is combined with Propafenone.	#F7B7B7	89.5415804088942	2.15450747221367e-30
Mesalazine	Azathioprine	0.309	-1.122	Moderate	66 (37/29)	The metabolism of Azathioprine can be decreased when combined with Mesalazine.	#B4D1E6	12.2102155103038	5.27142361601523e-58
Warfarin	Amiodarone	0.34	-1.364	Major	453 (232/221)	The therapeutic efficacy of Warfarin can be increased when used in combination with Amiodarone.	#B1CFE5	83.8064791843576	1.73167461667868e-83
Atenolol	Ibuprofen	0.161	1.379	Moderate	2388 (1585/803)	Ibuprofen may decrease the antihypertensive activities of Atenolol.	#F7B9B9	441.787797554627	1
Ranitidine	Acenocoumarol	0.27	-1.326	None	2046 (1062/984)		#B2D0E5	378.516680819416	1
Simvastatin	Amiodarone	0.336	-1.43	Major	2455 (1228/1227)	The serum concentration of Simvastatin can be increased when it is combined with Amiodarone.	#B1CFE5	454.183016330238	1
Digoxin	Verapamil	0.365	1.17	Moderate	543 (340/203)	The metabolism of Digoxin can be decreased when combined with Verapamil.	#F9BCBC	100.456773062045	6.45706406925821e-49
Bisoprolol	Repaglinide	0.329	-1.43	Moderate	1515 (758/757)		#B1CFE5	280.279946941063	1
Digoxin	Alprazolam	0.26	1.884	Moderate	1231 (898/333)		#F5B4B4	227.739019593696	1
Alendronic acid	Naproxen	0.131	6.777	Moderate	1327 (1203/124)	The risk or severity of adverse effects can be increased when Naproxen is combined with Alendronic acid.	#E28989	245.499333063229	1
Trazodone	Acenocoumarol	0.269	-1.024	None	1623 (946/677)		#B4D1E6	300.260299594288	1
Digoxin	Hydrochlorothiazide	0.292	1.28	Moderate	2138 (1383/755)	The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Digoxin.	#F8BABA	395.536981227719	1
Methotrexate	Hydroxychloroquine	0.252	1.972	Minor	65 (48/17)		#F5B4B4	12.0252122449961	2.68587285392576e-46
Spironolactone	Losartan	0.334	1.192	Major	1413 (891/522)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Losartan.	#F8BABA	261.409613879685	1
Simvastatin	Clarithromycin	0.064	1.196	Major	1839 (1161/678)	The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.	#F8BABA	340.221004900736	1
Omeprazole	Ketazolam	0.284	2.006	None	871 (646/225)		#F5B4B4	161.137844082948	1
Acetylsalicylic acid	Methylprednisolone	0.164	-1.313	Moderate	1737 (906/831)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Methylprednisolone.	#B2D0E5	321.350671839358	1
Valproic acid	Acetylsalicylic acid	0.379	-1.264	Moderate	855 (454/401)	The serum concentration of Valproic Acid can be increased when it is combined with Acetylsalicylic acid.	#B2D0E5	158.177791838026	1
Trimethoprim	Leucovorin	0.55	-1.812	Major	179 (79/100)		#AECDE3	33.1155844900662	1.56061351295176e-98
Bisoprolol	Salmeterol	0.291	-2.426	Moderate	2398 (890/1508)	Bisoprolol may decrease the bronchodilatory activities of Salmeterol.	#A8C8E1	443.637830207703	1
Hydrocortisone	Acetylsalicylic acid	0.161	-1.167	Moderate	1583 (872/711)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Hydrocortisone.	#B4D1E6	292.860168981983	1
Propranolol	Primidone	0.273	-1.601	Moderate	125 (59/66)	The metabolism of Propranolol can be increased when combined with Primidone.	#AFCEE4	23.1254081634541	8.75165153097982e-69
Paroxetine	Risperidone	0.278	1.653	Moderate	727 (511/216)	The metabolism of Risperidone can be decreased when combined with Paroxetine.	#F7B7B7	134.497373878649	1
Cyclosporine	Sirolimus	0.271	1.397	Moderate	3 (2/1)	The risk or severity of adverse effects can be increased when Sirolimus is combined with Cyclosporine.	#F7B9B9	0.555009795922898	0.00384648455498863
Azithromycin	Acenocoumarol	0.1	-1.555	None	2205 (1057/1148)	The metabolism of Acenocoumarol can be decreased when combined with Azithromycin.	#AFCEE4	407.93220000333	1
Acetylsalicylic acid	Acenocoumarol	0.204	-2.125	None	5220 (2101/3119)	Acetylsalicylic acid may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	965.717044905843	1
Levothyroxine	Iron	0.19	3.457	Moderate	708 (589/119)	The serum concentration of Levothyroxine can be decreased when it is combined with Iron.	#F0A7A7	130.982311837804	1
Propranolol	Ibuprofen	0.155	1.516	Moderate	1138 (779/359)	Ibuprofen may decrease the antihypertensive activities of Propranolol.	#F7B9B9	210.533715920086	1
Omeprazole	Midazolam	0.271	1.203	Moderate	716 (453/263)		#F8BABA	132.462337960265	1
Citalopram	Carvedilol	0.37	1.458	Moderate	809 (547/262)	The metabolism of Carvedilol can be decreased when combined with Citalopram.	#F7B9B9	149.667641633875	1
Fluoxetine	Acenocoumarol	0.314	1.588	None	753 (523/230)	The metabolism of Acenocoumarol can be decreased when combined with Fluoxetine.	#F7B7B7	139.307458776647	1
Galantamine	Sertraline	0.41	1.741	Moderate	426 (304/122)	The metabolism of Galantamine can be decreased when combined with Sertraline.	#F6B6B6	78.8113910210515	1.66724901751751e-07
Citalopram	Propranolol	0.323	2.439	Moderate	575 (447/128)	The metabolism of Propranolol can be decreased when combined with Citalopram.	#F3AFAF	106.376877551889	1
Norfloxacin	Acenocoumarol	0.091	1.851	None	1248 (906/342)	Norfloxacin may increase the anticoagulant activities of Acenocoumarol.	#F6B6B6	230.884075103926	1
Omeprazole	Itraconazole	0.087	1.173	Moderate	1045 (655/390)	The serum concentration of Itraconazole can be decreased when it is combined with Omeprazole.	#F9BCBC	193.328412246476	1
Bisoprolol	Insulin aspart	0.276	-1.088	Moderate	813 (462/351)		#B4D1E6	150.407654695105	1
Phenytoin	Omeprazole	0.367	-1.373	Moderate	905 (462/443)	The serum concentration of Omeprazole can be decreased when it is combined with Phenytoin.	#B1CFE5	167.427955103408	1
Ibuprofen	Carvedilol	0.134	-1.084	Moderate	1599 (910/689)	Ibuprofen may decrease the antihypertensive activities of Carvedilol.	#B4D1E6	295.820221226905	1
Methimazole	Acenocoumarol	0.294	1.579	None	414 (287/127)	Methimazole may decrease the anticoagulant activities of Acenocoumarol.	#F7B7B7	76.5913518373599	0.030377687184798
Salbutamol	Carvedilol	0.185	-1.776	Major	1163 (519/644)	Carvedilol may decrease the vasoconstricting activities of Salbutamol.	#AECDE3	215.158797552777	1
Trimethoprim	Rifampicin	0.683	-1.209	Moderate	83 (45/38)	The metabolism of Trimethoprim can be increased when combined with Rifampicin.	#B2D0E5	15.3552710205335	7.85668476905436e-42
Propranolol	Sertraline	0.336	2.679	Moderate	469 (372/97)	The metabolism of Propranolol can be decreased when combined with Sertraline.	#F2AEAE	86.7665314292797	1
Atenolol	Gliclazide	0.357	-1.1	None	810 (458/352)	Atenolol may increase the hypoglycemic activities of Gliclazide.	#B4D1E6	149.852644899182	1
Entacapone	Apomorphine	0.385	1.048	Moderate	5 (3/2)		#F9BCBC	0.925016326538163	4.22626482781283e-06
Mirtazapine	Galantamine	0.363	1.853	Moderate	274 (199/75)		#F6B6B6	50.6908946942914	1.60484309553126e-13
Gliclazide	Carvedilol	0.332	-1.52	None	738 (358/380)	Carvedilol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	136.532409797033	1
Ramipril	Spironolactone	0.357	-1.64	Major	738 (344/394)	The risk or severity of adverse effects can be increased when Ramipril is combined with Spironolactone.	#AFCEE4	136.532409797033	1
Carvedilol	Insulin aspart	0.267	-1.19	Moderate	379 (207/172)		#B2D0E5	70.1162375515928	6.68206268655624e-08
Repaglinide	Gliclazide	0.24	-1.207	None	575 (312/263)	Repaglinide may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	106.376877551889	1
Bisoprolol	Insulin detemir	0.312	-1.003	Moderate	631 (371/260)		#B4D1E6	116.737060409116	1
Propranolol	Paroxetine	0.35	2.715	Moderate	386 (307/79)	The metabolism of Propranolol can be decreased when combined with Paroxetine.	#F2AEAE	71.4112604087462	1
Sertraline	Carvedilol	0.346	1.397	Moderate	618 (412/206)	The metabolism of Carvedilol can be decreased when combined with Sertraline.	#F7B9B9	114.332017960117	1
Digoxin	Diazepam	0.24	1.766	Moderate	808 (579/229)		#F6B6B6	149.482638368567	1
Carbamazepine	Simvastatin	0.331	-1.001	Moderate	588 (346/242)	The metabolism of Simvastatin can be increased when combined with Carbamazepine.	#B4D1E6	108.781920000888	1
Tramadol	Escitalopram	0.236	2.536	Major	954 (748/206)	Escitalopram may increase the neuroexcitatory activities of Tramadol.	#F3AFAF	176.493115103482	1
Bisoprolol	Glyburide	0.288	-1.42	Moderate	1002 (503/499)	Bisoprolol may increase the hypoglycemic activities of Glyburide.	#B1CFE5	185.373271838248	1
Diltiazem	Amiodarone	0.346	-1.47	Major	535 (264/271)	The risk or severity of bradycardia can be increased when Diltiazem is combined with Amiodarone.	#B1CFE5	98.9767469395835	1
Repaglinide	Carvedilol	0.333	-1.786	Moderate	535 (238/297)		#AECDE3	98.9767469395835	0.0727428980186798
Atenolol	Glyburide	0.323	-1.113	Moderate	528 (297/231)	Atenolol may increase the hypoglycemic activities of Glyburide.	#B4D1E6	97.6817240824301	1
Carvedilol	Insulin detemir	0.315	-1.234	Moderate	311 (167/144)		#B2D0E5	57.5360155106738	3.09267435627928e-07
Salmeterol	Carvedilol	0.31	-2.231	Major	806 (315/491)	Carvedilol may decrease the vasoconstricting activities of Salmeterol.	#ABCBE2	149.112631837952	1
Paroxetine	Carvedilol	0.364	1.711	Moderate	476 (338/138)	The metabolism of Carvedilol can be decreased when combined with Paroxetine.	#F6B6B6	88.0615542864332	1
Fluconazole	Simvastatin	0.086	1.149	Major	812 (505/307)	The serum concentration of Simvastatin can be increased when it is combined with Fluconazole.	#F9BCBC	150.222651429798	1
Cyclosporine	Danazol	0.463	1.397	Moderate	3 (2/1)	Danazol may increase the hepatotoxic activities of Cyclosporine.	#F7B9B9	0.555009795922898	0.0171345664608941
Tramadol	Fluoxetine	0.235	4.08	Major	643 (549/94)	Fluoxetine may increase the neuroexcitatory activities of Tramadol.	#EDA1A1	118.957099592808	1
Pyridostigmine	Prednisone	0.351	-2.031	Moderate	179 (74/105)	The risk or severity of adverse effects can be increased when Prednisone is combined with Pyridostigmine.	#ACCCE3	33.1155844900662	2.40147010141116e-40
Sucralfate	Lansoprazole	0.281	1.124	Moderate	167 (103/64)		#F9BCBC	30.8955453063747	7.60985871626856e-17
Pravastatin	Fenofibrate	0.664	-1.187	Major	311 (170/141)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pravastatin.	#B2D0E5	57.5360155106738	0.000368545524758951
Digoxin	Methimazole	0.289	1.876	Moderate	199 (145/54)	The serum concentration of Digoxin can be increased when it is combined with Methimazole.	#F6B6B6	36.8156497962189	2.69945780147443e-07
Atenolol	Salbutamol	0.166	-1.217	Moderate	927 (501/426)	Atenolol may decrease the bronchodilatory activities of Salbutamol.	#B2D0E5	171.498026940175	1
Verapamil	Atorvastatin	0.385	-1.05	Moderate	475 (274/201)	Atorvastatin can cause a decrease in the absorption of Verapamil resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B4D1E6	87.8765510211255	1
Omeprazole	Flurazepam	0.275	1.446	Moderate	396 (267/129)		#F7B9B9	73.2612930618225	1
Clonidine	Nadolol	0.362	Inf	Major	2 (2/0)	Clonidine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.370006530615265	0.847558492676338
Amitriptyline	Carbamazepine	0.334	1.519	Moderate	127 (87/40)	The metabolism of Amitriptyline can be increased when combined with Carbamazepine.	#F7B9B9	23.4954146940693	6.53743719093989e-17
Propranolol	Escitalopram	0.299	3.058	None	242 (197/45)		#F1ABAB	44.7707902044471	1
Galantamine	Paroxetine	0.331	1.65	Moderate	279 (196/83)	The metabolism of Galantamine can be decreased when combined with Paroxetine.	#F7B7B7	51.6159110208295	1
Pentoxifylline	Acenocoumarol	0.331	-3.176	None	1252 (389/863)	Pentoxifylline may increase the anticoagulant activities of Acenocoumarol.	#A2C4DE	231.624088165156	1
Simvastatin	Colchicine	0.152	-3.379	Major	1008 (300/708)	Colchicine may increase the myopathic rhabdomyolysis activities of Simvastatin.	#A0C3DD	186.483291430094	1
Acetylsalicylic acid	Glipizide	0.346	-1.728	Moderate	459 (208/251)	Acetylsalicylic acid may increase the hypoglycemic activities of Glipizide.	#AECDE3	84.9164987762034	1
Omeprazole	Cilostazol	0.212	-3.864	Major	1058 (286/772)	The serum concentration of Cilostazol can be increased when it is combined with Omeprazole.	#9CBFDB	195.733454695475	1
Citalopram	Clarithromycin	0.11	2.364	Major	491 (379/112)	Clarithromycin may increase the QTc-prolonging activities of Citalopram.	#F4B1B1	90.8366032660476	1
Lidocaine	Bisoprolol	0.16	1.807	Moderate	477 (344/133)	The serum concentration of Lidocaine can be increased when it is combined with Bisoprolol.	#F6B6B6	88.2465575517408	1
Formoterol	Carvedilol	0.234	-2.04	Major	633 (261/372)	Carvedilol may decrease the vasoconstricting activities of Formoterol.	#ACCCE3	117.107066939731	1
Olanzapine	Rivastigmine	0.359	1.209	Moderate	142 (90/52)		#F8BABA	26.2704636736838	1.45971936649121e-15
Methotrexate	Acetylsalicylic acid	0.26	-1.089	Major	551 (313/238)	The serum concentration of Methotrexate can be increased when it is combined with Acetylsalicylic acid.	#B4D1E6	101.936799184506	1
Digoxin	Telmisartan	0.267	1.227	Moderate	386 (246/140)	The serum concentration of Digoxin can be increased when it is combined with Telmisartan.	#F8BABA	71.4112604087462	1
Alprazolam	Clarithromycin	0.128	2.084	Moderate	470 (352/118)	The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.	#F5B2B2	86.9515346945874	1
Moxifloxacin	Acenocoumarol	0.097	-1.951	None	853 (361/492)		#ACCCE3	157.807785307411	1
Venlafaxine	Metoclopramide	0.154	2.776	Moderate	373 (298/75)	The risk or severity of adverse effects can be increased when Metoclopramide is combined with Venlafaxine.	#F2ACAC	69.006217959747	1
Fenofibrate	Atorvastatin	0.417	-1.413	Major	465 (234/231)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.	#B1CFE5	86.0265183680492	1
Gemfibrozil	Acenocoumarol	0.311	-1.679	None	554 (255/299)	The metabolism of Acenocoumarol can be decreased when combined with Gemfibrozil.	#AFCEE4	102.491808980429	1
Amitriptyline	Salbutamol	0.211	1.21	Moderate	511 (324/187)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.	#F8BABA	94.5366685722003	1
Glyburide	Carvedilol	0.297	-1.62	Moderate	405 (190/215)	Carvedilol may increase the hypoglycemic activities of Glyburide.	#AFCEE4	74.9263224495912	1
Phenytoin	Furosemide	0.389	-1.277	Minor	316 (167/149)	Phenytoin may decrease the diuretic activities of Furosemide.	#B2D0E5	58.4610318372119	1
Acetylsalicylic acid	Dexamethasone	0.179	-2.211	Moderate	967 (380/587)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Dexamethasone.	#ABCBE2	178.898157552481	1
Amiodarone	Levofloxacin	0.173	-1.996	Major	711 (297/414)	Levofloxacin may increase the QTc-prolonging activities of Amiodarone.	#ACCCE3	131.537321633727	1
Ceftazidime	Gentamicin	1	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	0.378408265482468
Metformin	Glucosamine	0.208	1.067	None	675 (408/267)		#F9BCBC	124.877204082652	1
Atorvastatin	Clarithromycin	0.092	-1.291	Major	677 (356/321)	The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.	#B2D0E5	125.247210613267	1
Atenolol	Repaglinide	0.304	-1.062	Moderate	385 (221/164)		#B4D1E6	71.2262571434386	1
Levothyroxine	Warfarin	0.273	2.27	Moderate	255 (195/60)	Levothyroxine may increase the anticoagulant activities of Warfarin.	#F4B1B1	47.1758326534463	1
Dextromethorphan	Paroxetine	0.136	2.826	Major	328 (263/65)	Paroxetine may increase the serotonergic activities of Dextromethorphan.	#F2ACAC	60.6810710209035	1
Carbamazepine	Atorvastatin	0.329	-1.327	Moderate	289 (150/139)	The metabolism of Atorvastatin can be increased when combined with Carbamazepine.	#B2D0E5	53.4659436739058	1
Repaglinide	Glyburide	0.211	-1.254	None	302 (161/141)	Repaglinide may increase the hypoglycemic activities of Glyburide.	#B2D0E5	55.8709861229051	1
Fenofibrate	Acenocoumarol	0.305	-1.356	None	444 (228/216)	Fenofibrate may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	82.1414497965889	1
Simvastatin	Fenofibrate	0.34	-1.239	Major	653 (350/303)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Simvastatin.	#B2D0E5	120.807132245884	1
Indomethacin	Alendronic acid	0.216	3.984	Moderate	248 (211/37)	The risk or severity of adverse effects can be increased when Indomethacin is combined with Alendronic acid.	#EDA3A3	45.8808097962929	1
Clarithromycin	Acenocoumarol	0.084	-1.252	None	688 (367/321)	The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.	#B2D0E5	127.282246531651	1
Hydrocortisone	Acenocoumarol	0.154	-1.103	None	533 (301/232)		#B4D1E6	98.6067404089682	1
Warfarin	Propafenone	0.22	1.146	Moderate	66 (41/25)	The serum concentration of Warfarin can be increased when it is combined with Propafenone.	#F9BCBC	12.2102155103038	2.64106564289526e-11
Carvedilol	Escitalopram	0.352	1.242	None	300 (192/108)		#F8BABA	55.5009795922898	1
Lorazepam	Phenytoin	0.347	-1.056	Moderate	278 (160/118)	The serum concentration of Phenytoin can be increased when it is combined with Lorazepam.	#B4D1E6	51.4309077555219	1
Digoxin	Rabeprazole	0.22	1.177	Moderate	333 (209/124)		#F8BABA	61.6060873474417	1
Clozapine	Lamotrigine	0.359	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lamotrigine.	#B32020	0.370006530615265	1
Propranolol	Salbutamol	0.153	-1.042	Major	444 (257/187)		#B4D1E6	82.1414497965889	1
Spironolactone	Irbesartan	0.304	1.237	Major	302 (193/109)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Irbesartan.	#F8BABA	55.8709861229051	1
Phenytoin	Lamotrigine	0.528	-1.7	Moderate	35 (16/19)	The serum concentration of Lamotrigine can be decreased when it is combined with Phenytoin.	#AFCEE4	6.47511428576714	5.70578673707766e-18
Fluoxetine	Risperidone	0.292	2.058	Moderate	221 (165/56)	The metabolism of Risperidone can be decreased when combined with Fluoxetine.	#F5B2B2	40.8857216329868	1
Donepezil	Solifenacin	0.349	-1.285	Moderate	279 (147/132)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Donepezil.	#B2D0E5	51.6159110208295	1
Fluoxetine	Carvedilol	0.362	1.291	Moderate	225 (146/79)	The metabolism of Carvedilol can be decreased when combined with Fluoxetine.	#F8BABA	41.6257346942173	1
Methotrexate	Amoxicillin	0.122	1.202	Major	400 (253/147)	The serum concentration of Methotrexate can be increased when it is combined with Amoxicillin.	#F8BABA	74.0013061230531	1
Fluconazole	Alprazolam	0.182	2.064	Major	261 (195/66)	The metabolism of Alprazolam can be decreased when combined with Fluconazole.	#F5B2B2	48.2858522452921	1
Olanzapine	Donepezil	0.363	1.14	Moderate	129 (80/49)		#F9BCBC	23.8654212246846	4.19406730108107e-07
Cloxacillin	Acenocoumarol	0.084	-1.303	None	512 (268/244)	Cloxacillin may decrease the anticoagulant activities of Acenocoumarol.	#B2D0E5	94.7216718375079	1
Erythromycin	Simvastatin	0.086	1.57	Major	432 (299/133)	The serum concentration of Simvastatin can be increased when it is combined with Erythromycin.	#F7B7B7	79.9214106128973	1
Fentanyl	Amiodarone	0.24	1.332	Major	343 (225/118)	The serum concentration of Fentanyl can be increased when it is combined with Amiodarone.	#F8BABA	63.456120000518	1
Ciprofloxacin	Iron	0.26	-1.342	Moderate	651 (336/315)		#B2D0E5	120.437125715269	1
Allopurinol	Warfarin	0.281	-3.147	Moderate	371 (116/255)	Allopurinol may increase the anticoagulant activities of Warfarin.	#A2C4DE	68.6362114291317	1
Fluoxetine	Clomipramine	0.377	3.044	Major	75 (61/14)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Clomipramine.	#F1ABAB	13.8752448980725	1.54186295867491e-06
Triamcinolone	Acetylsalicylic acid	0.097	-1.566	Moderate	536 (256/280)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Triamcinolone.	#AFCEE4	99.1617502048911	1
Indomethacin	Furosemide	0.194	-1.581	Moderate	564 (268/296)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Indomethacin.	#AFCEE4	104.341841633505	1
Sertraline	Rasagiline	0.409	-1.159	Major	190 (105/85)	The risk or severity of adverse effects can be increased when Sertraline is combined with Rasagiline.	#B4D1E6	35.1506204084502	1
Diltiazem	Amlodipine	0.285	-1.377	Moderate	824 (420/404)	The metabolism of Amlodipine can be decreased when combined with Diltiazem.	#B1CFE5	152.442690613489	1
Lovastatin	Acenocoumarol	0.336	1.011	None	399 (236/163)	The metabolism of Acenocoumarol can be decreased when combined with Lovastatin.	#F9BCBC	73.8163028577454	1
Simvastatin	Gemfibrozil	0.234	-1.217	Major	568 (307/261)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Simvastatin.	#B2D0E5	105.081854694735	1
Omeprazole	Halazepam	0.266	1.734	Moderate	202 (144/58)		#F6B6B6	37.3706595921418	1
Duloxetine	Ciprofloxacin	0.125	1.914	Major	303 (222/81)		#F5B4B4	56.0559893882127	1
Spironolactone	Tolevamer	0.248	-1.564	Moderate	113 (54/59)		#AFCEE4	20.9053689797625	0.240917204153812
Acetylsalicylic acid	Insulin glulisine	0.229	-1.466	Moderate	251 (124/127)	Acetylsalicylic acid may increase the hypoglycemic activities of Insulin Glulisine.	#B1CFE5	46.4358195922158	1
Phenytoin	Alprazolam	0.355	2.071	Moderate	111 (83/28)	The serum concentration of Phenytoin can be increased when it is combined with Alprazolam.	#F5B2B2	20.5353624491472	1
Digoxin	Propafenone	0.31	1.257	Moderate	126 (81/45)	The serum concentration of Digoxin can be increased when it is combined with Propafenone.	#F8BABA	23.3104114287617	1
Citalopram	Rasagiline	0.378	-1.304	Major	214 (112/102)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rasagiline.	#B2D0E5	39.5906987758334	1
Galantamine	Tolterodine	0.377	-1.104	Moderate	147 (83/64)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Galantamine.	#B4D1E6	27.195480000222	0.751816254760846
Prednisone	Warfarin	0.181	-1.45	Moderate	320 (159/161)	Prednisone may increase the anticoagulant activities of Warfarin.	#B1CFE5	59.2010448984425	1
Sertraline	Clarithromycin	0.115	2.001	Moderate	313 (232/81)	The metabolism of Sertraline can be decreased when combined with Clarithromycin.	#F5B4B4	57.906022041289	1
Escitalopram	Rasagiline	0.406	-1.496	Major	137 (67/70)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Rasagiline.	#B1CFE5	25.3454473471457	0.000834166797634989
Propranolol	Phenobarbital	0.294	1.048	Moderate	55 (33/22)	The metabolism of Propranolol can be increased when combined with Phenobarbital.	#F9BCBC	10.1751795919198	1.58360399550108e-08
Folic acid	Phenytoin	0.312	-1.679	Moderate	113 (52/61)	The serum concentration of Phenytoin can be decreased when it is combined with Folic Acid.	#AFCEE4	20.9053689797625	1.38834591873514e-07
Fluvastatin	Acenocoumarol	0.33	-1.996	None	395 (165/230)	The metabolism of Acenocoumarol can be decreased when combined with Fluvastatin.	#ACCCE3	73.0762897965149	1
Donepezil	Tolterodine	0.421	-1.157	Moderate	226 (125/101)	The therapeutic efficacy of Tolterodine can be decreased when used in combination with Donepezil.	#B4D1E6	41.810737959525	1
Phenytoin	Quetiapine	0.324	-1.281	Major	108 (57/51)	The serum concentration of Quetiapine can be decreased when it is combined with Phenytoin.	#B2D0E5	19.9803526532243	0.00395325752482183
Trihexyphenidyl	Haloperidol	0.231	2.654	Moderate	24 (19/5)		#F2AEAE	4.44007836738318	5.67149638520286e-05
Citalopram	Warfarin	0.272	2.082	Moderate	203 (152/51)	The metabolism of Warfarin can be decreased when combined with Citalopram.	#F5B2B2	37.5556628574494	1
Cholestyramine	Ursodeoxycholic acid	0.38	1.148	None	37 (23/14)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Cholestyramine.	#F9BCBC	6.84512081638241	7.13298682758061e-10
Citalopram	Oxycodone	0.294	2.302	Moderate	189 (145/44)	The metabolism of Oxycodone can be decreased when combined with Citalopram.	#F4B1B1	34.9656171431426	1
Donepezil	Methotrimeprazine	0.205	1.478	Moderate	81 (55/26)	The metabolism of Donepezil can be decreased when combined with Methotrimeprazine.	#F7B9B9	14.9852644899182	0.0105197141233843
Torasemide	Indomethacin	0.212	-1.165	Moderate	263 (145/118)	The therapeutic efficacy of Torasemide can be decreased when used in combination with Indomethacin.	#B4D1E6	48.6558587759074	1
Metoclopramide	Levodopa	0.131	1.133	Moderate	333 (206/127)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Metoclopramide.	#F9BCBC	61.6060873474417	1
Methotrexate	Naproxen	0.173	1.683	Major	150 (106/44)	The serum concentration of Methotrexate can be increased when it is combined with Naproxen.	#F7B7B7	27.7504897961449	1
Propranolol	Gliclazide	0.329	-1.289	None	287 (151/136)	Propranolol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	53.0959371432906	1
Fluconazole	Atorvastatin	0.116	-1.192	Major	328 (179/149)	The serum concentration of Atorvastatin can be increased when it is combined with Fluconazole.	#B2D0E5	60.6810710209035	1
Ciprofloxacin	Rasagiline	0.098	-1.973	Major	264 (111/153)		#ACCCE3	48.840862041215	1
Propranolol	Formoterol	0.217	-1.292	Major	274 (144/130)		#B2D0E5	50.6908946942914	1
Amitriptyline	Fluoxetine	0.287	3.493	Major	132 (110/22)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.	#EFA6A6	24.4204310206075	1
Fluoxetine	Propranolol	0.345	2.231	Moderate	130 (99/31)	The metabolism of Propranolol can be decreased when combined with Fluoxetine.	#F5B2B2	24.0504244899922	1
Alprazolam	Carbamazepine	0.305	2.159	Moderate	135 (102/33)	The metabolism of Alprazolam can be increased when combined with Carbamazepine.	#F5B2B2	24.9754408165304	1
Venlafaxine	Rasagiline	0.377	1.138	Major	92 (57/35)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Rasagiline.	#F9BCBC	17.0203004083022	1
Cyclosporine	Omeprazole	0.377	-1.281	Moderate	180 (95/85)	The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.	#B2D0E5	33.3005877553739	1
Fluconazole	Fentanyl	0.339	1.04	Major	214 (128/86)	The serum concentration of Fentanyl can be increased when it is combined with Fluconazole.	#F9BCBC	39.5906987758334	1
Simvastatin	Itraconazole	0.1	1.139	Major	313 (194/119)	The serum concentration of Simvastatin can be increased when it is combined with Itraconazole.	#F9BCBC	57.906022041289	1
Bisoprolol	Terbutaline	0.123	-1.239	Moderate	332 (178/154)	Bisoprolol may decrease the bronchodilatory activities of Terbutaline.	#B2D0E5	61.4210840821341	1
Oxycodone	Sertraline	0.308	2.994	Moderate	148 (120/28)	The metabolism of Oxycodone can be decreased when combined with Sertraline.	#F1ABAB	27.3804832655296	1
Lovastatin	Diltiazem	0.44	1.116	Major	174 (107/67)	The serum concentration of Lovastatin can be increased when it is combined with Diltiazem.	#F9BCBC	32.1905681635281	1
Rivastigmine	Methotrimeprazine	0.23	1.108	Moderate	75 (46/29)		#F9BCBC	13.8752448980725	0.00305518228228536
Azithromycin	Lovastatin	0.071	1.154	Moderate	252 (157/95)	The serum concentration of Lovastatin can be increased when it is combined with Azithromycin.	#F9BCBC	46.6208228575234	1
Levothyroxine	Raloxifene	0.301	7.195	Moderate	113 (103/10)	Raloxifene can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.	#E08585	20.9053689797625	1
Fluoxetine	Dextromethorphan	0.171	2.434	Major	148 (115/33)	Fluoxetine may increase the serotonergic activities of Dextromethorphan.	#F3AFAF	27.3804832655296	1
Galantamine	Methotrimeprazine	0.277	-1.041	Moderate	57 (33/24)	The metabolism of Galantamine can be decreased when combined with Methotrimeprazine.	#B4D1E6	10.5451861225351	4.43907901883207e-07
Atenolol	Salmeterol	0.257	-1.976	Moderate	507 (213/294)	Atenolol may decrease the bronchodilatory activities of Salmeterol.	#ACCCE3	93.7966555109698	1
Prazosin	Oxprenolol	0.455	Inf	None	1 (1/0)	Oxprenolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.185003265307633	1
Indomethacin	Losartan	0.163	-1.167	Moderate	305 (168/137)	The metabolism of Indomethacin can be decreased when combined with Losartan.	#B4D1E6	56.425995918828	1
Amitriptyline	Duloxetine	0.314	2.27	Major	119 (91/28)	Duloxetine may increase the serotonergic activities of Amitriptyline.	#F4B1B1	22.0153885716083	1
Atenolol	Formoterol	0.211	-1.745	Moderate	446 (201/245)	Atenolol may decrease the bronchodilatory activities of Formoterol.	#AECDE3	82.5114563272042	1
Erythromycin	Alprazolam	0.124	2.425	Moderate	161 (125/36)	The serum concentration of Alprazolam can be increased when it is combined with Erythromycin.	#F3AFAF	29.7855257145289	1
Tacrolimus	Atorvastatin	0.27	-1.686	Moderate	196 (90/106)	The risk or severity of adverse effects can be increased when Tacrolimus is combined with Atorvastatin.	#AFCEE4	36.260640000296	1
Valproic acid	Carbamazepine	0.452	1.098	Moderate	36 (22/14)	The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Valproic Acid.	#F9BCBC	6.66011755107478	5.36876198485933e-05
Salbutamol	Clomipramine	0.146	2.305	Moderate	129 (99/30)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Salbutamol.	#F4B1B1	23.8654212246846	1
Mirtazapine	Rasagiline	0.434	-1.308	Major	111 (58/53)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Mirtazapine.	#B2D0E5	20.5353624491472	1
Atorvastatin	Gemfibrozil	0.252	-1.633	Major	319 (149/170)	The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Atorvastatin.	#AFCEE4	59.0160416331348	1
Tramadol	Carbamazepine	0.272	1.36	Moderate	224 (148/76)	Tramadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.	#F7B9B9	41.4407314289097	1
Phenytoin	Ciprofloxacin	0.121	-2.138	Moderate	187 (75/112)	The therapeutic efficacy of Phenytoin can be decreased when used in combination with Ciprofloxacin.	#ABCBE2	34.5956106125273	1
Naproxen	Acenocoumarol	0.096	-1.216	None	775 (419/356)	Naproxen may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	143.377530613415	1
Methotrexate	Ibuprofen	0.18	1.688	Major	246 (174/72)	The serum concentration of Methotrexate can be increased when it is combined with Ibuprofen.	#F7B7B7	45.5108032656776	1
Levofloxacin	Iron	0.25	-1.596	Moderate	442 (209/233)	The serum concentration of Levofloxacin can be decreased when it is combined with Iron.	#AFCEE4	81.7714432659736	1
Olanzapine	Galantamine	0.377	1.561	Moderate	55 (38/17)		#F7B7B7	10.1751795919198	0.305007772711501
Acarbose	Digoxin	0.34	1.029	Moderate	94 (56/38)	The serum concentration of Digoxin can be decreased when it is combined with Acarbose.	#F9BCBC	17.3903069389175	1
Carbamazepine	Acenocoumarol	0.31	-1.254	None	197 (105/92)	The serum concentration of Acenocoumarol can be decreased when it is combined with Carbamazepine.	#B2D0E5	36.4456432656036	1
Hydroxyzine	Donepezil	0.163	1.534	Moderate	147 (101/46)		#F7B7B7	27.195480000222	1
Spironolactone	Telmisartan	0.272	1.006	Major	205 (121/84)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Telmisartan.	#F9BCBC	37.9256693880647	1
Trazodone	Warfarin	0.27	1.067	Minor	139 (84/55)	Trazodone may decrease the anticoagulant activities of Warfarin.	#F9BCBC	25.7154538777609	1
Folic acid	Phenobarbital	0.322	-1.095	Moderate	60 (34/26)	The serum concentration of Phenobarbital can be decreased when it is combined with Folic Acid.	#B4D1E6	11.100195918458	0.65865462559671
Glimepiride	Repaglinide	0.24	-1.059	None	127 (73/54)	Glimepiride may increase the hypoglycemic activities of Repaglinide.	#B4D1E6	23.4954146940693	1
Nabumetone	Alendronic acid	0.182	15.368	Moderate	92 (88/4)	The risk or severity of adverse effects can be increased when Nabumetone is combined with Alendronic acid.	#BF3C3C	17.0203004083022	1
Prazosin	Nadolol	0.665	Inf	Moderate	2 (2/0)	Nadolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.370006530615265	1
Galantamine	Solifenacin	0.331	-1.779	Moderate	148 (66/82)	The therapeutic efficacy of Solifenacin can be decreased when used in combination with Galantamine.	#AECDE3	27.3804832655296	1
Paroxetine	Rasagiline	0.329	1.265	Major	104 (67/37)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rasagiline.	#F8BABA	19.2403395919938	1
Erythromycin	Acenocoumarol	0.099	1.282	None	207 (134/73)	The serum concentration of Acenocoumarol can be increased when it is combined with Erythromycin.	#F8BABA	38.29567591868	1
Lovastatin	Verapamil	0.5	1.715	Major	76 (54/22)	The serum concentration of Lovastatin can be increased when it is combined with Verapamil.	#F6B6B6	14.0602481633801	1
Sulfasalazine	Azathioprine	0.711	Inf	Moderate	4 (4/0)		#B32020	0.740013061230531	1
Phenytoin	Acenocoumarol	0.391	-1.78	None	166 (74/92)	Phenytoin may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	30.710542041067	1
Duloxetine	Nortriptyline	0.401	2.969	Major	21 (17/4)	Duloxetine may increase the serotonergic activities of Nortriptyline.	#F1ABAB	3.88506857146029	0.000609963095090033
Phenobarbital	Acenocoumarol	0.388	-1.22	None	113 (61/52)	The metabolism of Acenocoumarol can be increased when combined with Phenobarbital.	#B2D0E5	20.9053689797625	1
Glimepiride	Pregabalin	0.206	-1.102	None	177 (100/77)	The risk or severity of heart failure can be increased when Pregabalin is combined with Glimepiride.	#B4D1E6	32.745577959451	1
Biperiden	Donepezil	0.357	3.792	Moderate	45 (38/7)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Donepezil.	#EEA4A4	8.32514693884347	1
Warfarin	Levofloxacin	0.134	-1.693	Major	227 (104/123)	Levofloxacin may increase the anticoagulant activities of Warfarin.	#AFCEE4	41.9957412248326	1
Enalapril	Tizanidine	0.176	-1.095	Major	180 (102/78)	The risk or severity of hypotension can be increased when Tizanidine is combined with Enalapril.	#B4D1E6	33.3005877553739	1
Ticlopidine	Phenytoin	0.425	4.191	Moderate	7 (6/1)	The serum concentration of Phenytoin can be increased when it is combined with Ticlopidine.	#EC9F9F	1.29502285715343	1
Spironolactone	Captopril	0.356	1.026	Major	158 (94/64)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Captopril.	#F9BCBC	29.230515918606	1
Phenytoin	Diazepam	0.238	1.158	Moderate	93 (58/35)	The serum concentration of Phenytoin can be increased when it is combined with Diazepam.	#F9BCBC	17.2053036736098	1
Nabumetone	Acenocoumarol	0.132	1.243	None	139 (89/50)	Nabumetone may increase the anticoagulant activities of Acenocoumarol.	#F8BABA	25.7154538777609	1
Oxycodone	Paroxetine	0.262	4.621	Moderate	99 (86/13)	The metabolism of Oxycodone can be decreased when combined with Paroxetine.	#EB9C9C	18.3153232654556	1
Propranolol	Glyburide	0.309	-1.3	Moderate	166 (87/79)	Propranolol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	30.710542041067	1
Atorvastatin	Colchicine	0.173	-5.097	Major	415 (91/324)	The risk or severity of adverse effects can be increased when Colchicine is combined with Atorvastatin.	#91B7D7	76.7763551026676	1
Tramadol	Rasagiline	0.185	-1.168	Major	227 (125/102)	Tramadol may increase the neuroexcitatory activities of Rasagiline.	#B4D1E6	41.9957412248326	1
Methylprednisolone	Clarithromycin	0.501	1.092	Major	141 (86/55)	The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.	#F9BCBC	26.0854604083762	1
Warfarin	Ranitidine	0.245	-1.843	Moderate	183 (80/103)	The serum concentration of Warfarin can be increased when it is combined with Ranitidine.	#AECDE3	33.8555975512968	1
Metoprolol	Ibuprofen	0.152	-1.013	Moderate	152 (89/63)	Ibuprofen may decrease the antihypertensive activities of Metoprolol.	#B4D1E6	28.1204963267602	1
Furosemide	Gentamicin	0.158	1.085	Major	120 (73/47)	The serum concentration of Gentamicin can be increased when it is combined with Furosemide.	#F9BCBC	22.2003918369159	1
Levofloxacin	Methotrimeprazine	0.241	-1.123	Moderate	116 (65/51)	Methotrimeprazine may increase the QTc-prolonging activities of Levofloxacin.	#B4D1E6	21.4603787756854	1
Fluvoxamine	Clomipramine	0.298	2.27	Major	17 (13/4)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clomipramine.	#F4B1B1	3.14505551022976	0.00121746751639973
Warfarin	Paroxetine	0.263	1.82	Moderate	119 (86/33)	Paroxetine may increase the anticoagulant activities of Warfarin.	#F6B6B6	22.0153885716083	1
Propranolol	Salmeterol	0.261	-1.546	Major	235 (113/122)		#AFCEE4	43.4757673472937	1
Amitriptyline	Donepezil	0.276	3.603	Moderate	117 (98/19)		#EFA6A6	21.645382040993	1
Sumatriptan	Ergotamine	0.312	2.794	Major	5 (4/1)	Ergotamine may increase the vasoconstricting activities of Sumatriptan.	#F2ACAC	0.925016326538163	0.0632389191068713
Erythromycin	Atorvastatin	0.106	1.016	Major	189 (112/77)	The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin.	#F9BCBC	34.9656171431426	1
Ergotamine	Rizatriptan	0.413	1.164	Major	8 (5/3)	Ergotamine may increase the vasoconstricting activities of Rizatriptan.	#F9BCBC	1.48002612246106	0.000307750233893537
Erythromycin	Citalopram	0.092	2.665	Major	130 (103/27)	The metabolism of Citalopram can be decreased when combined with Erythromycin.	#F2AEAE	24.0504244899922	1
Fluoxetine	Clarithromycin	0.129	2.612	Moderate	109 (86/23)	Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.	#F2AEAE	20.165355918532	1
Digoxin	Indapamide	0.264	1.325	Moderate	197 (129/68)	The risk or severity of adverse effects can be increased when Indapamide is combined with Digoxin.	#F8BABA	36.4456432656036	1
Lamotrigine	Carbamazepine	0.462	-1.321	Moderate	25 (13/12)	The risk or severity of adverse effects can be increased when Lamotrigine is combined with Carbamazepine.	#B2D0E5	4.62508163269082	2.97346997863382e-05
Duloxetine	Rasagiline	0.417	1.315	Major	49 (32/17)	Rasagiline may increase the orthostatic hypotensive activities of Duloxetine.	#F8BABA	9.065160000074	1
Betamethasone	Acetylsalicylic acid	0.098	-1.001	Moderate	158 (93/65)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Betamethasone.	#B4D1E6	29.230515918606	1
Indomethacin	Bisoprolol	0.141	-1.88	Moderate	303 (131/172)	Indomethacin may decrease the antihypertensive activities of Bisoprolol.	#AECDE3	56.0559893882127	1
Phenytoin	Levodopa	0.35	-1.339	Moderate	60 (31/29)	The therapeutic efficacy of Levodopa can be decreased when used in combination with Phenytoin.	#B2D0E5	11.100195918458	1
Warfarin	Ibuprofen	0.147	-1.345	Major	351 (181/170)	Ibuprofen may increase the anticoagulant activities of Warfarin.	#B2D0E5	64.9361461229791	1
Fenofibrate	Rosuvastatin	0.452	-1.475	Major	67 (33/34)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Rosuvastatin.	#B1CFE5	12.3952187756114	1
Fluconazole	Acenocoumarol	0.108	-1.318	None	267 (139/128)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluconazole.	#B2D0E5	49.3958718371379	1
Omeprazole	Triazolam	0.262	2.279	Moderate	81 (62/19)		#F4B1B1	14.9852644899182	1
Lidocaine	Propranolol	0.154	3.027	Moderate	80 (65/15)	The serum concentration of Lidocaine can be increased when it is combined with Propranolol.	#F1ABAB	14.8002612246106	1
Dextromethorphan	Memantine	0.143	1.694	Minor	137 (97/40)	The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Memantine.	#F7B7B7	25.3454473471457	1
Lovastatin	Clarithromycin	0.077	1.459	Major	105 (71/34)	The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.	#F7B9B9	19.4253428573014	1
Sertraline	Propafenone	0.317	2.663	Moderate	77 (61/16)	Sertraline may increase the QTc-prolonging activities of Propafenone.	#F2AEAE	14.2452514286877	1
Atenolol	Insulin aspart	0.289	-1.016	Moderate	159 (93/66)		#B4D1E6	29.4155191839136	1
Bisoprolol	Insulin glulisine	0.241	-1.123	Moderate	91 (51/40)		#B4D1E6	16.8352971429946	1
Azathioprine	Acenocoumarol	0.337	-1.169	None	89 (49/40)	Azathioprine may decrease the anticoagulant activities of Acenocoumarol.	#B4D1E6	16.4652906123793	1
Haloperidol	Propranolol	0.214	1.459	Moderate	105 (71/34)	The metabolism of Propranolol can be decreased when combined with Haloperidol.	#F7B9B9	19.4253428573014	1
Carbamazepine	Levetiracetam	0.365	-2.045	Moderate	51 (21/30)	The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levetiracetam.	#ACCCE3	9.43516653068927	3.67578153888348e-05
Diazepam	Clarithromycin	0.251	2.057	Moderate	213 (159/54)	The metabolism of Diazepam can be decreased when combined with Clarithromycin.	#F5B2B2	39.4056955105258	1
Chlorthalidone	Digoxin	0.307	1.155	Moderate	138 (86/52)	The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Digoxin.	#F9BCBC	25.5304506124533	1
Carbamazepine	Sertraline	0.285	1.42	Moderate	94 (63/31)	The metabolism of Carbamazepine can be decreased when combined with Sertraline.	#F7B9B9	17.3903069389175	1
Moxifloxacin	Amiodarone	0.172	-1.652	Major	168 (78/90)	Moxifloxacin may increase the QTc-prolonging activities of Amiodarone.	#AFCEE4	31.0805485716823	1
Ranolazine	Simvastatin	0.373	-3.082	Major	227 (72/155)	The serum concentration of Simvastatin can be increased when it is combined with Ranolazine.	#A3C5DF	41.9957412248326	1
Lidocaine	Carvedilol	0.109	1.455	Moderate	111 (75/36)	The serum concentration of Lidocaine can be increased when it is combined with Carvedilol.	#F7B9B9	20.5353624491472	1
Glimepiride	Gemfibrozil	0.285	-1.578	Moderate	82 (39/43)	The metabolism of Glimepiride can be decreased when combined with Gemfibrozil.	#AFCEE4	15.1702677552259	1
Sucralfate	Levothyroxine	0.154	2.5	Minor	87 (68/19)	The serum concentration of Levothyroxine can be decreased when it is combined with Sucralfate.	#F3AFAF	16.095284081764	1
Diclofenac	Warfarin	0.156	-1.047	Major	187 (108/79)	Diclofenac may increase the anticoagulant activities of Warfarin.	#B4D1E6	34.5956106125273	1
Hydroxyzine	Galantamine	0.132	1.211	Moderate	82 (52/30)		#F8BABA	15.1702677552259	1
Pravastatin	Colchicine	0.18	-3.228	Major	166 (51/115)	Colchicine may increase the myopathic rhabdomyolysis activities of Pravastatin.	#A2C4DE	30.710542041067	1
Propranolol	Repaglinide	0.307	-1.294	Moderate	139 (73/66)		#B2D0E5	25.7154538777609	1
Atorvastatin	Itraconazole	0.12	1.15	Major	127 (79/48)	The risk or severity of adverse effects can be increased when Itraconazole is combined with Atorvastatin.	#F9BCBC	23.4954146940693	1
Fluconazole	Haloperidol	0.526	-1.166	Major	98 (54/44)	The metabolism of Haloperidol can be decreased when combined with Fluconazole.	#B4D1E6	18.130320000148	1
Ciprofloxacin	Methotrexate	0.154	-1.149	Moderate	146 (81/65)	The serum concentration of Methotrexate can be increased when it is combined with Ciprofloxacin.	#B4D1E6	27.0104767349144	1
Celecoxib	Acenocoumarol	0.147	-1.111	None	341 (192/149)	Celecoxib may increase the anticoagulant activities of Acenocoumarol.	#B4D1E6	63.0861134699027	1
Spironolactone	Lisinopril	0.252	-1.117	Major	251 (141/110)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Lisinopril.	#B4D1E6	46.4358195922158	1
Omeprazole	Ketoconazole	0.163	-2.086	Moderate	172 (70/102)	The serum concentration of Ketoconazole can be decreased when it is combined with Omeprazole.	#ABCBE2	31.8205616329128	1
Paroxetine	Propafenone	0.357	2.911	Moderate	62 (50/12)	The serum concentration of Propafenone can be increased when it is combined with Paroxetine.	#F2ACAC	11.4702024490732	1
Atenolol	Terbutaline	0.104	1.006	Moderate	122 (72/50)	Atenolol may decrease the bronchodilatory activities of Terbutaline.	#F9BCBC	22.5703983675312	1
Phenytoin	Fluoxetine	0.362	1.397	Moderate	36 (24/12)	The serum concentration of Phenytoin can be increased when it is combined with Fluoxetine.	#F7B9B9	6.66011755107478	1
Ziprasidone	Chlorpromazine	0.157	Inf	Major	2 (2/0)	Chlorpromazine may increase the QTc-prolonging activities of Ziprasidone.	#B32020	0.370006530615265	1
Phenytoin	Sertraline	0.358	-1.074	Moderate	77 (44/33)	The serum concentration of Phenytoin can be increased when it is combined with Sertraline.	#B4D1E6	14.2452514286877	1
Indomethacin	Atenolol	0.154	-1.554	Moderate	146 (70/76)	Indomethacin may decrease the antihypertensive activities of Atenolol.	#AFCEE4	27.0104767349144	1
Warfarin	Acetylsalicylic acid	0.214	-2.518	Major	469 (170/299)	Acetylsalicylic acid may increase the anticoagulant activities of Warfarin.	#A8C8E1	86.7665314292797	1
Phenytoin	Chlordiazepoxide	0.043	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Chlordiazepoxide.	#B32020	0.185003265307633	1
Norfloxacin	Iron	0.254	2.223	None	184 (140/44)	The serum concentration of Norfloxacin can be decreased when it is combined with Iron.	#F5B2B2	34.0406008166044	1
Haloperidol	Carbamazepine	0.253	1.048	Moderate	55 (33/22)	The metabolism of Haloperidol can be increased when combined with Carbamazepine.	#F9BCBC	10.1751795919198	1
Atenolol	Insulin detemir	0.295	-1.224	Moderate	141 (76/65)		#B2D0E5	26.0854604083762	1
Atenolol	Diltiazem	0.272	-1.152	Major	222 (123/99)	Diltiazem may increase the hypotensive activities of Atenolol.	#B4D1E6	41.0707248982945	1
Amitriptyline	Rivastigmine	0.229	1.477	Moderate	109 (74/35)		#F7B9B9	20.165355918532	1
Enalapril	Rifampicin	0.165	-1.167	None	118 (65/53)	The metabolism of Enalapril can be increased when combined with Rifampicin.	#B4D1E6	21.8303853063007	1
Metronidazole	Acenocoumarol	0.081	-1.188	None	194 (106/88)	The serum concentration of Acenocoumarol can be increased when it is combined with Metronidazole.	#B2D0E5	35.8906334696807	1
Alprazolam	Itraconazole	0.138	3.654	Major	81 (68/13)	The serum concentration of Alprazolam can be increased when it is combined with Itraconazole.	#EEA4A4	14.9852644899182	1
Terbutaline	Carvedilol	0.087	-1.508	Major	115 (56/59)	Carvedilol may decrease the vasoconstricting activities of Terbutaline.	#B1CFE5	21.2753755103778	1
Ciprofloxacin	Warfarin	0.128	-2.615	Major	277 (98/179)		#A6C7E0	51.2459044902143	1
Phenytoin	Megestrol acetate	0.299	1.319	Moderate	26 (17/9)		#F8BABA	4.81008489799845	1
Alprazolam	Ketoconazole	0.127	5.355	Major	26 (23/3)	The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.	#E89696	4.81008489799845	1
Erythromycin	Fluoxetine	0.14	3.58	Moderate	49 (41/8)	The metabolism of Fluoxetine can be decreased when combined with Erythromycin.	#EFA6A6	9.065160000074	1
Donepezil	Clomipramine	0.35	2.949	Moderate	47 (38/9)	The metabolism of Donepezil can be decreased when combined with Clomipramine.	#F1ABAB	8.69515346945874	1
Carbamazepine	Risperidone	0.297	1.012	Moderate	71 (42/29)	The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.	#F9BCBC	13.1352318368419	1
Disopyramide	Bisoprolol	0.314	Inf	Major	8 (8/0)	Disopyramide may increase the bradycardic activities of Bisoprolol.	#B32020	1.48002612246106	0.683199281558398
Clozapine	Midazolam	0.048	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Midazolam is combined with Clozapine.	#B32020	0.185003265307633	1
Methotrexate	Diclofenac	0.214	1.397	Major	117 (78/39)	The serum concentration of Methotrexate can be increased when it is combined with Diclofenac.	#F7B9B9	21.645382040993	1
Biperiden	Rivastigmine	0.332	-1.101	Moderate	46 (26/20)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Rivastigmine.	#B4D1E6	8.5101502041511	1
Zolmitriptan	Fluoxetine	0.263	2.794	Major	20 (16/4)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Fluoxetine.	#F2ACAC	3.70006530615265	1
Erythromycin	Sertraline	0.145	4.308	Moderate	86 (74/12)	The risk or severity of adverse effects can be increased when Erythromycin is combined with Sertraline.	#EC9F9F	15.9102808164564	1
Phenytoin	Prednisone	0.172	-1.968	Moderate	114 (48/66)	The serum concentration of Prednisone can be decreased when it is combined with Phenytoin.	#ACCCE3	21.0903722450701	1
Digoxin	Clarithromycin	0.135	-1.099	Major	198 (112/86)	The metabolism of Digoxin can be decreased when combined with Clarithromycin.	#B4D1E6	36.6306465309113	1
Cyclosporine	Ciprofloxacin	0.177	1.098	Moderate	36 (22/14)		#F9BCBC	6.66011755107478	1
Pyridostigmine	Fludrocortisone	0.331	-2.863	Moderate	6 (2/4)	The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Pyridostigmine.	#A5C6DF	1.1100195918458	0.00278256357119018
Bisoprolol	Glipizide	0.313	-1.789	Moderate	117 (52/65)	Bisoprolol may increase the hypoglycemic activities of Glipizide.	#AECDE3	21.645382040993	1
Ziprasidone	Galantamine	0.432	1.222	Moderate	11 (7/4)	Galantamine may increase the QTc-prolonging activities of Ziprasidone.	#F8BABA	2.03503591838396	0.0690342894031249
Clomipramine	Rasagiline	0.344	2.096	Major	20 (15/5)	Rasagiline may increase the serotonergic activities of Clomipramine.	#F5B2B2	3.70006530615265	1
Amiodarone	Clarithromycin	0.165	1.09	Major	128 (78/50)	Clarithromycin may increase the QTc-prolonging activities of Amiodarone.	#F9BCBC	23.680417959377	1
Topiramate	Carbamazepine	0.473	-1.145	Moderate	18 (10/8)	The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine.	#B4D1E6	3.33005877553739	0.0210836796117841
Phenytoin	Gabapentin	0.404	-1.247	Moderate	58 (31/27)	The risk or severity of adverse effects can be increased when Gabapentin is combined with Phenytoin.	#B2D0E5	10.7301893878427	1
Lidocaine	Atenolol	0.137	2.149	Moderate	106 (80/26)	The serum concentration of Lidocaine can be increased when it is combined with Atenolol.	#F5B2B2	19.6103461226091	1
Citalopram	Metoprolol	0.316	3.405	Moderate	47 (39/8)	The serum concentration of Metoprolol can be increased when it is combined with Citalopram.	#F0A7A7	8.69515346945874	1
Digoxin	Methotrexate	0.219	1.663	Moderate	71 (50/21)	Digoxin may decrease the cardiotoxic activities of Methotrexate.	#F7B7B7	13.1352318368419	1
Eletriptan	Ergotamine	0.2	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Eletriptan.	#B32020	0.185003265307633	1
Clarithromycin	Quetiapine	0.149	1.111	Major	158 (97/61)	The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.	#F9BCBC	29.230515918606	1
Imipramine	Duloxetine	0.221	9.081	Major	14 (13/1)	Duloxetine may increase the serotonergic activities of Imipramine.	#D97575	2.59004571430686	1
Pravastatin	Gemfibrozil	0.2	-1.244	Major	114 (61/53)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Pravastatin.	#B2D0E5	21.0903722450701	1
Cyclosporine	Methylphenidate	0.115	Inf	Minor	2 (2/0)		#B32020	0.370006530615265	1
Salbutamol	Rasagiline	0.176	-2.764	Moderate	170 (58/112)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Salbutamol.	#A5C6DF	31.4505551022976	1
Theophylline	Clarithromycin	0.332	-2.028	Moderate	58 (24/34)	The metabolism of Theophylline can be decreased when combined with Clarithromycin.	#ACCCE3	10.7301893878427	1
Levothyroxine	Cholestyramine	0.204	2.472	Moderate	59 (46/13)	The serum concentration of Levothyroxine can be decreased when it is combined with Cholestyramine.	#F3AFAF	10.9151926531503	1
Simvastatin	Fusidic acid	0.065	-1.132	None	120 (67/53)	The serum concentration of Simvastatin can be increased when it is combined with Fusidic Acid.	#B4D1E6	22.2003918369159	1
Bisoprolol	Verapamil	0.202	1.068	Major	177 (107/70)	The metabolism of Bisoprolol can be decreased when combined with Verapamil.	#F9BCBC	32.745577959451	1
Rivastigmine	Clomipramine	0.294	1.444	Moderate	46 (31/15)		#F7B9B9	8.5101502041511	1
Spironolactone	Cholestyramine	0.276	-1.629	Moderate	62 (29/33)	The risk or severity of adverse effects can be increased when Cholestyramine is combined with Spironolactone.	#AFCEE4	11.4702024490732	1
Fludrocortisone	Acetylsalicylic acid	0.281	-2.232	Moderate	87 (34/53)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Fludrocortisone.	#ABCBE2	16.095284081764	1
Gliclazide	Glucosamine	0.234	-1.142	None	151 (84/67)		#B4D1E6	27.9354930614525	1
Fluoxetine	Oxycodone	0.309	4.308	Moderate	43 (37/6)	The metabolism of Oxycodone can be decreased when combined with Fluoxetine.	#EC9F9F	7.95514040822821	1
Oxycodone	Escitalopram	0.253	2.295	Moderate	60 (46/14)	Oxycodone may increase the serotonergic activities of Escitalopram.	#F4B1B1	11.100195918458	1
Cyclosporine	Atorvastatin	0.396	-1.789	Major	45 (20/25)	The serum concentration of Atorvastatin can be increased when it is combined with Cyclosporine.	#AECDE3	8.32514693884347	1
Cyclosporine	Amiodarone	0.26	1.164	Moderate	16 (10/6)	The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.	#F9BCBC	2.96005224492212	1
Amitriptyline	Rasagiline	0.333	-1.728	Major	64 (29/35)	Rasagiline may increase the serotonergic activities of Amitriptyline.	#AECDE3	11.8402089796885	1
Cyclosporine	Ursodeoxycholic acid	0.505	-1.718	Minor	11 (5/6)		#AECDE3	2.03503591838396	0.00373772641020277
Carvedilol	Insulin glulisine	0.251	-1.507	Moderate	39 (19/20)		#B1CFE5	7.21512734699767	1
Sotalol	Ibuprofen	0.152	1.37	Moderate	77 (51/26)	Ibuprofen may decrease the antihypertensive activities of Sotalol.	#F7B9B9	14.2452514286877	1
Warfarin	Fenofibrate	0.342	-1.266	Major	49 (26/23)	Fenofibrate may increase the anticoagulant activities of Warfarin.	#B2D0E5	9.065160000074	1
Amiodarone	Flecainide	0.178	1.397	Major	60 (40/20)	The serum concentration of Flecainide can be increased when it is combined with Amiodarone.	#F7B9B9	11.100195918458	1
Glyburide	Glucosamine	0.259	-1.213	None	109 (59/50)		#B2D0E5	20.165355918532	1
Phenytoin	Mirtazapine	0.287	1.343	Moderate	38 (25/13)	Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.	#F8BABA	7.03012408169004	1
Metoprolol	Gliclazide	0.385	1.027	None	42 (25/17)	Metoprolol may increase the hypoglycemic activities of Gliclazide.	#F9BCBC	7.77013714292057	1
Spironolactone	Perindopril	0.403	-1.684	Major	74 (34/40)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Perindopril.	#AFCEE4	13.6902416327648	1
Warfarin	Phenobarbital	0.385	-1.171	Major	20 (11/9)	The metabolism of Warfarin can be increased when combined with Phenobarbital.	#B4D1E6	3.70006530615265	1
Tobramycin	Ceftriaxone	0.5	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Alendronic acid	Ketoprofen	0.095	3.912	Moderate	33 (28/5)	The risk or severity of adverse effects can be increased when Ketoprofen is combined with Alendronic acid.	#EDA3A3	6.10510775515188	1
Fluvoxamine	Acenocoumarol	0.285	-1.117	None	73 (41/32)	The metabolism of Acenocoumarol can be decreased when combined with Fluvoxamine.	#B4D1E6	13.5052383674572	1
Fluoxetine	Nortriptyline	0.495	1.676	Major	17 (12/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Nortriptyline.	#F7B7B7	3.14505551022976	1
Cyproheptadine	Donepezil	0.283	4.191	Moderate	7 (6/1)		#EC9F9F	1.29502285715343	1
Paroxetine	Rizatriptan	0.209	3.667	Major	25 (21/4)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Rizatriptan.	#EEA4A4	4.62508163269082	1
Moclobemide	Clomipramine	0.071	Inf	None	1 (1/0)	Moclobemide may increase the serotonergic activities of Clomipramine.	#B32020	0.185003265307633	1
Haloperidol	Lithium cation	0.295	-1.074	Major	21 (12/9)	Lithium may increase the neurotoxic activities of Haloperidol.	#B4D1E6	3.88506857146029	1
Raloxifene	Estriol	0.202	Inf	None	9 (9/0)		#B32020	1.66502938776869	1
Propranolol	Terbutaline	0.097	1.077	Major	61 (37/24)		#F9BCBC	11.2851991837656	1
Theophylline	Verapamil	0.422	-1.534	Moderate	29 (14/15)	The metabolism of Theophylline can be decreased when combined with Verapamil.	#AFCEE4	5.36509469392135	1
Trospium	Donepezil	0.323	2.654	Moderate	24 (19/5)	The therapeutic efficacy of Trospium can be decreased when used in combination with Donepezil.	#F2AEAE	4.44007836738318	1
Acetaminophen	Isoniazid	0.201	-1.491	Moderate	98 (48/50)	The risk or severity of adverse effects can be increased when Isoniazid is combined with Acetaminophen.	#B1CFE5	18.130320000148	1
Lansoprazole	Itraconazole	0.112	1.63	Moderate	50 (35/15)	The serum concentration of Itraconazole can be decreased when it is combined with Lansoprazole.	#F7B7B7	9.25016326538163	1
Pyridostigmine	Methylprednisolone	0.333	1.746	Moderate	14 (10/4)	The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Pyridostigmine.	#F6B6B6	2.59004571430686	1
Repaglinide	Gemfibrozil	0.274	-1.897	Major	93 (40/53)	The serum concentration of Repaglinide can be increased when it is combined with Gemfibrozil.	#ACCCE3	17.2053036736098	1
Ziprasidone	Donepezil	0.369	-1.273	Moderate	17 (9/8)	The metabolism of Donepezil can be decreased when combined with Ziprasidone.	#B2D0E5	3.14505551022976	0.0535118888183623
Fluconazole	Diazepam	0.371	-1.023	Moderate	132 (77/55)	The metabolism of Diazepam can be decreased when combined with Fluconazole.	#B4D1E6	24.4204310206075	1
Spironolactone	Eplerenone	0.177	-2.863	Major	87 (29/58)	Eplerenone may increase the hyperkalemic activities of Spironolactone.	#A5C6DF	16.095284081764	1
Fluvoxamine	Olanzapine	0.555	2.096	Moderate	12 (9/3)	The metabolism of Olanzapine can be decreased when combined with Fluvoxamine.	#F5B2B2	2.22003918369159	1
Fludrocortisone	Acenocoumarol	0.274	-1.281	None	36 (19/17)		#B2D0E5	6.66011755107478	1
Prednisone	Phenobarbital	0.232	-1.342	Moderate	62 (32/30)	The serum concentration of Prednisone can be decreased when it is combined with Phenobarbital.	#B2D0E5	11.4702024490732	1
Enalapril	Lithium cation	0.214	1.669	Moderate	61 (43/18)	The serum concentration of Lithium can be increased when it is combined with Enalapril.	#F7B7B7	11.2851991837656	1
Trimipramine	Pseudoephedrine	0.029	Inf	None	1 (1/0)	Trimipramine may decrease the antihypertensive activities of Pseudoephedrine.	#B32020	0.185003265307633	1
Fluoxetine	Warfarin	0.272	1.647	Moderate	47 (33/14)	The metabolism of Warfarin can be decreased when combined with Fluoxetine.	#F7B7B7	8.69515346945874	1
Clarithromycin	Solifenacin	0.085	-1.03	Major	98 (57/41)	The metabolism of Solifenacin can be decreased when combined with Clarithromycin.	#B4D1E6	18.130320000148	1
Propranolol	Maprotiline	0.355	3.26	Minor	17 (14/3)		#F0A9A9	3.14505551022976	1
Phenytoin	Topiramate	0.411	-2.863	Moderate	18 (6/12)	The serum concentration of Phenytoin can be increased when it is combined with Topiramate.	#A5C6DF	3.33005877553739	4.10491188592309e-05
Warfarin	Norfloxacin	0.118	1.327	Major	87 (57/30)	Norfloxacin may increase the anticoagulant activities of Warfarin.	#F8BABA	16.095284081764	1
Trazodone	Ginkgo biloba	0.26	1.237	Moderate	97 (62/35)		#F8BABA	17.9453167348404	1
Trospium	Tolterodine	0.188	1.31	Moderate	23 (15/8)	The risk or severity of adverse effects can be increased when Trospium is combined with Tolterodine.	#F8BABA	4.25507510207555	1
Citalopram	Rizatriptan	0.175	8.732	Major	27 (25/2)	The risk or severity of adverse effects can be increased when Citalopram is combined with Rizatriptan.	#DA7878	4.99508816330608	1
Verapamil	Carvedilol	0.225	1.155	Major	69 (43/26)	The metabolism of Carvedilol can be decreased when combined with Verapamil.	#F9BCBC	12.7652253062267	1
Repaglinide	Glipizide	0.197	-1.113	None	32 (18/14)	Repaglinide may increase the hypoglycemic activities of Glipizide.	#B4D1E6	5.92010448984425	1
Dexamethasone	Acenocoumarol	0.191	-2.121	None	201 (81/120)		#ABCBE2	37.1856563268342	1
Citalopram	Selegiline	0.307	1.552	Major	29 (20/9)	The risk or severity of adverse effects can be increased when Citalopram is combined with Selegiline.	#F7B7B7	5.36509469392135	1
Acenocoumarol	Etoricoxib	0.101	-1.224	None	217 (117/100)	Etoricoxib may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	40.1457085717563	1
Phenytoin	Oxcarbazepine	0.571	-2.577	Moderate	14 (5/9)	The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Phenytoin resulting in a loss in efficacy.	#A8C8E1	2.59004571430686	0.00615117828605596
Fluvoxamine	Tramadol	0.236	2.445	Major	63 (49/14)	Fluvoxamine may increase the neuroexcitatory activities of Tramadol.	#F3AFAF	11.6552057143809	1
Donepezil	Oxybutynin	0.35	1.281	Moderate	34 (22/12)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.	#F8BABA	6.29011102045951	1
Azithromycin	Warfarin	0.117	-1.525	Moderate	126 (61/65)	The metabolism of Warfarin can be decreased when combined with Azithromycin.	#B1CFE5	23.3104114287617	1
Repaglinide	Clarithromycin	0.123	-1.237	Moderate	110 (59/51)	The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.	#B2D0E5	20.3503591838396	1
Trospium	Solifenacin	0.2	-1.622	Moderate	32 (15/17)	The risk or severity of adverse effects can be increased when Trospium is combined with Solifenacin.	#AFCEE4	5.92010448984425	1
Pantoprazole	Itraconazole	0.124	1.164	Moderate	72 (45/27)	The serum concentration of Itraconazole can be decreased when it is combined with Pantoprazole.	#F9BCBC	13.3202351021496	1
Ibandronate	Iron	0.178	6.287	Moderate	50 (45/5)		#E38D8D	9.25016326538163	1
Galantamine	Periciazine	0.068	1.397	None	3 (2/1)		#F7B9B9	0.555009795922898	1
Cyclosporine	Nifedipine	0.386	-1.67	Moderate	13 (6/7)	The metabolism of Nifedipine can be decreased when combined with Cyclosporine.	#AFCEE4	2.40504244899922	0.624716368995684
Moxifloxacin	Ziprasidone	0.187	Inf	Major	7 (7/0)	Moxifloxacin may increase the QTc-prolonging activities of Ziprasidone.	#B32020	1.29502285715343	1
Warfarin	Pentoxifylline	0.307	-2.953	Moderate	98 (32/66)	Pentoxifylline may increase the anticoagulant activities of Warfarin.	#A3C5DF	18.130320000148	1
Fluoxetine	Rasagiline	0.428	-1.041	Major	38 (22/16)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rasagiline.	#B4D1E6	7.03012408169004	1
Piroxicam	Alendronic acid	0.159	18.86	None	28 (27/1)	The risk or severity of adverse effects can be increased when Piroxicam is combined with Alendronic acid.	#B32020	5.18009142861372	1
Carbamazepine	Verapamil	0.25	1.696	Major	24 (17/7)	The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.	#F7B7B7	4.44007836738318	1
Pregabalin	Pioglitazone	0.257	1.068	Moderate	43 (26/17)	The risk or severity of heart failure can be increased when Pregabalin is combined with Pioglitazone.	#F9BCBC	7.95514040822821	1
Hydrochlorothiazide	Lithium cation	0.205	2.305	Major	43 (33/10)	Hydrochlorothiazide may decrease the excretion rate of Lithium which could result in a higher serum level.	#F4B1B1	7.95514040822821	1
Verapamil	Midazolam	0.444	2.794	Moderate	15 (12/3)	The metabolism of Midazolam can be decreased when combined with Verapamil.	#F2ACAC	2.77504897961449	1
Phenytoin	Clarithromycin	0.139	1.106	Moderate	31 (19/12)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.	#F9BCBC	5.73510122453661	1
Acenocoumarol	Cholestyramine	0.237	-1.711	None	90 (41/49)	Cholestyramine can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#AECDE3	16.6502938776869	1
Almotriptan	Escitalopram	0.278	2.561	Major	14 (11/3)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.	#F3AFAF	2.59004571430686	1
Primidone	Acenocoumarol	0.269	-2.174	None	68 (27/41)	The metabolism of Acenocoumarol can be increased when combined with Primidone.	#ABCBE2	12.580222040919	1
Omeprazole	Quazepam	0.268	2.515	Moderate	23 (18/5)	The metabolism of Quazepam can be decreased when combined with Omeprazole.	#F3AFAF	4.25507510207555	1
Indomethacin	Acenocoumarol	0.154	-2.223	None	194 (76/118)	Indomethacin may increase the anticoagulant activities of Acenocoumarol.	#ABCBE2	35.8906334696807	1
Dihydroergotamine	Nadolol	0.151	Inf	Moderate	3 (3/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#B32020	0.555009795922898	1
Diltiazem	Propranolol	0.278	1.011	Major	93 (55/38)	The metabolism of Propranolol can be decreased when combined with Diltiazem.	#F9BCBC	17.2053036736098	1
Zolmitriptan	Ergotamine	0.451	-1.432	Major	6 (3/3)	Ergotamine may increase the vasoconstricting activities of Zolmitriptan.	#B1CFE5	1.1100195918458	0.0970744906683301
Itraconazole	Solifenacin	0.15	1.461	Major	34 (23/11)	The metabolism of Solifenacin can be decreased when combined with Itraconazole.	#F7B9B9	6.29011102045951	1
Trospium	Amitriptyline	0.187	3.493	Moderate	18 (15/3)		#EFA6A6	3.33005877553739	1
Imipramine	Fluoxetine	0.416	1.537	Major	16 (11/5)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Imipramine.	#F7B7B7	2.96005224492212	1
Tacrolimus	Nifedipine	0.336	-1.622	Moderate	32 (15/17)	The serum concentration of Tacrolimus can be increased when it is combined with Nifedipine.	#AFCEE4	5.92010448984425	1
Erythromycin	Digoxin	0.13	1.572	Moderate	65 (45/20)	The metabolism of Digoxin can be decreased when combined with Erythromycin.	#F7B7B7	12.0252122449961	1
Fluvoxamine	Mirtazapine	0.357	-1.352	Major	35 (18/17)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Mirtazapine.	#B2D0E5	6.47511428576714	1
Spironolactone	Eprosartan	0.334	-1.065	Major	68 (39/29)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.	#B4D1E6	12.580222040919	1
Gentamicin	Cefonicid	0.508	-1.432	Moderate	10 (5/5)		#B1CFE5	1.85003265307633	0.716775522862614
Selegiline	Escitalopram	0.396	-1.301	Major	21 (11/10)	The risk or severity of adverse effects can be increased when Escitalopram is combined with Selegiline.	#B2D0E5	3.88506857146029	1
Duloxetine	Flecainide	0.31	3.493	Moderate	30 (25/5)	The metabolism of Flecainide can be decreased when combined with Duloxetine.	#EFA6A6	5.55009795922898	1
Amitriptyline	Galantamine	0.272	1.934	Moderate	49 (36/13)		#F5B4B4	9.065160000074	1
Galantamine	Biperiden	0.145	1.513	Moderate	19 (13/6)	The therapeutic efficacy of Biperiden can be decreased when used in combination with Galantamine.	#F7B9B9	3.51506204084502	1
Lovastatin	Warfarin	0.205	1.746	Moderate	35 (25/10)	The metabolism of Warfarin can be decreased when combined with Lovastatin.	#F6B6B6	6.47511428576714	1
Hydroxyzine	Rivastigmine	0.16	1.084	Moderate	74 (45/29)		#F9BCBC	13.6902416327648	1
Fluoxetine	Carbamazepine	0.297	1.334	Moderate	32 (21/11)	The metabolism of Carbamazepine can be decreased when combined with Fluoxetine.	#F8BABA	5.92010448984425	1
Diltiazem	Carbamazepine	0.2	-1.166	Major	49 (27/22)	The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem.	#B4D1E6	9.065160000074	1
Venlafaxine	Propafenone	0.372	2.008	Moderate	31 (23/8)	The serum concentration of Venlafaxine can be increased when it is combined with Propafenone.	#F5B4B4	5.73510122453661	1
Triamcinolone	Acenocoumarol	0.119	-1.629	None	124 (58/66)		#AFCEE4	22.9404048981465	1
Propranolol	Ergotamine	0.268	1.921	Moderate	15 (11/4)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B4B4	2.77504897961449	1
Galantamine	Oxybutynin	0.313	-1.101	Moderate	23 (13/10)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.	#B4D1E6	4.25507510207555	1
Phenytoin	Dexamethasone	0.493	-1.952	Moderate	26 (11/15)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenytoin.	#ACCCE3	4.81008489799845	1
Fluconazole	Clonazepam	0.188	1.002	None	56 (33/23)	The metabolism of Clonazepam can be decreased when combined with Fluconazole.	#F9BCBC	10.3601828572274	1
Erythromycin	Verapamil	0.119	2.934	Major	26 (21/5)	The metabolism of Verapamil can be decreased when combined with Erythromycin.	#F2ACAC	4.81008489799845	1
Indomethacin	Carvedilol	0.16	-2.863	Moderate	108 (36/72)	Indomethacin may decrease the antihypertensive activities of Carvedilol.	#A5C6DF	19.9803526532243	1
Citalopram	Zolmitriptan	0.2	5.355	Major	26 (23/3)	The risk or severity of adverse effects can be increased when Citalopram is combined with Zolmitriptan.	#E89696	4.81008489799845	1
Ezetimibe	Cholestyramine	0.367	1.098	Moderate	18 (11/7)	Cholestyramine can cause a decrease in the absorption of Ezetimibe resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	3.33005877553739	1
Spironolactone	Quinapril	0.323	-1.227	Major	52 (28/24)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Quinapril.	#B2D0E5	9.6201697959969	1
Trazodone	Itraconazole	0.131	3.094	Moderate	38 (31/7)	The metabolism of Trazodone can be decreased when combined with Itraconazole.	#F1ABAB	7.03012408169004	1
Clozapine	Rivastigmine	0.297	1.397	Moderate	3 (2/1)		#F7B9B9	0.555009795922898	1
Imipramine	Salbutamol	0.198	1.098	Moderate	36 (22/14)	The risk or severity of adverse effects can be increased when Imipramine is combined with Salbutamol.	#F9BCBC	6.66011755107478	1
Ibuprofen	Oxprenolol	0.094	2.096	None	20 (15/5)	Ibuprofen may decrease the antihypertensive activities of Oxprenolol.	#F5B2B2	3.70006530615265	1
Almotriptan	Sertraline	0.31	5.239	Major	17 (15/2)	The risk or severity of adverse effects can be increased when Almotriptan is combined with Sertraline.	#E89696	3.14505551022976	1
Cyclosporine	Simvastatin	0.386	-1.489	Major	51 (25/26)	The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.	#B1CFE5	9.43516653068927	1
Citalopram	Josamycin	0.13	2.561	None	28 (22/6)		#F3AFAF	5.18009142861372	1
Theophylline	Ciprofloxacin	0.182	-5.249	Major	154 (33/121)		#90B6D6	28.4905028573754	1
Erythromycin	Diazepam	0.181	2.178	Moderate	70 (53/17)	The metabolism of Diazepam can be decreased when combined with Erythromycin.	#F5B2B2	12.9502285715343	1
Theophylline	Pentoxifylline	0.267	-3.913	Moderate	56 (15/41)	The serum concentration of Theophylline can be increased when it is combined with Pentoxifylline.	#9CBFDB	10.3601828572274	1
Bupropion	Rasagiline	0.316	1.746	Major	7 (5/2)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Bupropion.	#F6B6B6	1.29502285715343	1
Glipizide	Carvedilol	0.355	-1.516	Moderate	35 (17/18)	Carvedilol may increase the hypoglycemic activities of Glipizide.	#B1CFE5	6.47511428576714	1
Ibuprofen	Nadolol	0.187	1.441	Moderate	49 (33/16)	Ibuprofen may decrease the antihypertensive activities of Nadolol.	#F7B9B9	9.065160000074	1
Simvastatin	Rifampicin	0.116	-1.396	Major	79 (40/39)	The metabolism of Simvastatin can be increased when combined with Rifampicin.	#B1CFE5	14.615257959303	1
Sotalol	Levofloxacin	0.085	-1.933	Major	47 (20/27)	Levofloxacin may increase the QTc-prolonging activities of Sotalol.	#ACCCE3	8.69515346945874	1
Warfarin	Primidone	0.129	1.63	Major	10 (7/3)	The metabolism of Warfarin can be increased when combined with Primidone.	#F7B7B7	1.85003265307633	1
Esomeprazole	Itraconazole	0.292	1.461	Moderate	34 (23/11)	The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.	#F7B9B9	6.29011102045951	1
Imipramine	Rasagiline	0.338	3.493	Major	6 (5/1)	Rasagiline may increase the serotonergic activities of Imipramine.	#EFA6A6	1.1100195918458	1
Fluoxetine	Lithium cation	0.218	1.572	Major	13 (9/4)	Lithium may increase the serotonergic activities of Fluoxetine.	#F7B7B7	2.40504244899922	1
Metoprolol	Formoterol	0.199	-1.193	Moderate	33 (18/15)	The metabolism of Formoterol can be decreased when combined with Metoprolol.	#B2D0E5	6.10510775515188	1
Gentamicin	Ceftriaxone	0.333	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Valproic acid	Nimodipine	0.449	1.135	Minor	21 (13/8)		#F9BCBC	3.88506857146029	1
Dihydroergotamine	Bisoprolol	0.188	2.894	Moderate	36 (29/7)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F2ACAC	6.66011755107478	1
Venlafaxine	Almotriptan	0.34	Inf	Major	9 (9/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Almotriptan.	#B32020	1.66502938776869	1
Pantoprazole	Ketoconazole	0.168	1.816	Moderate	18 (13/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole.	#F6B6B6	3.33005877553739	1
Itraconazole	Acenocoumarol	0.079	-1.344	None	95 (49/46)	The serum concentration of Acenocoumarol can be increased when it is combined with Itraconazole.	#B2D0E5	17.5753102042251	1
Procyclidine	Haloperidol	0.333	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Metoprolol	Paroxetine	0.354	1.996	Moderate	27 (20/7)	The serum concentration of Metoprolol can be increased when it is combined with Paroxetine.	#F5B4B4	4.99508816330608	1
Cimetidine	Flurazepam	0.542	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Ampicillin	Tetracycline	0.5	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Bisoprolol	Ergotamine	0.163	2.183	Moderate	33 (25/8)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F5B2B2	6.10510775515188	1
Phenytoin	Amiodarone	0.438	-1.7	Moderate	35 (16/19)	The serum concentration of Phenytoin can be increased when it is combined with Amiodarone.	#AFCEE4	6.47511428576714	1
Erythromycin	Levofloxacin	0.571	1.173	Moderate	75 (47/28)	Erythromycin may increase the QTc-prolonging activities of Levofloxacin.	#F9BCBC	13.8752448980725	1
Fluoxetine	Ergotamine	0.254	3.493	Major	12 (10/2)	The risk or severity of adverse effects can be increased when Ergotamine is combined with Fluoxetine.	#EFA6A6	2.22003918369159	1
Alprazolam	Josamycin	0.152	3.493	None	24 (20/4)	The serum concentration of Alprazolam can be increased when it is combined with Josamycin.	#EFA6A6	4.44007836738318	1
Atorvastatin	Josamycin	0.047	-1.171	None	40 (22/18)	The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin.	#B4D1E6	7.40013061230531	1
Sucralfate	Ibandronate	0.257	Inf	Moderate	14 (14/0)		#B32020	2.59004571430686	1
Ibuprofen	Lithium cation	0.25	1.274	Moderate	48 (31/17)	The serum concentration of Lithium can be increased when it is combined with Ibuprofen.	#F8BABA	8.88015673476637	1
Methylphenidate	Rasagiline	0.334	-1.432	Moderate	8 (4/4)	Rasagiline may increase the hypertensive activities of Methylphenidate.	#B1CFE5	1.48002612246106	1
Metoprolol	Sertraline	0.559	1.182	Moderate	35 (22/13)	The serum concentration of Metoprolol can be increased when it is combined with Sertraline.	#F8BABA	6.47511428576714	1
Chlorpropamide	Acetylsalicylic acid	0.472	-2.147	None	25 (10/15)	Acetylsalicylic acid may increase the hypoglycemic activities of Chlorpropamide.	#ABCBE2	4.62508163269082	1
Fluconazole	Amitriptyline	0.127	1.597	Moderate	46 (32/14)	Amitriptyline may increase the QTc-prolonging activities of Fluconazole.	#F7B7B7	8.5101502041511	1
Doxycycline	Amoxicillin	0.475	-1.352	Moderate	105 (54/51)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Doxycycline.	#B2D0E5	19.4253428573014	1
Nortriptyline	Salbutamol	0.209	2.096	Moderate	24 (18/6)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Salbutamol.	#F5B2B2	4.44007836738318	1
Simvastatin	Ketoconazole	0.086	1.027	Major	42 (25/17)	The serum concentration of Simvastatin can be increased when it is combined with Ketoconazole.	#F9BCBC	7.77013714292057	1
Fluvoxamine	Carbamazepine	0.346	4.191	Moderate	7 (6/1)	The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.	#EC9F9F	1.29502285715343	1
Trospium	Quetiapine	0.322	1.08	Moderate	28 (17/11)		#F9BCBC	5.18009142861372	1
Fenofibrate	Ursodeoxycholic acid	0.347	1.048	None	25 (15/10)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.	#F9BCBC	4.62508163269082	1
Phenytoin	Hydrocortisone	0.254	-1.101	Moderate	23 (13/10)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenytoin.	#B4D1E6	4.25507510207555	1
Fluoxetine	Propafenone	0.375	1.319	Moderate	26 (17/9)	Propafenone may increase the QTc-prolonging activities of Fluoxetine.	#F8BABA	4.81008489799845	1
Valsartan	Lithium cation	0.225	1.08	Moderate	28 (17/11)	The serum concentration of Lithium can be increased when it is combined with Valsartan.	#F9BCBC	5.18009142861372	1
Digoxin	Hydroxychloroquine	0.308	1.207	Moderate	30 (19/11)	The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.	#F8BABA	5.55009795922898	1
Methotrexate	Cloxacillin	0.102	2.096	Major	24 (18/6)	The serum concentration of Methotrexate can be increased when it is combined with Cloxacillin.	#F5B2B2	4.44007836738318	1
Zolmitriptan	Escitalopram	0.183	8.382	Major	13 (12/1)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Escitalopram.	#DC7B7B	2.40504244899922	1
Disopyramide	Omeprazole	0.356	Inf	None	11 (11/0)		#B32020	2.03503591838396	1
Gemfibrozil	Ursodeoxycholic acid	0.417	-1.241	None	28 (15/13)	The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gemfibrozil.	#B2D0E5	5.18009142861372	1
Propranolol	Hydralazine	0.326	-1.497	Minor	45 (22/23)	Hydralazine may increase the hypotensive activities of Propranolol.	#B1CFE5	8.32514693884347	1
Citalopram	Almotriptan	0.21	10.478	Major	16 (15/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Almotriptan.	#D36868	2.96005224492212	1
Fluconazole	Tolterodine	0.177	1.029	Moderate	47 (28/19)	The metabolism of Tolterodine can be decreased when combined with Fluconazole.	#F9BCBC	8.69515346945874	1
Verapamil	Triazolam	0.468	2.794	Moderate	5 (4/1)	The metabolism of Triazolam can be decreased when combined with Verapamil.	#F2ACAC	0.925016326538163	1
Cyclosporine	Ezetimibe	0.283	-1.432	Moderate	8 (4/4)	The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.	#B1CFE5	1.48002612246106	1
Glyburide	Oxprenolol	0.472	1.397	None	6 (4/2)	Oxprenolol may increase the hypoglycemic activities of Glyburide.	#F7B9B9	1.1100195918458	1
Bleomycin	Digoxin	0.091	Inf	Moderate	1 (1/0)	Digoxin may decrease the cardiotoxic activities of Bleomycin.	#B32020	0.185003265307633	1
Imipramine	Galantamine	0.325	4.89	Moderate	8 (7/1)	The metabolism of Galantamine can be decreased when combined with Imipramine.	#E99999	1.48002612246106	1
Dihydroergotamine	Atenolol	0.292	2.235	Moderate	21 (16/5)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F4B1B1	3.88506857146029	1
Gentamicin	Bumetanide	0.2	Inf	Major	1 (1/0)	The serum concentration of Gentamicin can be increased when it is combined with Bumetanide.	#B32020	0.185003265307633	1
Ropinirole	Ciprofloxacin	0.12	-1.982	Moderate	62 (26/36)	The serum concentration of Ropinirole can be increased when it is combined with Ciprofloxacin.	#ACCCE3	11.4702024490732	1
Atorvastatin	Bezafibrate	0.301	1.29	None	37 (24/13)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin.	#F8BABA	6.84512081638241	1
Cyclosporine	Allopurinol	0.308	-8.053	Moderate	53 (8/45)		#77A4CB	9.80517306130453	8.86878203398843e-06
Erythromycin	Quetiapine	0.075	3.293	Major	40 (33/7)	The metabolism of Quetiapine can be decreased when combined with Erythromycin.	#F0A7A7	7.40013061230531	1
Galantamine	Moclobemide	0.062	Inf	None	1 (1/0)		#B32020	0.185003265307633	1
Fluconazole	Lovastatin	0.123	1.785	Major	32 (23/9)	The serum concentration of Lovastatin can be increased when it is combined with Fluconazole.	#F6B6B6	5.92010448984425	1
Digoxin	Josamycin	0.096	4.89	None	16 (14/2)	The serum concentration of Digoxin can be increased when it is combined with Josamycin.	#E99999	2.96005224492212	1
Metoprolol	Repaglinide	0.39	-1.074	Moderate	21 (12/9)		#B4D1E6	3.88506857146029	1
Phenytoin	Fludrocortisone	0.381	1.397	Moderate	3 (2/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenytoin.	#F7B9B9	0.555009795922898	1
Hydrocortisone	Phenobarbital	0.122	1.397	Moderate	15 (10/5)	The serum concentration of Hydrocortisone can be decreased when it is combined with Phenobarbital.	#F7B9B9	2.77504897961449	1
Cyclosporine	Methotrexate	0.232	Inf	Moderate	3 (3/0)	The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.	#B32020	0.555009795922898	1
Paroxetine	Almotriptan	0.32	Inf	Major	11 (11/0)	The metabolism of Almotriptan can be decreased when combined with Paroxetine.	#B32020	2.03503591838396	1
Tobramycin	Furosemide	0.198	2.096	Major	16 (12/4)	The serum concentration of Tobramycin can be increased when it is combined with Furosemide.	#F5B2B2	2.96005224492212	1
Cyclosporine	Repaglinide	0.436	1.048	Major	10 (6/4)	The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.	#F9BCBC	1.85003265307633	1
Fluvoxamine	Amitriptyline	0.473	4.191	Major	14 (12/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.	#EC9F9F	2.59004571430686	1
Metoprolol	Glyburide	0.357	-2.267	Moderate	31 (12/19)	Metoprolol may increase the hypoglycemic activities of Glyburide.	#A9C9E1	5.73510122453661	1
Fentanyl	Ketoconazole	0.218	-1.432	Major	20 (10/10)	The serum concentration of Fentanyl can be increased when it is combined with Ketoconazole.	#B1CFE5	3.70006530615265	1
Indomethacin	Propranolol	0.191	-1.253	Moderate	45 (24/21)	Indomethacin may decrease the antihypertensive activities of Propranolol.	#B2D0E5	8.32514693884347	1
Amitriptyline	Terbutaline	0.145	1.715	Moderate	38 (27/11)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.	#F6B6B6	7.03012408169004	1
Metoprolol	Salmeterol	0.35	-1.789	Moderate	36 (16/20)	Metoprolol may decrease the bronchodilatory activities of Salmeterol.	#AECDE3	6.66011755107478	1
Doxycycline	Acenocoumarol	0.094	-2.309	None	81 (31/50)	The metabolism of Acenocoumarol can be decreased when combined with Doxycycline.	#A9C9E1	14.9852644899182	1
Ranolazine	Diltiazem	0.413	-3.698	Major	43 (12/31)	The serum concentration of Ranolazine can be increased when it is combined with Diltiazem.	#9DC0DC	7.95514040822821	1
Griseofulvin	Acetylsalicylic acid	0.044	2.096	Minor	8 (6/2)		#F5B2B2	1.48002612246106	1
Dihydroergotamine	Nitroglycerin	0.192	1.397	Moderate	27 (18/9)	The bioavailability of Dihydroergotamine can be increased when combined with Nitroglycerin.	#F7B9B9	4.99508816330608	1
Atenolol	Verapamil	0.37	1.561	Major	55 (38/17)	Verapamil may increase the hypotensive activities of Atenolol.	#F7B7B7	10.1751795919198	1
Torasemide	Gentamicin	0.157	1.659	Major	27 (19/8)	The serum concentration of Gentamicin can be increased when it is combined with Torasemide.	#F7B7B7	4.99508816330608	1
Tolterodine	Itraconazole	0.227	1.188	Moderate	27 (17/10)	The serum concentration of Tolterodine can be increased when it is combined with Itraconazole.	#F8BABA	4.99508816330608	1
Trospium	Galantamine	0.257	1.863	Moderate	11 (8/3)	The therapeutic efficacy of Trospium can be decreased when used in combination with Galantamine.	#F6B6B6	2.03503591838396	1
Nortriptyline	Donepezil	0.18	1.048	Moderate	15 (9/6)		#F9BCBC	2.77504897961449	1
Risperidone	Itraconazole	0.22	1.461	None	34 (23/11)	The metabolism of Risperidone can be decreased when combined with Itraconazole.	#F7B9B9	6.29011102045951	1
Sotalol	Gliclazide	0.31	-1.211	None	24 (13/11)	Sotalol may increase the hypoglycemic activities of Gliclazide.	#B2D0E5	4.44007836738318	1
Mesalazine	Mercaptopurine	0.238	-2.863	Moderate	3 (1/2)	The metabolism of Mercaptopurine can be decreased when combined with Mesalazine.	#A5C6DF	0.555009795922898	1
Atorvastatin	Fusidic acid	0.061	-1.307	None	44 (23/21)	The serum concentration of Atorvastatin can be increased when it is combined with Fusidic Acid.	#B2D0E5	8.14014367353584	1
Moxifloxacin	Iron	0.314	-1.851	Moderate	94 (41/53)		#AECDE3	17.3903069389175	1
Paroxetine	Moclobemide	0.319	Inf	None	2 (2/0)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Moclobemide.	#B32020	0.370006530615265	1
Fluconazole	Tacrolimus	0.37	2.561	Major	14 (11/3)	The serum concentration of Tacrolimus can be increased when it is combined with Fluconazole.	#F3AFAF	2.59004571430686	1
Cyclosporine	Verapamil	0.276	1.397	Moderate	6 (4/2)	The metabolism of Cyclosporine can be decreased when combined with Verapamil.	#F7B9B9	1.1100195918458	1
Trihexyphenidyl	Rivastigmine	0.267	4.191	Moderate	7 (6/1)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Rivastigmine.	#EC9F9F	1.29502285715343	1
Cyclosporine	Azithromycin	0.071	-1.575	Moderate	21 (10/11)	The metabolism of Cyclosporine can be decreased when combined with Azithromycin.	#AFCEE4	3.88506857146029	1
Metoprolol	Escitalopram	0.387	1.816	Minor	18 (13/5)	The serum concentration of Metoprolol can be increased when it is combined with Escitalopram.	#F6B6B6	3.33005877553739	1
Theophylline	Josamycin	0.36	2.096	None	4 (3/1)	The metabolism of Theophylline can be decreased when combined with Josamycin.	#F5B2B2	0.740013061230531	1
Atenolol	Glipizide	0.338	-1.853	Moderate	39 (17/22)	Atenolol may increase the hypoglycemic activities of Glipizide.	#AECDE3	7.21512734699767	1
Fentanyl	Rifampicin	0.275	1.63	Major	20 (14/6)	The serum concentration of Fentanyl can be decreased when it is combined with Rifampicin.	#F7B7B7	3.70006530615265	1
Moxifloxacin	Warfarin	0.146	-2.277	Major	57 (22/35)		#A9C9E1	10.5451861225351	1
Verapamil	Telithromycin	0.055	1.397	Moderate	3 (2/1)	The serum concentration of Verapamil can be increased when it is combined with Telithromycin.	#F7B9B9	0.555009795922898	1
Dextropropoxyphene	Acenocoumarol	0.241	4.191	None	7 (6/1)		#EC9F9F	1.29502285715343	1
Tenoxicam	Alendronic acid	0.229	Inf	None	11 (11/0)	The risk or severity of adverse effects can be increased when Tenoxicam is combined with Alendronic acid.	#B32020	2.03503591838396	1
Losartan	Lithium cation	0.28	1.048	Moderate	30 (18/12)	The serum concentration of Lithium can be increased when it is combined with Losartan.	#F9BCBC	5.55009795922898	1
Metoprolol	Salbutamol	0.12	-1.909	Moderate	49 (21/28)	Metoprolol may decrease the bronchodilatory activities of Salbutamol.	#ACCCE3	9.065160000074	1
Citalopram	Clozapine	0.058	Inf	Major	3 (3/0)	The serum concentration of Clozapine can be increased when it is combined with Citalopram.	#B32020	0.555009795922898	1
Leflunomide	Acenocoumarol	0.279	1.075	None	33 (20/13)	Leflunomide may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	6.10510775515188	1
Phenytoin	Warfarin	0.525	1.118	Moderate	13 (8/5)	Phenytoin may increase the anticoagulant activities of Warfarin.	#F9BCBC	2.40504244899922	1
Fenofibrate	Fluvastatin	0.476	-1.841	Major	32 (14/18)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.	#AECDE3	5.92010448984425	1
Cyclosporine	Fluconazole	0.067	Inf	Moderate	4 (4/0)	The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.	#B32020	0.740013061230531	1
Diazepam	Itraconazole	0.197	1.49	Moderate	47 (32/15)	The metabolism of Diazepam can be decreased when combined with Itraconazole.	#F7B9B9	8.69515346945874	1
Lovastatin	Rifampicin	0.106	2.445	Major	9 (7/2)	The metabolism of Lovastatin can be increased when combined with Rifampicin.	#F3AFAF	1.66502938776869	1
Cyclosporine	Fluoxetine	0.366	1.746	Moderate	7 (5/2)	The metabolism of Fluoxetine can be decreased when combined with Cyclosporine.	#F6B6B6	1.29502285715343	1
Sumatriptan	Paroxetine	0.176	1.746	Major	14 (10/4)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Paroxetine.	#F6B6B6	2.59004571430686	1
Amikacin	Cefonicid	1	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Cyclosporine	Carvedilol	0.399	-2.386	Moderate	16 (6/10)	The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.	#A9C9E1	2.96005224492212	1
Fluvoxamine	Dihydroergotamine	0.04	Inf	Major	3 (3/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluvoxamine.	#B32020	0.555009795922898	1
Erlotinib	Clarithromycin	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Erlotinib can be increased when it is combined with Clarithromycin.	#B32020	0.185003265307633	1
Trospium	Risperidone	0.209	1.135	Moderate	21 (13/8)		#F9BCBC	3.88506857146029	1
Theophylline	Norfloxacin	0.239	-1.356	Moderate	37 (19/18)	The metabolism of Theophylline can be decreased when combined with Norfloxacin.	#B1CFE5	6.84512081638241	1
Fluoxetine	Almotriptan	0.304	Inf	Major	6 (6/0)	The metabolism of Almotriptan can be decreased when combined with Fluoxetine.	#B32020	1.1100195918458	1
Rosuvastatin	Gemfibrozil	0.315	-1.329	Major	27 (14/13)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Rosuvastatin.	#B2D0E5	4.99508816330608	1
Fentanyl	Itraconazole	0.241	1.651	Major	37 (26/11)	The serum concentration of Fentanyl can be increased when it is combined with Itraconazole.	#F7B7B7	6.84512081638241	1
Repaglinide	Glucosamine	0.23	-1.041	None	57 (33/24)		#B4D1E6	10.5451861225351	1
Erythromycin	Lovastatin	0.133	1.319	Major	26 (17/9)	The serum concentration of Lovastatin can be increased when it is combined with Erythromycin.	#F8BABA	4.81008489799845	1
Sucralfate	Ciprofloxacin	0.307	-1.297	Moderate	61 (32/29)		#B2D0E5	11.2851991837656	1
Atenolol	Ergotamine	0.297	1.197	Moderate	19 (12/7)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F8BABA	3.51506204084502	1
Fluorouracil	Acenocoumarol	0.086	-3.068	None	44 (14/30)	The serum concentration of Acenocoumarol can be increased when it is combined with Fluorouracil.	#A3C5DF	8.14014367353584	1
Dihydroergotamine	Propranolol	0.281	2.096	Moderate	12 (9/3)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#F5B2B2	2.22003918369159	1
Metoprolol	Prazosin	0.237	Inf	Moderate	1 (1/0)	Metoprolol may increase the orthostatic hypotensive activities of Prazosin.	#B32020	0.185003265307633	1
Warfarin	Fluvastatin	0.26	-1.542	Minor	27 (13/14)	The metabolism of Warfarin can be decreased when combined with Fluvastatin.	#AFCEE4	4.99508816330608	1
Warfarin	Clarithromycin	0.142	-1.074	Major	42 (24/18)	The metabolism of Warfarin can be decreased when combined with Clarithromycin.	#B4D1E6	7.77013714292057	1
Pyridostigmine	Hydrocortisone	0.111	2.096	Moderate	8 (6/2)	The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Pyridostigmine.	#F5B2B2	1.48002612246106	1
Trospium	Fexofenadine	0.086	1.397	None	3 (2/1)		#F7B9B9	0.555009795922898	1
Phenytoin	Methotrexate	0.307	1.048	Moderate	10 (6/4)	The serum concentration of Phenytoin can be decreased when it is combined with Methotrexate.	#F9BCBC	1.85003265307633	1
Trospium	Rivastigmine	0.346	-1.145	Moderate	18 (10/8)	The therapeutic efficacy of Trospium can be decreased when used in combination with Rivastigmine.	#B4D1E6	3.33005877553739	1
Fluoxetine	Selegiline	0.447	1.397	Major	9 (6/3)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Selegiline.	#F7B9B9	1.66502938776869	1
Clozapine	Ciprofloxacin	0.174	2.096	Major	4 (3/1)	Ciprofloxacin may increase the QTc-prolonging activities of Clozapine.	#F5B2B2	0.740013061230531	1
Pioglitazone	Gemfibrozil	0.342	-1.074	Major	14 (8/6)	The metabolism of Pioglitazone can be decreased when combined with Gemfibrozil.	#B4D1E6	2.59004571430686	1
Imipramine	Rivastigmine	0.285	1.863	Moderate	11 (8/3)		#F6B6B6	2.03503591838396	1
Fluconazole	Eplerenone	0.108	-1.288	Moderate	19 (10/9)	The serum concentration of Eplerenone can be increased when it is combined with Fluconazole.	#B2D0E5	3.51506204084502	1
Lansoprazole	Ketoconazole	0.333	2.445	Moderate	9 (7/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Lansoprazole.	#F3AFAF	1.66502938776869	1
Pioglitazone	Glucosamine	0.22	2.561	None	14 (11/3)		#F3AFAF	2.59004571430686	1
Glimepiride	Glucosamine	0.208	-1.369	None	45 (23/22)		#B1CFE5	8.32514693884347	1
Trospium	Ipratropium	0.237	1.327	Moderate	29 (19/10)	The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Trospium.	#F8BABA	5.36509469392135	1
Rifampicin	Clomipramine	0.32	Inf	Minor	4 (4/0)	The metabolism of Clomipramine can be increased when combined with Rifampicin.	#B32020	0.740013061230531	1
Entacapone	Epinephrine	0.019	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Sotalol	Clarithromycin	0.097	3.143	Major	11 (9/2)	Clarithromycin may increase the QTc-prolonging activities of Sotalol.	#F0A9A9	2.03503591838396	1
Bisoprolol	Rifampicin	0.192	-1.959	Moderate	45 (19/26)	The metabolism of Bisoprolol can be increased when combined with Rifampicin.	#ACCCE3	8.32514693884347	1
Tizanidine	Lisinopril	0.151	1.497	Major	22 (15/7)	Tizanidine may increase the hypotensive activities of Lisinopril.	#F7B9B9	4.07007183676792	1
Digoxin	Penicillamine	0.194	Inf	Moderate	1 (1/0)	The serum concentration of Digoxin can be decreased when it is combined with Penicillamine.	#B32020	0.185003265307633	1
Erythromycin	Methylprednisolone	0.388	1.397	Moderate	27 (18/9)	The metabolism of Methylprednisolone can be decreased when combined with Erythromycin.	#F7B9B9	4.99508816330608	1
Morphine	Rifampicin	0.422	-1.145	Moderate	9 (5/4)	The serum concentration of Morphine can be decreased when it is combined with Rifampicin.	#B4D1E6	1.66502938776869	1
Diazepam	Rifampicin	0.245	1.497	Minor	22 (15/7)	The metabolism of Diazepam can be increased when combined with Rifampicin.	#F7B9B9	4.07007183676792	1
Sotalol	Formoterol	0.189	-1.041	Major	19 (11/8)	Formoterol may increase the QTc-prolonging activities of Sotalol.	#B4D1E6	3.51506204084502	1
Donepezil	Maprotiline	0.468	2.328	Moderate	13 (10/3)		#F4B1B1	2.40504244899922	1
Maprotiline	Rivastigmine	0.281	2.096	Moderate	12 (9/3)		#F5B2B2	2.22003918369159	1
Propranolol	Chlorpropamide	0.218	1.397	Moderate	3 (2/1)	Propranolol may increase the hypoglycemic activities of Chlorpropamide.	#F7B9B9	0.555009795922898	1
Phenytoin	Methylprednisolone	0.218	-2.72	Moderate	29 (10/19)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenytoin.	#A6C7E0	5.36509469392135	1
Itraconazole	Budesonide	0.285	-1.385	Major	61 (31/30)	The serum concentration of Budesonide can be increased when it is combined with Itraconazole.	#B1CFE5	11.2851991837656	1
Ciprofloxacin	Tizanidine	0.262	-1.363	Major	41 (21/20)	Tizanidine may increase the QTc-prolonging activities of Ciprofloxacin.	#B1CFE5	7.58513387761294	1
Omeprazole	Chlordiazepoxide	0.193	Inf	Moderate	7 (7/0)		#B32020	1.29502285715343	1
Cyclosporine	Tacrolimus	0.098	1.397	Major	3 (2/1)	Tacrolimus may increase the nephrotoxic activities of Cyclosporine.	#F7B9B9	0.555009795922898	1
Diclofenac	Lithium cation	0.181	5.239	Moderate	17 (15/2)	The serum concentration of Lithium can be increased when it is combined with Diclofenac.	#E89696	3.14505551022976	1
Rizatriptan	Escitalopram	0.233	1.257	Major	14 (9/5)	The risk or severity of adverse effects can be increased when Rizatriptan is combined with Escitalopram.	#F8BABA	2.59004571430686	1
Cyclosporine	Metoclopramide	0.036	1.118	Moderate	13 (8/5)	Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.	#F9BCBC	2.40504244899922	1
Metoprolol	Fluoxetine	0.361	3.143	Moderate	11 (9/2)	The serum concentration of Metoprolol can be increased when it is combined with Fluoxetine.	#F0A9A9	2.03503591838396	1
Fluvoxamine	Doxepin	0.241	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Doxepin.	#B32020	0.185003265307633	1
Nortriptyline	Rivastigmine	0.272	4.89	Moderate	8 (7/1)		#E99999	1.48002612246106	1
Pimozide	Escitalopram	0.161	Inf	Major	3 (3/0)	The risk or severity of QTc prolongation can be increased when Pimozide is combined with Escitalopram.	#B32020	0.555009795922898	1
Lovastatin	Carbamazepine	0.358	-1.193	None	22 (12/10)	The metabolism of Lovastatin can be increased when combined with Carbamazepine.	#B2D0E5	4.07007183676792	1
Chlorpromazine	Rivastigmine	0.24	-1.909	Moderate	14 (6/8)		#ACCCE3	2.59004571430686	1
Digoxin	Cholestyramine	0.287	-1.179	Moderate	31 (17/14)	Cholestyramine can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B2D0E5	5.73510122453661	1
Warfarin	Gemfibrozil	0.201	-1.329	Major	27 (14/13)	The metabolism of Warfarin can be decreased when combined with Gemfibrozil.	#B2D0E5	4.99508816330608	1
Propranolol	Propafenone	0.287	1.135	Moderate	21 (13/8)	The serum concentration of Propranolol can be increased when it is combined with Propafenone.	#F9BCBC	3.88506857146029	1
Propranolol	Rizatriptan	0.192	-1.841	Moderate	16 (7/9)	The serum concentration of Rizatriptan can be increased when it is combined with Propranolol.	#AECDE3	2.96005224492212	1
Rifampicin	Acenocoumarol	0.251	-1.67	None	39 (18/21)	The metabolism of Acenocoumarol can be increased when combined with Rifampicin.	#AFCEE4	7.21512734699767	1
Prednisone	Itraconazole	0.421	-1.108	Moderate	55 (31/24)	The serum concentration of Prednisone can be increased when it is combined with Itraconazole.	#B4D1E6	10.1751795919198	1
Methylphenidate	Carbamazepine	0.036	2.096	None	4 (3/1)		#F5B2B2	0.740013061230531	1
Prednisone	Primidone	0.179	-3.34	Moderate	50 (15/35)	The serum concentration of Prednisone can be decreased when it is combined with Primidone.	#A0C3DD	9.25016326538163	1
Gentamicin	Cefuroxime	0.648	-1.193	Moderate	22 (12/10)		#B2D0E5	4.07007183676792	1
Terbinafine	Acenocoumarol	0.111	-1.962	None	64 (27/37)		#ACCCE3	11.8402089796885	1
Flutamide	Acenocoumarol	0.32	-10.021	None	40 (5/35)		#6697C4	7.40013061230531	1
Donepezil	Promethazine	0.167	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Atenolol	Piroxicam	0.115	2.561	Moderate	14 (11/3)	Piroxicam may decrease the antihypertensive activities of Atenolol.	#F3AFAF	2.59004571430686	1
Lovastatin	Colchicine	0.214	-2.028	Major	29 (12/17)	The serum concentration of Colchicine can be increased when it is combined with Lovastatin.	#ACCCE3	5.36509469392135	1
Trifluoperazine	Rivastigmine	0.091	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Theophylline	Phenobarbital	0.14	-1.432	Moderate	6 (3/3)	The metabolism of Theophylline can be increased when combined with Phenobarbital.	#B1CFE5	1.1100195918458	1
Colestipol	Levothyroxine	0.311	6.287	Moderate	10 (9/1)	The serum concentration of Levothyroxine can be decreased when it is combined with Colestipol.	#E38D8D	1.85003265307633	1
Ranitidine	Itraconazole	0.176	-1.568	Moderate	44 (21/23)	The serum concentration of Itraconazole can be decreased when it is combined with Ranitidine.	#AFCEE4	8.14014367353584	1
Trospium	Loratadine	0.104	1.816	None	18 (13/5)		#F6B6B6	3.33005877553739	1
Rifampicin	Atorvastatin	0.206	-1.789	Major	36 (16/20)	The metabolism of Atorvastatin can be increased when combined with Rifampicin.	#AECDE3	6.66011755107478	1
Cyclosporine	Nabumetone	0.141	Inf	Moderate	2 (2/0)	Nabumetone may increase the nephrotoxic activities of Cyclosporine.	#B32020	0.370006530615265	1
Ketoconazole	Budesonide	0.329	-1.575	Major	21 (10/11)	The serum concentration of Budesonide can be increased when it is combined with Ketoconazole.	#AFCEE4	3.88506857146029	1
Duloxetine	Propafenone	0.321	1.281	Moderate	17 (11/6)	The serum concentration of Duloxetine can be increased when it is combined with Propafenone.	#F8BABA	3.14505551022976	1
Cyclosporine	Sevelamer	0.129	Inf	Moderate	1 (1/0)	The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.	#B32020	0.185003265307633	1
Donepezil	Cyclobenzaprine	0.154	3.726	Moderate	19 (16/3)		#EEA4A4	3.51506204084502	1
Doxycycline	Digoxin	0.157	-1.253	Moderate	30 (16/14)	The metabolism of Digoxin can be decreased when combined with Doxycycline.	#B2D0E5	5.55009795922898	1
Diltiazem	Rifampicin	0.231	-1.909	Major	21 (9/12)	The serum concentration of Diltiazem can be decreased when it is combined with Rifampicin.	#ACCCE3	3.88506857146029	1
Propranolol	Verapamil	0.218	1.397	Major	30 (20/10)	The metabolism of Propranolol can be decreased when combined with Verapamil.	#F7B9B9	5.55009795922898	1
Meloxicam	Acenocoumarol	0.164	-1.304	None	86 (45/41)	Meloxicam may increase the anticoagulant activities of Acenocoumarol.	#B2D0E5	15.9102808164564	1
Digoxin	Sulfasalazine	0.287	1.222	Moderate	11 (7/4)	The serum concentration of Digoxin can be increased when it is combined with Sulfasalazine.	#F8BABA	2.03503591838396	1
Indomethacin	Warfarin	0.163	-1.211	Major	24 (13/11)	Indomethacin may increase the anticoagulant activities of Warfarin.	#B2D0E5	4.44007836738318	1
Cyproheptadine	Galantamine	0.082	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Trospium	Cetirizine	0.108	3.027	None	16 (13/3)		#F1ABAB	2.96005224492212	1
Nortriptyline	Rasagiline	0.269	1.048	Major	5 (3/2)	Rasagiline may increase the serotonergic activities of Nortriptyline.	#F9BCBC	0.925016326538163	1
Sertraline	Cilostazol	0.298	-3.149	Moderate	48 (15/33)	The serum concentration of Cilostazol can be increased when it is combined with Sertraline.	#A2C4DE	8.88015673476637	1
Galantamine	Flavoxate	0.37	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Eprosartan	Lithium cation	0.336	Inf	Moderate	4 (4/0)	The serum concentration of Lithium can be increased when it is combined with Eprosartan.	#B32020	0.740013061230531	1
Verapamil	Primidone	0.207	3.493	Moderate	6 (5/1)	The metabolism of Verapamil can be increased when combined with Primidone.	#EFA6A6	1.1100195918458	1
Losartan	Rifampicin	0.199	-1.011	Moderate	29 (17/12)	The serum concentration of Losartan can be decreased when it is combined with Rifampicin.	#B4D1E6	5.36509469392135	1
Chlorpromazine	Galantamine	0.198	-1.074	Moderate	7 (4/3)	The metabolism of Galantamine can be decreased when combined with Chlorpromazine.	#B4D1E6	1.29502285715343	1
Miglitol	Glucosamine	0.322	3.493	None	6 (5/1)		#EFA6A6	1.1100195918458	1
Alendronic acid	Flurbiprofen	0.141	3.143	Moderate	11 (9/2)	The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Alendronic acid.	#F0A9A9	2.03503591838396	1
Trospium	Tiotropium	0.318	-3.758	Moderate	29 (8/21)	Trospium may increase the anticholinergic activities of Tiotropium.	#9DC0DC	5.36509469392135	1
Verapamil	Phenobarbital	0.519	4.191	Moderate	7 (6/1)	The metabolism of Verapamil can be increased when combined with Phenobarbital.	#EC9F9F	1.29502285715343	1
Metoprolol	Terbutaline	0.094	2.096	Moderate	8 (6/2)	Metoprolol may decrease the bronchodilatory activities of Terbutaline.	#F5B2B2	1.48002612246106	1
Spironolactone	Fosinopril	0.341	-1.193	Major	22 (12/10)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Fosinopril.	#B2D0E5	4.07007183676792	1
Disopyramide	Atenolol	0.528	Inf	Major	2 (2/0)	Disopyramide may increase the bradycardic activities of Atenolol.	#B32020	0.370006530615265	1
Digoxin	Itraconazole	0.121	1.222	Major	33 (21/12)	The serum concentration of Digoxin can be increased when it is combined with Itraconazole.	#F8BABA	6.10510775515188	1
Ergotamine	Nitroglycerin	0.327	1.197	Moderate	19 (12/7)	The bioavailability of Ergotamine can be increased when combined with Nitroglycerin.	#F8BABA	3.51506204084502	1
Eplerenone	Tolevamer	0.282	-5.01	None	18 (4/14)		#93B8D7	3.33005877553739	1
Chlorpromazine	Donepezil	0.192	-1.909	Moderate	14 (6/8)	The metabolism of Donepezil can be decreased when combined with Chlorpromazine.	#ACCCE3	2.59004571430686	1
Captopril	Lithium cation	0.156	1.164	Moderate	8 (5/3)	The serum concentration of Lithium can be increased when it is combined with Captopril.	#F9BCBC	1.48002612246106	1
Pregabalin	Rosiglitazone	0.222	1.746	Moderate	14 (10/4)	The risk or severity of heart failure can be increased when Pregabalin is combined with Rosiglitazone.	#F6B6B6	2.59004571430686	1
Galantamine	Clomipramine	0.262	1.397	Moderate	15 (10/5)	The metabolism of Galantamine can be decreased when combined with Clomipramine.	#F7B9B9	2.77504897961449	1
Ciprofloxacin	Sevelamer	0.177	-2.863	Moderate	39 (13/26)		#A5C6DF	7.21512734699767	1
Chlorpromazine	Propranolol	0.095	1.164	Moderate	8 (5/3)	The metabolism of Propranolol can be decreased when combined with Chlorpromazine.	#F9BCBC	1.48002612246106	1
Disopyramide	Galantamine	0.611	Inf	Moderate	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Disopyramide.	#B32020	0.185003265307633	1
Prednisolone	Acetylsalicylic acid	0.051	2.328	Moderate	13 (10/3)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Prednisolone.	#F4B1B1	2.40504244899922	1
Doxycycline	Acitretin	0.111	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Doxycycline is combined with Acitretin.	#B32020	0.185003265307633	1
Tizanidine	Captopril	0.218	2.445	Major	9 (7/2)	The risk or severity of hypotension can be increased when Tizanidine is combined with Captopril.	#F3AFAF	1.66502938776869	1
Trospium	Imipramine	0.246	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Trospium	Haloperidol	0.362	5.588	Moderate	9 (8/1)		#E69393	1.66502938776869	1
Diclofenac	Rifampicin	0.334	-1.336	Moderate	29 (15/14)	The serum concentration of Diclofenac can be decreased when it is combined with Rifampicin.	#B2D0E5	5.36509469392135	1
Fluvoxamine	Duloxetine	0.163	-1.023	Major	12 (7/5)	The serum concentration of Duloxetine can be increased when it is combined with Fluvoxamine.	#B4D1E6	2.22003918369159	1
Tizanidine	Quinapril	0.088	2.794	Major	5 (4/1)	The risk or severity of hypotension can be increased when Tizanidine is combined with Quinapril.	#F2ACAC	0.925016326538163	1
Nifedipine	Phenobarbital	0.568	1.048	Major	10 (6/4)	The serum concentration of Nifedipine can be decreased when it is combined with Phenobarbital.	#F9BCBC	1.85003265307633	1
Dextromethorphan	Selegiline	0.096	1.048	Major	10 (6/4)	Selegiline may increase the serotonergic activities of Dextromethorphan.	#F9BCBC	1.85003265307633	1
Lovastatin	Gemfibrozil	0.259	-1.05	Major	26 (15/11)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Lovastatin.	#B4D1E6	4.81008489799845	1
Fluconazole	Fluvastatin	0.132	-1.312	Moderate	23 (12/11)	The serum concentration of Fluvastatin can be increased when it is combined with Fluconazole.	#B2D0E5	4.25507510207555	1
Trihexyphenidyl	Donepezil	0.453	1.164	Moderate	8 (5/3)	The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Donepezil.	#F9BCBC	1.48002612246106	1
Verapamil	Eplerenone	0.475	1.863	Moderate	11 (8/3)	The serum concentration of Eplerenone can be increased when it is combined with Verapamil.	#F6B6B6	2.03503591838396	1
Amitriptyline	Moclobemide	0.148	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.	#B32020	0.185003265307633	1
Paroxetine	Selegiline	0.33	1.863	Major	11 (8/3)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Selegiline.	#F6B6B6	2.03503591838396	1
Cyclosporine	Diltiazem	0.324	-1.145	Moderate	9 (5/4)	The metabolism of Cyclosporine can be decreased when combined with Diltiazem.	#B4D1E6	1.66502938776869	1
Nabumetone	Methotrexate	0.33	2.096	Major	8 (6/2)	The serum concentration of Methotrexate can be increased when it is combined with Nabumetone.	#F5B2B2	1.48002612246106	1
Cyclosporine	Josamycin	0.333	Inf	None	1 (1/0)	The metabolism of Cyclosporine can be decreased when combined with Josamycin.	#B32020	0.185003265307633	1
Methotrexate	Flurbiprofen	0.138	-3.579	Major	7 (2/5)	The serum concentration of Methotrexate can be increased when it is combined with Flurbiprofen.	#9FC1DD	1.29502285715343	1
Warfarin	Cloxacillin	0.089	1.497	Moderate	22 (15/7)	Cloxacillin may decrease the anticoagulant activities of Warfarin.	#F7B9B9	4.07007183676792	1
Metronidazole	Phenobarbital	0.046	1.746	Moderate	7 (5/2)	The serum concentration of Metronidazole can be decreased when it is combined with Phenobarbital.	#F6B6B6	1.29502285715343	1
Phenytoin	Triamcinolone	0.117	3.493	Moderate	6 (5/1)	The metabolism of Triamcinolone can be increased when combined with Phenytoin.	#EFA6A6	1.1100195918458	1
Fluconazole	Everolimus	1	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Fluconazole.	#B32020	0.185003265307633	1
Diltiazem	Tacrolimus	0.21	-1.652	Moderate	28 (13/15)	The metabolism of Tacrolimus can be decreased when combined with Diltiazem.	#AFCEE4	5.18009142861372	1
Rivastigmine	Oxybutynin	0.259	-2.434	Moderate	27 (10/17)	The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.	#A8C8E1	4.99508816330608	1
Minocycline	Acenocoumarol	0.106	-1.762	None	29 (13/16)	Minocycline may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	5.36509469392135	1
Gliclazide	Nadolol	0.248	2.794	None	10 (8/2)	Nadolol may increase the hypoglycemic activities of Gliclazide.	#F2ACAC	1.85003265307633	1
Dihydroergotamine	Fluoxetine	0.276	1.63	Major	10 (7/3)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Fluoxetine.	#F7B7B7	1.85003265307633	1
Zolmitriptan	Paroxetine	0.294	-1.002	Major	17 (10/7)	The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Paroxetine.	#B4D1E6	3.14505551022976	1
Rifampicin	Amiodarone	0.294	-1.432	Major	14 (7/7)	The serum concentration of Amiodarone can be decreased when it is combined with Rifampicin.	#B1CFE5	2.59004571430686	1
Warfarin	Methimazole	0.233	1.257	Moderate	14 (9/5)	Methimazole may decrease the anticoagulant activities of Warfarin.	#F8BABA	2.59004571430686	1
Ketoconazole	Quetiapine	0.15	1.397	Major	9 (6/3)	The serum concentration of Quetiapine can be increased when it is combined with Ketoconazole.	#F7B9B9	1.66502938776869	1
Phenytoin	Estradiol	0.024	Inf	Moderate	1 (1/0)	The therapeutic efficacy of Estradiol can be decreased when used in combination with Phenytoin.	#B32020	0.185003265307633	1
Minocycline	Amoxicillin	0.326	-1.217	Moderate	37 (20/17)	The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Minocycline.	#B2D0E5	6.84512081638241	1
Phenytoin	Midazolam	0.291	-2.863	Moderate	9 (3/6)	The serum concentration of Phenytoin can be increased when it is combined with Midazolam.	#A5C6DF	1.66502938776869	1
Warfarin	Cholestyramine	0.286	-1.909	Moderate	14 (6/8)	Cholestyramine can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ACCCE3	2.59004571430686	1
Erythromycin	Amiodarone	0.142	1.08	Major	28 (17/11)	Erythromycin may increase the QTc-prolonging activities of Amiodarone.	#F9BCBC	5.18009142861372	1
Rifampicin	Clarithromycin	0.631	-1.841	Moderate	16 (7/9)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.	#AECDE3	2.96005224492212	1
Sucralfate	Levofloxacin	0.287	-2.004	Moderate	48 (20/28)	The serum concentration of Levofloxacin can be decreased when it is combined with Sucralfate.	#ACCCE3	8.88015673476637	1
Lovastatin	Itraconazole	0.102	1.164	Major	16 (10/6)	The serum concentration of Lovastatin can be increased when it is combined with Itraconazole.	#F9BCBC	2.96005224492212	1
Phenytoin	Theophylline	0.247	-3.818	Moderate	11 (3/8)	The serum concentration of Theophylline can be decreased when it is combined with Phenytoin.	#9DC0DC	2.03503591838396	1
Nortriptyline	Galantamine	0.308	2.794	Moderate	5 (4/1)		#F2ACAC	0.925016326538163	1
Erythromycin	Repaglinide	0.069	-1.968	Moderate	38 (16/22)	The serum concentration of Repaglinide can be increased when it is combined with Erythromycin.	#ACCCE3	7.03012408169004	1
Colestipol	Ursodeoxycholic acid	0.141	1.397	None	3 (2/1)	The serum concentration of Ursodeoxycholic acid can be decreased when it is combined with Colestipol.	#F7B9B9	0.555009795922898	1
Trospium	Hydroxyzine	0.142	4.89	Moderate	8 (7/1)		#E99999	1.48002612246106	1
Clonidine	Bisoprolol	0.209	1.048	Major	5 (3/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F9BCBC	0.925016326538163	1
Cyclophosphamide	Acenocoumarol	0.197	-2.147	None	20 (8/12)		#ABCBE2	3.70006530615265	1
Pseudoephedrine	Clomipramine	0.116	3.493	None	6 (5/1)	Clomipramine may decrease the antihypertensive activities of Pseudoephedrine.	#EFA6A6	1.1100195918458	1
Galantamine	Maprotiline	0.226	1.746	Moderate	7 (5/2)		#F6B6B6	1.29502285715343	1
Ranolazine	Amiodarone	0.349	-3.272	Major	23 (7/16)	The serum concentration of Ranolazine can be increased when it is combined with Amiodarone.	#A2C4DE	4.25507510207555	1
Bisoprolol	Epinephrine	0.094	1.397	Moderate	15 (10/5)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Bisoprolol.	#F7B9B9	2.77504897961449	1
Clozapine	Clonazepam	0.138	-1.432	Moderate	2 (1/1)	The risk or severity of adverse effects can be increased when Clonazepam is combined with Clozapine.	#B1CFE5	0.370006530615265	1
Propranolol	Epinephrine	0.417	Inf	Major	4 (4/0)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Propranolol.	#B32020	0.740013061230531	1
Rabeprazole	Itraconazole	0.087	-1.074	Moderate	21 (12/9)	The serum concentration of Itraconazole can be decreased when it is combined with Rabeprazole.	#B4D1E6	3.88506857146029	1
Fluconazole	Nortriptyline	0.069	Inf	Moderate	4 (4/0)	The metabolism of Nortriptyline can be decreased when combined with Fluconazole.	#B32020	0.740013061230531	1
Lovastatin	Tacrolimus	0.067	1.397	Moderate	12 (8/4)	The serum concentration of Lovastatin can be increased when it is combined with Tacrolimus.	#F7B9B9	2.22003918369159	1
Galantamine	Ketoconazole	0.103	2.096	Moderate	4 (3/1)	The metabolism of Galantamine can be decreased when combined with Ketoconazole.	#F5B2B2	0.740013061230531	1
Fluconazole	Midazolam	0.381	-1.909	Major	14 (6/8)	The metabolism of Midazolam can be decreased when combined with Fluconazole.	#ACCCE3	2.59004571430686	1
Citalopram	Sumatriptan	0.327	1.572	Major	13 (9/4)	The risk or severity of adverse effects can be increased when Citalopram is combined with Sumatriptan.	#F7B7B7	2.40504244899922	1
Lovastatin	Fenofibrate	0.198	-1.432	Major	26 (13/13)	The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Lovastatin.	#B1CFE5	4.81008489799845	1
Rifampicin	Glipizide	0.162	Inf	Moderate	2 (2/0)	The serum concentration of Glipizide can be decreased when it is combined with Rifampicin.	#B32020	0.370006530615265	1
Fluconazole	Celecoxib	0.302	2.328	Moderate	26 (20/6)	The metabolism of Celecoxib can be decreased when combined with Fluconazole.	#F4B1B1	4.81008489799845	1
Clozapine	Haloperidol	0.2	Inf	Major	1 (1/0)	Clozapine may increase the QTc-prolonging activities of Haloperidol.	#B32020	0.185003265307633	1
Diltiazem	Triazolam	0.257	1.397	Moderate	6 (4/2)	The metabolism of Triazolam can be decreased when combined with Diltiazem.	#F7B9B9	1.1100195918458	1
Fluoxetine	Trimipramine	0.386	-1.432	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Trimipramine.	#B1CFE5	0.370006530615265	1
Cyclosporine	Norfloxacin	0.19	Inf	Moderate	6 (6/0)	The metabolism of Cyclosporine can be decreased when combined with Norfloxacin.	#B32020	1.1100195918458	1
Cyclosporine	Oxcarbazepine	0.222	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Folic acid	Primidone	0.178	-2.454	Moderate	19 (7/12)	The serum concentration of Primidone can be decreased when it is combined with Folic Acid.	#A8C8E1	3.51506204084502	1
Terbutaline	Clomipramine	0.149	2.794	Moderate	10 (8/2)	The risk or severity of adverse effects can be increased when Clomipramine is combined with Terbutaline.	#F2ACAC	1.85003265307633	1
Colestipol	Acenocoumarol	0.232	-1.432	None	16 (8/8)	Colestipol can cause a decrease in the absorption of Acenocoumarol resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	2.96005224492212	1
Triamcinolone	Primidone	0.188	1.048	Moderate	5 (3/2)	The metabolism of Triamcinolone can be increased when combined with Primidone.	#F9BCBC	0.925016326538163	1
Amitriptyline	Pseudoephedrine	0.075	6.985	None	11 (10/1)	Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#E18888	2.03503591838396	1
Paroxetine	Naratriptan	0.115	1.397	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Paroxetine is combined with Naratriptan.	#F7B9B9	0.555009795922898	1
Metoprolol	Dihydroergotamine	0.038	Inf	Moderate	2 (2/0)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Metoprolol.	#B32020	0.370006530615265	1
Fluconazole	Phenytoin	0.131	-1.909	Moderate	14 (6/8)	The serum concentration of Phenytoin can be increased when it is combined with Fluconazole.	#ACCCE3	2.59004571430686	1
Tizanidine	Donepezil	0.141	2.794	Moderate	10 (8/2)	Tizanidine may increase the bradycardic activities of Donepezil.	#F2ACAC	1.85003265307633	1
Fludrocortisone	Phenobarbital	0.333	Inf	Moderate	1 (1/0)	The serum concentration of Fludrocortisone can be decreased when it is combined with Phenobarbital.	#B32020	0.185003265307633	1
Verapamil	Colchicine	0.171	-3.579	Major	28 (8/20)	The serum concentration of Colchicine can be increased when it is combined with Verapamil.	#9FC1DD	5.18009142861372	1
Metoprolol	Phenobarbital	0.156	Inf	Moderate	2 (2/0)	The serum concentration of Metoprolol can be decreased when it is combined with Phenobarbital.	#B32020	0.370006530615265	1
Sotalol	Glyburide	0.301	-1.193	Moderate	11 (6/5)	Sotalol may increase the hypoglycemic activities of Glyburide.	#B2D0E5	2.03503591838396	1
Propranolol	Glipizide	0.211	-1.636	Moderate	15 (7/8)	Propranolol may increase the hypoglycemic activities of Glipizide.	#AFCEE4	2.77504897961449	1
Donepezil	Pimozide	0.341	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Colestipol	Digoxin	0.13	-1.432	Moderate	10 (5/5)	Colestipol can cause a decrease in the absorption of Digoxin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	1.85003265307633	1
Methylprednisolone	Rifampicin	0.359	-1.718	Moderate	11 (5/6)	The serum concentration of Methylprednisolone can be decreased when it is combined with Rifampicin.	#AECDE3	2.03503591838396	1
Dihydroergotamine	Clarithromycin	0.344	Inf	Major	7 (7/0)	The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.	#B32020	1.29502285715343	1
Sumatriptan	Escitalopram	0.2	3.493	Major	6 (5/1)	The risk or severity of adverse effects can be increased when Sumatriptan is combined with Escitalopram.	#EFA6A6	1.1100195918458	1
Cyclobenzaprine	Rasagiline	0.178	1.164	Major	8 (5/3)	Cyclobenzaprine may increase the serotonergic activities of Rasagiline.	#F9BCBC	1.48002612246106	1
Betamethasone	Acenocoumarol	0.082	-1.611	None	34 (16/18)		#AFCEE4	6.29011102045951	1
Ticlopidine	Carbamazepine	0.222	-1.432	Moderate	4 (2/2)	The metabolism of Ticlopidine can be increased when combined with Carbamazepine.	#B1CFE5	0.740013061230531	1
Diltiazem	Midazolam	0.356	-1.591	Moderate	19 (9/10)	The metabolism of Midazolam can be decreased when combined with Diltiazem.	#AFCEE4	3.51506204084502	1
Imipramine	Donepezil	0.361	4.191	Moderate	7 (6/1)	The metabolism of Donepezil can be decreased when combined with Imipramine.	#EC9F9F	1.29502285715343	1
Doxycycline	Rifampicin	0.5	-1.432	Moderate	4 (2/2)	The serum concentration of Doxycycline can be decreased when it is combined with Rifampicin.	#B1CFE5	0.740013061230531	1
Warfarin	Hydrocortisone	0.115	-1.101	Moderate	23 (13/10)	Hydrocortisone may increase the anticoagulant activities of Warfarin.	#B4D1E6	4.25507510207555	1
Phenytoin	Trimethoprim	0.096	-1.432	Moderate	12 (6/6)	The serum concentration of Phenytoin can be increased when it is combined with Trimethoprim.	#B1CFE5	2.22003918369159	1
Glyburide	Nadolol	0.265	-1.718	Moderate	11 (5/6)	Nadolol may increase the hypoglycemic activities of Glyburide.	#AECDE3	2.03503591838396	1
Erythromycin	Moxifloxacin	0.539	1.135	Major	21 (13/8)	Erythromycin may increase the QTc-prolonging activities of Moxifloxacin.	#F9BCBC	3.88506857146029	1
Ticlopidine	Acetylsalicylic acid	0.165	-2.195	Moderate	38 (15/23)	The risk or severity of adverse effects can be increased when Ticlopidine is combined with Acetylsalicylic acid.	#ABCBE2	7.03012408169004	1
Lovastatin	Ketoconazole	0.037	Inf	Major	3 (3/0)	The serum concentration of Lovastatin can be increased when it is combined with Ketoconazole.	#B32020	0.555009795922898	1
Fluoxetine	Josamycin	0.303	Inf	None	5 (5/0)		#B32020	0.925016326538163	1
Cyclosporine	Digoxin	0.188	-2.291	Moderate	13 (5/8)	The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.	#A9C9E1	2.40504244899922	1
Carbamazepine	Felodipine	0.221	1.048	Moderate	5 (3/2)	The metabolism of Felodipine can be increased when combined with Carbamazepine.	#F9BCBC	0.925016326538163	1
Dihydroergotamine	Carvedilol	0.284	4.89	Moderate	8 (7/1)	Dihydroergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#E99999	1.48002612246106	1
Naltrexone	Buprenorphine	1	Inf	Major	1 (1/0)	The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Naltrexone.	#B32020	0.185003265307633	1
Pimozide	Sertraline	0.077	Inf	Major	3 (3/0)	Sertraline may increase the QTc-prolonging activities of Pimozide.	#B32020	0.555009795922898	1
Cyclosporine	Rosuvastatin	0.115	1.397	Major	3 (2/1)	The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.	#F7B9B9	0.555009795922898	1
Fluconazole	Rifampicin	0.653	-2.147	Major	10 (4/6)	The metabolism of Rifampicin can be decreased when combined with Fluconazole.	#ABCBE2	1.85003265307633	1
Labetalol	Glyburide	0.215	1.397	Moderate	3 (2/1)	Labetalol may increase the hypoglycemic activities of Glyburide.	#F7B9B9	0.555009795922898	1
Clonazepam	Itraconazole	0.215	-1.002	None	17 (10/7)	The metabolism of Clonazepam can be decreased when combined with Itraconazole.	#B4D1E6	3.14505551022976	1
Amikacin	Furosemide	0.063	-2.004	Major	12 (5/7)	The serum concentration of Amikacin can be increased when it is combined with Furosemide.	#ACCCE3	2.22003918369159	1
Propranolol	Rifampicin	0.133	1.164	Moderate	8 (5/3)	The metabolism of Propranolol can be increased when combined with Rifampicin.	#F9BCBC	1.48002612246106	1
Ergotamine	Almotriptan	0.125	Inf	Major	1 (1/0)	Ergotamine may increase the vasoconstricting activities of Almotriptan.	#B32020	0.185003265307633	1
Phenytoin	Flurazepam	0.076	-1.432	Moderate	4 (2/2)	The serum concentration of Phenytoin can be increased when it is combined with Flurazepam.	#B1CFE5	0.740013061230531	1
Nabumetone	Warfarin	0.098	2.096	Major	8 (6/2)	Nabumetone may increase the anticoagulant activities of Warfarin.	#F5B2B2	1.48002612246106	1
Piroxicam	Propranolol	0.085	3.493	Moderate	6 (5/1)	Piroxicam may decrease the antihypertensive activities of Propranolol.	#EFA6A6	1.1100195918458	1
Atenolol	Chlorpropamide	0.131	-2.147	Moderate	5 (2/3)	Atenolol may increase the hypoglycemic activities of Chlorpropamide.	#ABCBE2	0.925016326538163	1
Cyclosporine	Ibuprofen	0.139	-2.473	Moderate	30 (11/19)	Ibuprofen may increase the nephrotoxic activities of Cyclosporine.	#A8C8E1	5.55009795922898	1
Moxifloxacin	Sucralfate	0.321	1.257	Moderate	14 (9/5)		#F8BABA	2.59004571430686	1
Carbamazepine	Clarithromycin	0.252	1.098	Major	18 (11/7)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.	#F9BCBC	3.33005877553739	1
Ramipril	Tizanidine	0.166	-2.505	Major	22 (8/14)	The risk or severity of hypotension can be increased when Tizanidine is combined with Ramipril.	#A8C8E1	4.07007183676792	1
Clozapine	Donepezil	0.347	Inf	Moderate	1 (1/0)	The metabolism of Donepezil can be decreased when combined with Clozapine.	#B32020	0.185003265307633	1
Moxifloxacin	Sotalol	0.102	1.164	Major	8 (5/3)	Moxifloxacin may increase the QTc-prolonging activities of Sotalol.	#F9BCBC	1.48002612246106	1
Ranitidine	Ketoconazole	0.084	3.493	Moderate	6 (5/1)	The serum concentration of Ketoconazole can be decreased when it is combined with Ranitidine.	#EFA6A6	1.1100195918458	1
Doxepin	Rasagiline	0.3	Inf	Major	1 (1/0)	Rasagiline may increase the serotonergic activities of Doxepin.	#B32020	0.185003265307633	1
Fluconazole	Warfarin	0.135	-1.288	Major	19 (10/9)	The serum concentration of Warfarin can be increased when it is combined with Fluconazole.	#B2D0E5	3.51506204084502	1
Fluvoxamine	Ropinirole	0.358	1.397	Moderate	3 (2/1)	Fluvoxamine may increase the sedative activities of Ropinirole.	#F7B9B9	0.555009795922898	1
Phenytoin	Triazolam	0.022	Inf	Moderate	1 (1/0)	The serum concentration of Phenytoin can be increased when it is combined with Triazolam.	#B32020	0.185003265307633	1
Colestipol	Warfarin	0.302	1.397	Minor	3 (2/1)	Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F7B9B9	0.555009795922898	1
Trospium	Cyclobenzaprine	0.468	Inf	Moderate	3 (3/0)		#B32020	0.555009795922898	1
Cyclobenzaprine	Rivastigmine	0.299	6.985	Moderate	11 (10/1)		#E18888	2.03503591838396	1
Fluoxetine	Doxepin	0.201	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Doxepin.	#B32020	0.370006530615265	1
Tobramycin	Cefuroxime	0.625	2.096	Moderate	4 (3/1)		#F5B2B2	0.740013061230531	1
Phenobarbital	Dexamethasone	0.227	-1.432	Moderate	8 (4/4)	The serum concentration of Dexamethasone can be decreased when it is combined with Phenobarbital.	#B1CFE5	1.48002612246106	1
Warfarin	Fludrocortisone	0.236	Inf	Moderate	2 (2/0)	Fludrocortisone may increase the anticoagulant activities of Warfarin.	#B32020	0.370006530615265	1
Rosuvastatin	Colchicine	0.193	-2.863	Moderate	18 (6/12)	Colchicine may increase the myopathic rhabdomyolysis activities of Rosuvastatin.	#A5C6DF	3.33005877553739	1
Trospium	Clomipramine	0.111	1.048	Moderate	5 (3/2)		#F9BCBC	0.925016326538163	1
Erythromycin	Carbamazepine	0.283	Inf	Major	6 (6/0)	The metabolism of Carbamazepine can be decreased when combined with Erythromycin.	#B32020	1.1100195918458	1
Warfarin	Terbinafine	0.059	1.164	Moderate	8 (5/3)		#F9BCBC	1.48002612246106	1
Doxycycline	Insulin aspart	0.147	-1.193	Moderate	11 (6/5)		#B2D0E5	2.03503591838396	1
Frovatriptan	Sertraline	0.106	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Frovatriptan is combined with Sertraline.	#B32020	0.370006530615265	1
Clemastine	Galantamine	0.104	Inf	Moderate	2 (2/0)	The metabolism of Galantamine can be decreased when combined with Clemastine.	#B32020	0.370006530615265	1
Erythromycin	Pimozide	0.05	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Erythromycin.	#B32020	0.185003265307633	1
Fluconazole	Carbamazepine	0.357	2.445	Moderate	9 (7/2)	The serum concentration of Carbamazepine can be increased when it is combined with Fluconazole.	#F3AFAF	1.66502938776869	1
Repaglinide	Josamycin	0.047	-1.145	None	9 (5/4)	The serum concentration of Repaglinide can be increased when it is combined with Josamycin.	#B4D1E6	1.66502938776869	1
Doxycycline	Insulin glulisine	0.12	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Prednisone	Rifampicin	0.296	-3.722	Moderate	36 (10/26)	The serum concentration of Prednisone can be decreased when it is combined with Rifampicin.	#9DC0DC	6.66011755107478	1
Methylprednisolone	Ketoconazole	0.316	-1.432	Major	6 (3/3)	The serum concentration of Methylprednisolone can be increased when it is combined with Ketoconazole.	#B1CFE5	1.1100195918458	1
Erythromycin	Warfarin	0.158	1.863	Major	11 (8/3)	The serum concentration of Warfarin can be increased when it is combined with Erythromycin.	#F6B6B6	2.03503591838396	1
Cyclosporine	Glipizide	0.241	Inf	Moderate	1 (1/0)	The metabolism of Glipizide can be decreased when combined with Cyclosporine.	#B32020	0.185003265307633	1
Carbamazepine	Metronidazole	0.258	1.397	Moderate	9 (6/3)	The metabolism of Metronidazole can be increased when combined with Carbamazepine.	#F7B9B9	1.66502938776869	1
Fluvastatin	Gemfibrozil	0.35	-2.684	Major	23 (8/15)	The risk or severity of rhabdomyolysis. myoglobinuria. and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Fluvastatin.	#A6C7E0	4.25507510207555	1
Trandolapril	Tizanidine	0.059	Inf	Major	2 (2/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Trandolapril.	#B32020	0.370006530615265	1
Thiethylperazine	Levofloxacin	0.441	-1.101	None	46 (26/20)		#B4D1E6	8.5101502041511	1
Fosinopril	Tizanidine	0.519	Inf	Major	2 (2/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Fosinopril.	#B32020	0.370006530615265	1
Diltiazem	Cilostazol	0.28	-10.021	Major	56 (7/49)	The serum concentration of Cilostazol can be increased when it is combined with Diltiazem.	#6697C4	10.3601828572274	1
Warfarin	Naproxen	0.114	-1.058	Major	40 (23/17)	Naproxen may increase the anticoagulant activities of Warfarin.	#B4D1E6	7.40013061230531	1
Phenytoin	Felodipine	0.169	-1.432	Major	4 (2/2)	The metabolism of Felodipine can be increased when combined with Phenytoin.	#B1CFE5	0.740013061230531	1
Carbamazepine	Warfarin	0.309	-2.863	Moderate	18 (6/12)	The serum concentration of Warfarin can be decreased when it is combined with Carbamazepine.	#A5C6DF	3.33005877553739	1
Cilazapril	Lithium cation	0.1	Inf	None	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Cilazapril.	#B32020	0.185003265307633	1
Methylprednisolone	Phenobarbital	0.209	-1.145	Moderate	9 (5/4)	The serum concentration of Methylprednisolone can be decreased when it is combined with Phenobarbital.	#B4D1E6	1.66502938776869	1
Rivastigmine	Doxepin	0.396	-1.432	Moderate	4 (2/2)		#B1CFE5	0.740013061230531	1
Doxycycline	Cloxacillin	0.649	-1.193	Moderate	11 (6/5)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Doxycycline.	#B2D0E5	2.03503591838396	1
Triamcinolone	Phenobarbital	0.145	2.096	Moderate	4 (3/1)	The metabolism of Triamcinolone can be increased when combined with Phenobarbital.	#F5B2B2	0.740013061230531	1
Acitretin	Methotrexate	0.029	Inf	Major	1 (1/0)	Acitretin may increase the hepatotoxic activities of Methotrexate.	#B32020	0.185003265307633	1
Sulindac	Furosemide	0.418	Inf	Moderate	3 (3/0)	The therapeutic efficacy of Furosemide can be decreased when used in combination with Sulindac.	#B32020	0.555009795922898	1
Celecoxib	Warfarin	0.138	-1.227	Moderate	26 (14/12)	Celecoxib may increase the anticoagulant activities of Warfarin.	#B2D0E5	4.81008489799845	1
Doxycycline	Phenobarbital	0.187	1.397	Moderate	3 (2/1)	The serum concentration of Doxycycline can be decreased when it is combined with Phenobarbital.	#F7B9B9	0.555009795922898	1
Nortriptyline	Carbamazepine	0.425	1.397	Moderate	3 (2/1)	The metabolism of Nortriptyline can be increased when combined with Carbamazepine.	#F7B9B9	0.555009795922898	1
Allopurinol	Azathioprine	0.108	-2.25	Major	18 (7/11)	The serum concentration of the active metabolites of Azathioprine can be increased when Azathioprine is used in combination with Allopurinol.	#A9C9E1	3.33005877553739	1
Danazol	Acenocoumarol	0.155	2.096	None	4 (3/1)	Danazol may increase the anticoagulant activities of Acenocoumarol.	#F5B2B2	0.740013061230531	1
Perphenazine	Rivastigmine	0.274	-1.432	Moderate	6 (3/3)		#B1CFE5	1.1100195918458	1
Fluoxetine	Naratriptan	0.043	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Naratriptan.	#B32020	0.185003265307633	1
Donepezil	Flavoxate	0.349	Inf	Moderate	2 (2/0)		#B32020	0.370006530615265	1
Citalopram	Pimozide	0.103	2.096	Major	4 (3/1)	The risk or severity of QTc prolongation can be increased when Citalopram is combined with Pimozide.	#F5B2B2	0.740013061230531	1
Dextromethorphan	Rasagiline	0.139	-2.577	Major	28 (10/18)	Rasagiline may increase the serotonergic activities of Dextromethorphan.	#A8C8E1	5.18009142861372	1
Salbutamol	Nadolol	0.212	-1.611	Major	17 (8/9)		#AFCEE4	3.14505551022976	1
Phenytoin	Isoniazid	0.274	-1.432	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Isoniazid.	#B1CFE5	0.370006530615265	1
Trospium	Olanzapine	0.251	1.048	Moderate	5 (3/2)		#F9BCBC	0.925016326538163	1
Ketoconazole	Tolterodine	0.133	2.096	Moderate	4 (3/1)	The serum concentration of Tolterodine can be increased when it is combined with Ketoconazole.	#F5B2B2	0.740013061230531	1
Cyclosporine	Pravastatin	0.455	-2.505	Major	11 (4/7)	The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.	#A8C8E1	2.03503591838396	1
Erythromycin	Theophylline	0.286	-1.074	Moderate	7 (4/3)	The metabolism of Theophylline can be decreased when combined with Erythromycin.	#B4D1E6	1.29502285715343	1
Haloperidol	Itraconazole	0.371	2.096	Moderate	12 (9/3)	The metabolism of Haloperidol can be decreased when combined with Itraconazole.	#F5B2B2	2.22003918369159	1
Clarithromycin	Colchicine	0.187	-1.288	Major	19 (10/9)	The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.	#B2D0E5	3.51506204084502	1
Doxycycline	Insulin detemir	0.076	1.746	Moderate	7 (5/2)		#F6B6B6	1.29502285715343	1
Dihydroergotamine	Almotriptan	0.611	-2.863	Major	3 (1/2)	Dihydroergotamine may increase the vasoconstricting activities of Almotriptan.	#A5C6DF	0.555009795922898	1
Cyclosporine	Phenytoin	0.133	Inf	Moderate	1 (1/0)	The metabolism of Cyclosporine can be increased when combined with Phenytoin.	#B32020	0.185003265307633	1
Amitriptyline	Clonidine	0.567	Inf	Major	1 (1/0)	Amitriptyline may decrease the antihypertensive activities of Clonidine.	#B32020	0.185003265307633	1
Thiethylperazine	Bromocriptine	0.857	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Theophylline	Carbamazepine	0.41	-3.34	Moderate	10 (3/7)	The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.	#A0C3DD	1.85003265307633	1
Ketoconazole	Clonazepam	0.103	Inf	None	3 (3/0)	The metabolism of Clonazepam can be decreased when combined with Ketoconazole.	#B32020	0.555009795922898	1
Ofloxacin	Acenocoumarol	0.072	-3.34	None	30 (9/21)		#A0C3DD	5.55009795922898	1
Phenylbutazone	Acenocoumarol	0.059	Inf	None	1 (1/0)	Phenylbutazone may increase the anticoagulant activities of Acenocoumarol.	#B32020	0.185003265307633	1
Rosiglitazone	Gemfibrozil	0.186	-1.909	Moderate	7 (3/4)	The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.	#ACCCE3	1.29502285715343	1
Clarithromycin	Everolimus	0.167	Inf	Major	1 (1/0)	The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.	#B32020	0.185003265307633	1
Imipramine	Terbutaline	0.218	2.096	Moderate	4 (3/1)	The risk or severity of adverse effects can be increased when Imipramine is combined with Terbutaline.	#F5B2B2	0.740013061230531	1
Fluoxetine	Rizatriptan	0.504	1.397	Major	6 (4/2)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Rizatriptan.	#F7B9B9	1.1100195918458	1
Celecoxib	Rifampicin	0.34	3.493	Moderate	6 (5/1)	The metabolism of Celecoxib can be increased when combined with Rifampicin.	#EFA6A6	1.1100195918458	1
Galantamine	Tizanidine	0.058	Inf	Moderate	4 (4/0)	Galantamine may increase the bradycardic activities of Tizanidine.	#B32020	0.740013061230531	1
Eplerenone	Clarithromycin	0.115	-1.611	Major	17 (8/9)	The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.	#AFCEE4	3.14505551022976	1
Ketoconazole	Rabeprazole	0.191	-2.386	Moderate	8 (3/5)	The serum concentration of Ketoconazole can be decreased when it is combined with Rabeprazole.	#A9C9E1	1.48002612246106	1
Atenolol	Insulin glulisine	0.228	2.445	Moderate	9 (7/2)		#F3AFAF	1.66502938776869	1
Midazolam	Ketoconazole	0.4	Inf	Major	1 (1/0)	The serum concentration of Midazolam can be increased when it is combined with Ketoconazole.	#B32020	0.185003265307633	1
Galantamine	Perphenazine	0.353	-1.432	Moderate	4 (2/2)		#B1CFE5	0.740013061230531	1
Phenytoin	Estriol	0.24	Inf	None	2 (2/0)		#B32020	0.370006530615265	1
Imipramine	Carbamazepine	0.873	Inf	Moderate	2 (2/0)	The metabolism of Imipramine can be increased when combined with Carbamazepine.	#B32020	0.370006530615265	1
Carbamazepine	Josamycin	0.101	1.397	None	3 (2/1)	The metabolism of Carbamazepine can be decreased when combined with Josamycin.	#F7B9B9	0.555009795922898	1
Phenytoin	Itraconazole	0.076	1.048	Moderate	5 (3/2)	The serum concentration of Itraconazole can be decreased when it is combined with Phenytoin.	#F9BCBC	0.925016326538163	1
Trazodone	Ketoconazole	0.252	-2.505	Moderate	11 (4/7)	The metabolism of Trazodone can be decreased when combined with Ketoconazole.	#A8C8E1	2.03503591838396	1
Fluvastatin	Colchicine	0.313	-3.722	Major	18 (5/13)	Colchicine may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#9DC0DC	3.33005877553739	1
Moxifloxacin	Josamycin	0.522	2.794	None	5 (4/1)		#F2ACAC	0.925016326538163	1
Fluvoxamine	Almotriptan	0.023	Inf	Major	1 (1/0)	The metabolism of Almotriptan can be decreased when combined with Fluvoxamine.	#B32020	0.185003265307633	1
Eletriptan	Fluoxetine	0.167	Inf	Major	1 (1/0)	The metabolism of Eletriptan can be decreased when combined with Fluoxetine.	#B32020	0.185003265307633	1
Piroxicam	Bisoprolol	0.194	-1.002	Moderate	17 (10/7)	Piroxicam may decrease the antihypertensive activities of Bisoprolol.	#B4D1E6	3.14505551022976	1
Warfarin	Azathioprine	0.29	2.096	Moderate	4 (3/1)	Azathioprine may decrease the anticoagulant activities of Warfarin.	#F5B2B2	0.740013061230531	1
Amitriptyline	Epinephrine	0.208	Inf	Major	3 (3/0)	Amitriptyline may decrease the antihypertensive activities of Epinephrine.	#B32020	0.555009795922898	1
Itraconazole	Aripiprazole	0.098	Inf	Moderate	2 (2/0)	The serum concentration of Aripiprazole can be increased when it is combined with Itraconazole.	#B32020	0.370006530615265	1
Celecoxib	Lithium cation	0.13	1.397	Major	6 (4/2)	The serum concentration of Lithium can be increased when it is combined with Celecoxib.	#F7B9B9	1.1100195918458	1
Spironolactone	Cilazapril	0.264	-1.432	None	10 (5/5)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Cilazapril.	#B1CFE5	1.85003265307633	1
Acetylsalicylic acid	Paramethasone	1	Inf	None	1 (1/0)	The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Paramethasone.	#B32020	0.185003265307633	1
Medroxyprogesterone acetate	Warfarin	0.059	Inf	None	1 (1/0)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Warfarin.	#B32020	0.185003265307633	1
Diltiazem	Sirolimus	0.472	Inf	Moderate	1 (1/0)	The metabolism of Sirolimus can be decreased when combined with Diltiazem.	#B32020	0.185003265307633	1
Levofloxacin	Josamycin	0.505	-1.841	None	16 (7/9)		#AECDE3	2.96005224492212	1
Midazolam	Clarithromycin	0.322	1.048	Moderate	10 (6/4)	The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.	#F9BCBC	1.85003265307633	1
Venlafaxine	Naratriptan	0.476	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Naratriptan.	#B32020	0.185003265307633	1
Doxycycline	Methotrexate	0.564	2.096	Moderate	4 (3/1)		#F5B2B2	0.740013061230531	1
Fluconazole	Ergotamine	0.15	Inf	Moderate	3 (3/0)	The metabolism of Ergotamine can be decreased when combined with Fluconazole.	#B32020	0.555009795922898	1
Rifampicin	Leflunomide	0.25	Inf	Major	1 (1/0)	The serum concentration of the active metabolites of Leflunomide can be increased when Leflunomide is used in combination with Rifampicin.	#B32020	0.185003265307633	1
Methotrexate	Cholestyramine	0.362	-1.909	None	7 (3/4)	Cholestyramine can cause a decrease in the absorption of Methotrexate resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ACCCE3	1.29502285715343	1
Atenolol	Epinephrine	0.068	2.794	Moderate	5 (4/1)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#F2ACAC	0.925016326538163	1
Alendronic acid	Mefenamic acid	0.041	Inf	Moderate	2 (2/0)	The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Alendronic acid.	#B32020	0.370006530615265	1
Venlafaxine	Frovatriptan	0.051	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Venlafaxine is combined with Frovatriptan.	#B32020	0.185003265307633	1
Phenytoin	Doxycycline	0.138	-2.863	Moderate	6 (2/4)	The serum concentration of Doxycycline can be decreased when it is combined with Phenytoin.	#A5C6DF	1.1100195918458	1
Labetalol	Salmeterol	0.149	-2.147	Major	5 (2/3)	Labetalol may decrease the vasoconstricting activities of Salmeterol.	#ABCBE2	0.925016326538163	1
Phenytoin	Fluorouracil	0.062	-1.432	Moderate	2 (1/1)	The serum concentration of Phenytoin can be increased when it is combined with Fluorouracil.	#B1CFE5	0.370006530615265	1
Labetalol	Gliclazide	0.321	-3.579	None	7 (2/5)	Labetalol may increase the hypoglycemic activities of Gliclazide.	#9FC1DD	1.29502285715343	1
Clozapine	Lisinopril	0.048	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Clozapine is combined with Lisinopril.	#B32020	0.185003265307633	1
Theophylline	Propranolol	0.139	-1.718	Major	11 (5/6)	The metabolism of Propranolol can be decreased when combined with Theophylline.	#AECDE3	2.03503591838396	1
Warfarin	Itraconazole	0.09	1.746	Moderate	7 (5/2)	The serum concentration of Warfarin can be increased when it is combined with Itraconazole.	#F6B6B6	1.29502285715343	1
Donepezil	Zuclopenthixol	0.21	1.397	None	3 (2/1)		#F7B9B9	0.555009795922898	1
Ticlopidine	Theophylline	0.163	-4.295	Moderate	4 (1/3)	The metabolism of Theophylline can be decreased when combined with Ticlopidine.	#99BDDA	0.740013061230531	1
Sotalol	Repaglinide	0.343	-1.789	Moderate	9 (4/5)		#AECDE3	1.66502938776869	1
Prednisone	Estriol	0.214	6.985	None	11 (10/1)	The serum concentration of Prednisone can be increased when it is combined with Estriol.	#E18888	2.03503591838396	1
Epinephrine	Carvedilol	0.111	-1.909	Major	7 (3/4)	Epinephrine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#ACCCE3	1.29502285715343	1
Tacrolimus	Metronidazole	0.149	-1.432	Moderate	8 (4/4)		#B1CFE5	1.48002612246106	1
Ramipril	Lithium cation	0.268	-1.432	Moderate	8 (4/4)	The serum concentration of Lithium can be increased when it is combined with Ramipril.	#B1CFE5	1.48002612246106	1
Fluvoxamine	Lithium cation	0.622	-1.432	Major	2 (1/1)	Lithium may increase the serotonergic activities of Fluvoxamine.	#B1CFE5	0.370006530615265	1
Megestrol acetate	Phenobarbital	0.358	-1.432	Moderate	6 (3/3)		#B1CFE5	1.1100195918458	1
Flurazepam	Itraconazole	0.125	1.397	None	3 (2/1)	The metabolism of Flurazepam can be decreased when combined with Itraconazole.	#F7B9B9	0.555009795922898	1
Sucralfate	Norfloxacin	0.391	-1.041	Moderate	19 (11/8)	The serum concentration of Norfloxacin can be decreased when it is combined with Sucralfate.	#B4D1E6	3.51506204084502	1
Mefenamic acid	Acenocoumarol	0.135	-1.432	None	4 (2/2)	Mefenamic acid may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.740013061230531	1
Chlorpromazine	Levofloxacin	0.414	-4.295	Moderate	20 (5/15)	Chlorpromazine may increase the QTc-prolonging activities of Levofloxacin.	#99BDDA	3.70006530615265	1
Tacrolimus	Itraconazole	0.48	-1.432	Major	6 (3/3)	The serum concentration of Tacrolimus can be increased when it is combined with Itraconazole.	#B1CFE5	1.1100195918458	1
Salbutamol	Doxepin	0.324	-3.34	Moderate	10 (3/7)	The risk or severity of adverse effects can be increased when Doxepin is combined with Salbutamol.	#A0C3DD	1.85003265307633	1
Ergotamine	Isosorbide mononitrate	0.245	2.096	Moderate	4 (3/1)		#F5B2B2	0.740013061230531	1
Salmeterol	Oxprenolol	0.238	1.397	None	3 (2/1)	Oxprenolol may decrease the bronchodilatory activities of Salmeterol.	#F7B9B9	0.555009795922898	1
Gliclazide	Oxprenolol	0.371	-1.432	None	4 (2/2)	Oxprenolol may increase the hypoglycemic activities of Gliclazide.	#B1CFE5	0.740013061230531	1
Dihydroergotamine	Rizatriptan	0.056	Inf	Major	1 (1/0)	Dihydroergotamine may increase the vasoconstricting activities of Rizatriptan.	#B32020	0.185003265307633	1
Eletriptan	Venlafaxine	0.088	Inf	Major	1 (1/0)	The serum concentration of Eletriptan can be increased when it is combined with Venlafaxine.	#B32020	0.185003265307633	1
Prednisone	Ketoconazole	0.292	-6.872	Moderate	29 (5/24)	The serum concentration of Prednisone can be increased when it is combined with Ketoconazole.	#82ACD0	5.36509469392135	1
Ergotamine	Clarithromycin	0.115	1.397	Major	6 (4/2)	The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.	#F7B9B9	1.1100195918458	1
Lorazepam	Clozapine	0.117	1.397	Major	3 (2/1)	The risk or severity of adverse effects can be increased when Lorazepam is combined with Clozapine.	#F7B9B9	0.555009795922898	1
Topiramate	Lithium cation	0.458	-1.432	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Topiramate.	#B1CFE5	0.370006530615265	1
Erythromycin	Midazolam	0.043	1.048	Moderate	5 (3/2)	The serum concentration of Midazolam can be increased when it is combined with Erythromycin.	#F9BCBC	0.925016326538163	1
Atenolol	Prazosin	0.133	1.397	Moderate	3 (2/1)	Atenolol may increase the orthostatic hypotensive activities of Prazosin.	#F7B9B9	0.555009795922898	1
Isoniazid	Acenocoumarol	0.185	-2.004	None	12 (5/7)	The metabolism of Acenocoumarol can be decreased when combined with Isoniazid.	#ACCCE3	2.22003918369159	1
Digoxin	Cyclophosphamide	0.209	2.096	Moderate	4 (3/1)	Digoxin may decrease the cardiotoxic activities of Cyclophosphamide.	#F5B2B2	0.740013061230531	1
Capecitabine	Acenocoumarol	0.263	-2.147	None	15 (6/9)	The serum concentration of Acenocoumarol can be increased when it is combined with Capecitabine.	#ABCBE2	2.77504897961449	1
Rifampicin	Gliclazide	0.151	-1.718	None	11 (5/6)	The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.	#AECDE3	2.03503591838396	1
Zolmitriptan	Dihydroergotamine	0.511	-2.863	Major	3 (1/2)	Dihydroergotamine may increase the vasoconstricting activities of Zolmitriptan.	#A5C6DF	0.555009795922898	1
Ergotamine	Carvedilol	0.14	-1.074	Moderate	7 (4/3)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#B4D1E6	1.29502285715343	1
Trandolapril	Lithium cation	0.5	-1.432	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Trandolapril.	#B1CFE5	0.370006530615265	1
Primidone	Methylprednisolone	0.179	2.096	Moderate	4 (3/1)	The serum concentration of Methylprednisolone can be decreased when it is combined with Primidone.	#F5B2B2	0.740013061230531	1
Felodipine	Josamycin	0.03	Inf	None	1 (1/0)		#B32020	0.185003265307633	1
Itraconazole	Phenobarbital	0.216	1.397	Moderate	3 (2/1)	The serum concentration of Itraconazole can be decreased when it is combined with Phenobarbital.	#F7B9B9	0.555009795922898	1
Colestipol	Raloxifene	0.175	Inf	Moderate	1 (1/0)	Colestipol can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.185003265307633	1
Carbamazepine	Isoniazid	0.105	Inf	Moderate	1 (1/0)	The metabolism of Carbamazepine can be decreased when combined with Isoniazid.	#B32020	0.185003265307633	1
Conjugated estrogens	Prednisone	0.25	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.	#B32020	0.185003265307633	1
Medroxyprogesterone acetate	Acenocoumarol	0.321	1.048	None	5 (3/2)	Medroxyprogesterone acetate may decrease the anticoagulant activities of Acenocoumarol.	#F9BCBC	0.925016326538163	1
Ketoconazole	Atorvastatin	0.211	-5.44	Major	24 (5/19)	The serum concentration of Atorvastatin can be increased when it is combined with Ketoconazole.	#8EB5D5	4.44007836738318	1
Felodipine	Itraconazole	0.026	Inf	Major	2 (2/0)	The serum concentration of Felodipine can be increased when it is combined with Itraconazole.	#B32020	0.370006530615265	1
Metoprolol	Verapamil	0.092	Inf	Major	3 (3/0)	The serum concentration of Metoprolol can be increased when it is combined with Verapamil.	#B32020	0.555009795922898	1
Trospium	Potassium chloride	0.189	1.397	Major	3 (2/1)	Trospium may increase the ulcerogenic activities of Potassium Chloride.	#F7B9B9	0.555009795922898	1
Warfarin	Dexamethasone	0.212	-2.386	Moderate	16 (6/10)	Dexamethasone may increase the anticoagulant activities of Warfarin.	#A9C9E1	2.96005224492212	1
Famotidine	Itraconazole	0.072	-1.432	Moderate	4 (2/2)	The serum concentration of Itraconazole can be decreased when it is combined with Famotidine.	#B1CFE5	0.740013061230531	1
Rifabutin	Simvastatin	0.124	-4.295	None	4 (1/3)	The metabolism of Simvastatin can be increased when combined with Rifabutin.	#99BDDA	0.740013061230531	1
Metoprolol	Diltiazem	0.294	3.493	Major	6 (5/1)	The serum concentration of Metoprolol can be increased when it is combined with Diltiazem.	#EFA6A6	1.1100195918458	1
Sucralfate	Itraconazole	0.525	1.048	None	5 (3/2)	Sucralfate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#F9BCBC	0.925016326538163	1
Atenolol	Clonidine	0.469	-2.863	Major	3 (1/2)	Clonidine may increase the atrioventricular blocking (AV block) activities of Atenolol.	#A5C6DF	0.555009795922898	1
Tizanidine	Cilazapril	0.1	Inf	None	1 (1/0)	The risk or severity of hypotension can be increased when Tizanidine is combined with Cilazapril.	#B32020	0.185003265307633	1
Tetracycline	Acenocoumarol	0.087	-1.432	None	10 (5/5)		#B1CFE5	1.85003265307633	1
Fluvoxamine	Imipramine	0.26	-1.432	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Imipramine.	#B1CFE5	0.370006530615265	1
Clozapine	Sertraline	0.217	Inf	Major	1 (1/0)	The serum concentration of Clozapine can be increased when it is combined with Sertraline.	#B32020	0.185003265307633	1
Repaglinide	Nadolol	0.344	-1.909	Moderate	7 (3/4)		#ACCCE3	1.29502285715343	1
Indapamide	Lithium cation	0.212	-2.386	Major	8 (3/5)	Indapamide may decrease the excretion rate of Lithium which could result in a higher serum level.	#A9C9E1	1.48002612246106	1
Labetalol	Ibuprofen	0.161	-1.432	Moderate	8 (4/4)	Ibuprofen may decrease the antihypertensive activities of Labetalol.	#B1CFE5	1.48002612246106	1
Hydrocortisone	Rifampicin	0.273	-4.772	Moderate	13 (3/10)	The serum concentration of Hydrocortisone can be decreased when it is combined with Rifampicin.	#94B9D8	2.40504244899922	1
Theophylline	Propafenone	0.719	-2.147	Moderate	5 (2/3)	The serum concentration of Theophylline can be increased when it is combined with Propafenone.	#ABCBE2	0.925016326538163	1
Clemastine	Donepezil	0.201	-1.432	Moderate	4 (2/2)	The metabolism of Donepezil can be decreased when combined with Clemastine.	#B1CFE5	0.740013061230531	1
Tetracycline	Quinapril	0.019	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Sucralfate	Ketoconazole	0.588	-1.432	Minor	2 (1/1)	Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	0.370006530615265	1
Salmeterol	Nadolol	0.314	-1.789	Major	9 (4/5)		#AECDE3	1.66502938776869	1
Prednisolone	Acenocoumarol	0.065	-1.432	None	6 (3/3)		#B1CFE5	1.1100195918458	1
Fluconazole	Halazepam	0.051	-1.432	None	4 (2/2)		#B1CFE5	0.740013061230531	1
Bumetanide	Ibuprofen	0.318	-1.432	Moderate	8 (4/4)	The therapeutic efficacy of Bumetanide can be decreased when used in combination with Ibuprofen.	#B1CFE5	1.48002612246106	1
Bisoprolol	Chlorpropamide	0.534	Inf	Moderate	2 (2/0)	Bisoprolol may increase the hypoglycemic activities of Chlorpropamide.	#B32020	0.370006530615265	1
Tizanidine	Rivastigmine	0.17	2.794	Moderate	5 (4/1)	Tizanidine may increase the bradycardic activities of Rivastigmine.	#F2ACAC	0.925016326538163	1
Naproxen	Lithium cation	0.184	3.493	Major	6 (5/1)	The serum concentration of Lithium can be increased when it is combined with Naproxen.	#EFA6A6	1.1100195918458	1
Phenytoin	Sucralfate	0.17	1.397	Moderate	3 (2/1)		#F7B9B9	0.555009795922898	1
Primidone	Estriol	0.333	Inf	None	1 (1/0)		#B32020	0.185003265307633	1
Carbamazepine	Midazolam	0.189	-2.863	Moderate	6 (2/4)	The metabolism of Midazolam can be increased when combined with Carbamazepine.	#A5C6DF	1.1100195918458	1
Cyclosporine	Nicardipine	0.2	Inf	Moderate	1 (1/0)	The metabolism of Nicardipine can be decreased when combined with Cyclosporine.	#B32020	0.185003265307633	1
Amitriptyline	Phenylephrine	0.042	Inf	Major	1 (1/0)	Amitriptyline may increase the vasopressor activities of Phenylephrine.	#B32020	0.185003265307633	1
Rivastigmine	Pimozide	0.105	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Oxcarbazepine	Felodipine	0.6	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Lisinopril	Lithium cation	0.268	-1.074	Moderate	7 (4/3)	The serum concentration of Lithium can be increased when it is combined with Lisinopril.	#B4D1E6	1.29502285715343	1
Cyclosporine	Glyburide	0.164	1.397	Moderate	3 (2/1)	The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.	#F7B9B9	0.555009795922898	1
Pravastatin	Bezafibrate	0.407	1.164	None	8 (5/3)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Pravastatin.	#F9BCBC	1.48002612246106	1
Cimetidine	Diazepam	0.307	1.397	Moderate	3 (2/1)	The metabolism of Diazepam can be decreased when combined with Cimetidine.	#F7B9B9	0.555009795922898	1
Digoxin	Minocycline	0.121	-1.789	Moderate	9 (4/5)		#AECDE3	1.66502938776869	1
Metformin	Cimetidine	0.263	-2.386	Moderate	8 (3/5)	The serum concentration of Metformin can be increased when it is combined with Cimetidine.	#A9C9E1	1.48002612246106	1
Ketoconazole	Solifenacin	0.151	-1.432	Major	4 (2/2)	The metabolism of Solifenacin can be decreased when combined with Ketoconazole.	#B1CFE5	0.740013061230531	1
Megestrol acetate	Primidone	0.4	-1.432	Moderate	4 (2/2)		#B1CFE5	0.740013061230531	1
Haloperidol	Ketoconazole	0.236	-1.432	Major	4 (2/2)	The metabolism of Haloperidol can be decreased when combined with Ketoconazole.	#B1CFE5	0.740013061230531	1
Clozapine	Alprazolam	0.052	-2.863	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Alprazolam is combined with Clozapine.	#A5C6DF	0.555009795922898	1
Telithromycin	Atorvastatin	0.185	-6.442	Major	11 (2/9)	The risk or severity of adverse effects can be increased when Telithromycin is combined with Atorvastatin.	#86AFD2	2.03503591838396	1
Flurbiprofen	Acenocoumarol	0.168	-1.789	None	9 (4/5)	Flurbiprofen may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	1.66502938776869	1
Midazolam	Rifampicin	0.5	Inf	Minor	1 (1/0)	The metabolism of Midazolam can be increased when combined with Rifampicin.	#B32020	0.185003265307633	1
Trospium	Maprotiline	0.636	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Rifampicin	Dexamethasone	0.683	-1.432	Moderate	4 (2/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Rifampicin.	#B1CFE5	0.740013061230531	1
Galantamine	Zuclopenthixol	0.111	Inf	None	1 (1/0)	Galantamine may increase the QTc-prolonging activities of Zuclopenthixol.	#B32020	0.185003265307633	1
Cyclosporine	Clarithromycin	0.031	1.397	Major	3 (2/1)	The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.	#F7B9B9	0.555009795922898	1
Codeine	Cimetidine	0.396	-1.432	Moderate	4 (2/2)	The therapeutic efficacy of Codeine can be decreased when used in combination with Cimetidine.	#B1CFE5	0.740013061230531	1
Felodipine	Phenobarbital	0.062	Inf	Moderate	1 (1/0)	The metabolism of Felodipine can be increased when combined with Phenobarbital.	#B32020	0.185003265307633	1
Indomethacin	Sotalol	0.095	-1.432	Moderate	4 (2/2)	Indomethacin may decrease the antihypertensive activities of Sotalol.	#B1CFE5	0.740013061230531	1
Theophylline	Sotalol	0.023	Inf	Major	1 (1/0)	Sotalol may decrease the bronchodilatory activities of Theophylline.	#B32020	0.185003265307633	1
Repaglinide	Rifampicin	0.154	-2.386	Moderate	8 (3/5)	The serum concentration of Repaglinide can be decreased when it is combined with Rifampicin.	#A9C9E1	1.48002612246106	1
Fluvastatin	Bezafibrate	0.081	Inf	None	2 (2/0)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Fluvastatin.	#B32020	0.370006530615265	1
Erythromycin	Triazolam	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Triazolam can be increased when it is combined with Erythromycin.	#B32020	0.185003265307633	1
Amitriptyline	Rifampicin	0.076	1.048	Minor	5 (3/2)	The metabolism of Amitriptyline can be increased when combined with Rifampicin.	#F9BCBC	0.925016326538163	1
Raloxifene	Cholestyramine	0.179	Inf	Moderate	2 (2/0)	Cholestyramine can cause a decrease in the absorption of Raloxifene resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B32020	0.370006530615265	1
Sotalol	Terbutaline	0.102	-1.432	Major	4 (2/2)	Terbutaline may increase the QTc-prolonging activities of Sotalol.	#B1CFE5	0.740013061230531	1
Triamcinolone	Warfarin	0.178	-2.505	Moderate	11 (4/7)	Triamcinolone may increase the anticoagulant activities of Warfarin.	#A8C8E1	2.03503591838396	1
Labetalol	Salbutamol	0.043	-2.863	Major	6 (2/4)	Labetalol may decrease the vasoconstricting activities of Salbutamol.	#A5C6DF	1.1100195918458	1
Phenytoin	Rifampicin	0.199	-2.863	Major	3 (1/2)	The serum concentration of Phenytoin can be decreased when it is combined with Rifampicin.	#A5C6DF	0.555009795922898	1
Cyproheptadine	Fluoxetine	0.13	-1.432	Moderate	2 (1/1)	The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Cyproheptadine.	#B1CFE5	0.370006530615265	1
Fluoxetine	Sumatriptan	0.336	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Fluoxetine is combined with Sumatriptan.	#B32020	0.370006530615265	1
Colestipol	Fluvastatin	0.9	-1.432	Moderate	2 (1/1)	Colestipol can cause a decrease in the absorption of Fluvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	0.370006530615265	1
Erythromycin	Dihydroergotamine	0.078	Inf	Major	2 (2/0)	The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Erythromycin.	#B32020	0.370006530615265	1
Fluconazole	Imipramine	0.081	Inf	Moderate	2 (2/0)	The metabolism of Imipramine can be decreased when combined with Fluconazole.	#B32020	0.370006530615265	1
Verapamil	Rifampicin	0.14	1.397	Moderate	3 (2/1)	The metabolism of Verapamil can be increased when combined with Rifampicin.	#F7B9B9	0.555009795922898	1
Tacrolimus	Clarithromycin	0.604	1.164	Major	8 (5/3)	The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.	#F9BCBC	1.48002612246106	1
Allopurinol	Mercaptopurine	0.418	-7.158	Major	6 (1/5)	The serum concentration of Mercaptopurine can be increased when it is combined with Allopurinol.	#80ABCF	1.1100195918458	1
Itraconazole	Clarithromycin	0.844	-2.147	Moderate	15 (6/9)	The metabolism of Clarithromycin can be decreased when combined with Itraconazole.	#ABCBE2	2.77504897961449	1
Betamethasone	Phenobarbital	0.039	-1.432	Moderate	2 (1/1)	The serum concentration of Betamethasone can be decreased when it is combined with Phenobarbital.	#B1CFE5	0.370006530615265	1
Fluvoxamine	Cilostazol	0.348	-5.726	Major	5 (1/4)	The serum concentration of Cilostazol can be increased when it is combined with Fluvoxamine.	#8CB4D5	0.925016326538163	1
Erythromycin	Felodipine	0.287	-2.863	Moderate	6 (2/4)	The metabolism of Felodipine can be decreased when combined with Erythromycin.	#A5C6DF	1.1100195918458	1
Simvastatin	Telithromycin	0.04	-1.909	Major	7 (3/4)	The serum concentration of Simvastatin can be increased when it is combined with Telithromycin.	#ACCCE3	1.29502285715343	1
Cyclosporine	Naproxen	0.029	1.048	Moderate	5 (3/2)	Naproxen may increase the nephrotoxic activities of Cyclosporine.	#F9BCBC	0.925016326538163	1
Fluoxetine	Cilostazol	0.167	-2.386	Moderate	8 (3/5)	The serum concentration of Cilostazol can be increased when it is combined with Fluoxetine.	#A9C9E1	1.48002612246106	1
Erythromycin	Cabergoline	0.08	-2.863	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Cabergoline is combined with Erythromycin.	#A5C6DF	0.555009795922898	1
Cyproheptadine	Rivastigmine	0.091	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Salbutamol	Oxprenolol	0.094	1.397	None	3 (2/1)	Oxprenolol may decrease the bronchodilatory activities of Salbutamol.	#F7B9B9	0.555009795922898	1
Terbinafine	Rifampicin	0.5	Inf	Minor	1 (1/0)	The serum concentration of Terbinafine can be decreased when it is combined with Rifampicin.	#B32020	0.185003265307633	1
Rifampicin	Nifedipine	0.23	-1.432	Major	4 (2/2)	The serum concentration of Nifedipine can be decreased when it is combined with Rifampicin.	#B1CFE5	0.740013061230531	1
Sucralfate	Ofloxacin	0.143	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Piroxicam	Acenocoumarol	0.269	1.048	None	10 (6/4)	Piroxicam may increase the anticoagulant activities of Acenocoumarol.	#F9BCBC	1.85003265307633	1
Cimetidine	Donepezil	0.071	-1.432	Moderate	2 (1/1)	The metabolism of Donepezil can be decreased when combined with Cimetidine.	#B1CFE5	0.370006530615265	1
Ketoconazole	Acenocoumarol	0.177	-5.01	None	18 (4/14)	The serum concentration of Acenocoumarol can be increased when it is combined with Ketoconazole.	#93B8D7	3.33005877553739	1
Formoterol	Nadolol	0.162	-2.863	Major	9 (3/6)		#A5C6DF	1.66502938776869	1
Lovastatin	Josamycin	0.029	-1.432	None	4 (2/2)	The serum concentration of Lovastatin can be increased when it is combined with Josamycin.	#B1CFE5	0.740013061230531	1
Fluphenazine	Levofloxacin	0.24	-1.432	Moderate	4 (2/2)		#B1CFE5	0.740013061230531	1
Fluconazole	Ranolazine	0.162	-5.01	Major	9 (2/7)	The serum concentration of Ranolazine can be increased when it is combined with Fluconazole.	#93B8D7	1.66502938776869	1
Warfarin	Isoniazid	0.3	-1.432	Moderate	2 (1/1)	The metabolism of Warfarin can be decreased when combined with Isoniazid.	#B1CFE5	0.370006530615265	1
Perindopril	Lithium cation	0.159	-1.432	Moderate	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Perindopril.	#B1CFE5	0.370006530615265	1
Fluvoxamine	Warfarin	0.232	-1.432	Moderate	4 (2/2)	The metabolism of Warfarin can be decreased when combined with Fluvoxamine.	#B1CFE5	0.740013061230531	1
Fluconazole	Flurazepam	0.185	Inf	None	2 (2/0)	The metabolism of Flurazepam can be decreased when combined with Fluconazole.	#B32020	0.370006530615265	1
Eplerenone	Itraconazole	0.034	1.397	Major	3 (2/1)	The serum concentration of Eplerenone can be increased when it is combined with Itraconazole.	#F7B9B9	0.555009795922898	1
Halazepam	Itraconazole	0.527	-1.432	None	2 (1/1)		#B1CFE5	0.370006530615265	1
Metoprolol	Indomethacin	0.166	1.397	Moderate	3 (2/1)	Indomethacin may decrease the antihypertensive activities of Metoprolol.	#F7B9B9	0.555009795922898	1
Fluconazole	Triazolam	0.333	Inf	Major	1 (1/0)	The metabolism of Triazolam can be decreased when combined with Fluconazole.	#B32020	0.185003265307633	1
Fluconazole	Cyclophosphamide	0.75	-1.432	None	2 (1/1)	The metabolism of Cyclophosphamide can be decreased when combined with Fluconazole.	#B1CFE5	0.370006530615265	1
Fluvoxamine	Theophylline	1	Inf	Major	1 (1/0)	The metabolism of Theophylline can be decreased when combined with Fluvoxamine.	#B32020	0.185003265307633	1
Diazepam	Ketoconazole	0.303	-1.432	Moderate	6 (3/3)	The metabolism of Diazepam can be decreased when combined with Ketoconazole.	#B1CFE5	1.1100195918458	1
Fluconazole	Dihydroergotamine	0.179	1.397	Moderate	3 (2/1)	The metabolism of Dihydroergotamine can be decreased when combined with Fluconazole.	#F7B9B9	0.555009795922898	1
Isotretinoin	Acenocoumarol	0.104	-2.863	None	3 (1/2)		#A5C6DF	0.555009795922898	1
Trospium	Desloratadine	0.289	1.397	None	3 (2/1)	The risk or severity of adverse effects can be increased when Trospium is combined with Desloratadine.	#F7B9B9	0.555009795922898	1
Warfarin	Ceftriaxone	0.143	Inf	Moderate	1 (1/0)	Ceftriaxone may increase the anticoagulant activities of Warfarin.	#B32020	0.185003265307633	1
Telmisartan	Lithium cation	0.384	-1.432	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Telmisartan.	#B1CFE5	0.740013061230531	1
Fluvoxamine	Phenytoin	0.684	-5.726	Moderate	5 (1/4)	The serum concentration of Phenytoin can be increased when it is combined with Fluvoxamine.	#8CB4D5	0.925016326538163	1
Eletriptan	Sertraline	0.113	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Sertraline.	#B32020	0.185003265307633	1
Fluvastatin	Cholestyramine	0.474	-2.147	Moderate	5 (2/3)	The serum concentration of Fluvastatin can be decreased when it is combined with Cholestyramine.	#ABCBE2	0.925016326538163	1
Dextromethorphan	Terbinafine	0.833	1.397	Major	6 (4/2)	The metabolism of Dextromethorphan can be decreased when combined with Terbinafine.	#F7B9B9	1.1100195918458	1
Hydrocortisone	Cholestyramine	0.202	-1.432	Moderate	6 (3/3)	Cholestyramine can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#B1CFE5	1.1100195918458	1
Phenytoin	Betamethasone	0.026	-1.432	Moderate	2 (1/1)	The serum concentration of Betamethasone can be decreased when it is combined with Phenytoin.	#B1CFE5	0.370006530615265	1
Methylprednisolone	Itraconazole	0.314	-2.147	Major	10 (4/6)	The serum concentration of Methylprednisolone can be increased when it is combined with Itraconazole.	#ABCBE2	1.85003265307633	1
Rifampicin	Propafenone	0.042	-2.863	Moderate	3 (1/2)	The serum concentration of Propafenone can be decreased when it is combined with Rifampicin.	#A5C6DF	0.555009795922898	1
Ampicillin	Acenocoumarol	0.124	-4.772	None	13 (3/10)	Ampicillin may increase the anticoagulant activities of Acenocoumarol.	#94B9D8	2.40504244899922	1
Carbamazepine	Bupropion	0.468	-2.863	Moderate	3 (1/2)	The metabolism of Bupropion can be increased when combined with Carbamazepine.	#A5C6DF	0.555009795922898	1
Donepezil	Glycopyrronium	0.281	-7.158	None	18 (3/15)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Donepezil.	#80ABCF	3.33005877553739	1
Citalopram	Frovatriptan	0.381	Inf	Major	1 (1/0)	The risk or severity of adverse effects can be increased when Citalopram is combined with Frovatriptan.	#B32020	0.185003265307633	1
Ethinylestradiol	Amoxicillin	0.521	-1.432	Moderate	2 (1/1)		#B1CFE5	0.370006530615265	1
Cyclosporine	Glimepiride	0.182	Inf	Moderate	1 (1/0)	The metabolism of Glimepiride can be decreased when combined with Cyclosporine.	#B32020	0.185003265307633	1
Donepezil	Doxepin	0.163	-2.863	Moderate	3 (1/2)		#A5C6DF	0.555009795922898	1
Prazosin	Bisoprolol	0.343	-2.147	Moderate	5 (2/3)	Bisoprolol may increase the orthostatic hypotensive activities of Prazosin.	#ABCBE2	0.925016326538163	1
Tetracycline	Amoxicillin	0.629	1.746	Moderate	7 (5/2)		#F6B6B6	1.29502285715343	1
Carbamazepine	Itraconazole	0.077	-2.147	Moderate	5 (2/3)	The serum concentration of Itraconazole can be decreased when it is combined with Carbamazepine.	#ABCBE2	0.925016326538163	1
Lovastatin	Bezafibrate	0.526	-2.147	None	5 (2/3)	Bezafibrate may increase the myopathic rhabdomyolysis activities of Lovastatin.	#ABCBE2	0.925016326538163	1
Doxycycline	Warfarin	0.093	-2.147	Moderate	5 (2/3)	The metabolism of Warfarin can be decreased when combined with Doxycycline.	#ABCBE2	0.925016326538163	1
Irbesartan	Lithium cation	0.227	-1.432	Moderate	4 (2/2)	The serum concentration of Lithium can be increased when it is combined with Irbesartan.	#B1CFE5	0.740013061230531	1
Methotrexate	Sulfamethoxazole	0.098	-3.818	Moderate	11 (3/8)	The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Methotrexate.	#9DC0DC	2.03503591838396	1
Labetalol	Formoterol	0.359	-1.432	Major	2 (1/1)	Labetalol may decrease the vasoconstricting activities of Formoterol.	#B1CFE5	0.370006530615265	1
Haloperidol	Rifampicin	0.133	-2.863	Major	6 (2/4)	The metabolism of Haloperidol can be increased when combined with Rifampicin.	#A5C6DF	1.1100195918458	1
Citalopram	Eletriptan	0.078	-1.432	Major	2 (1/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Eletriptan.	#B1CFE5	0.370006530615265	1
Paroxetine	Pimozide	0.059	Inf	Major	1 (1/0)	The serum concentration of Pimozide can be increased when it is combined with Paroxetine.	#B32020	0.185003265307633	1
Ergotamine	Itraconazole	0.02	Inf	Major	1 (1/0)	The serum concentration of Ergotamine can be increased when it is combined with Itraconazole.	#B32020	0.185003265307633	1
Cyclosporine	Lovastatin	0.25	Inf	Major	1 (1/0)	The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.	#B32020	0.185003265307633	1
Ceftriaxone	Acenocoumarol	0.082	-1.432	None	6 (3/3)	Ceftriaxone may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	1.1100195918458	1
Ofloxacin	Iron	0.573	-1.432	None	4 (2/2)		#B1CFE5	0.740013061230531	1
Warfarin	Etoricoxib	0.192	-2.291	None	13 (5/8)	Etoricoxib may increase the anticoagulant activities of Warfarin.	#A9C9E1	2.40504244899922	1
Erythromycin	Eplerenone	0.046	-4.295	Moderate	8 (2/6)	The serum concentration of Eplerenone can be increased when it is combined with Erythromycin.	#99BDDA	1.48002612246106	1
Ketoprofen	Acenocoumarol	0.105	-1.789	None	9 (4/5)	Ketoprofen may increase the anticoagulant activities of Acenocoumarol.	#AECDE3	1.66502938776869	1
Piroxicam	Methotrexate	0.074	-1.432	Major	2 (1/1)	The serum concentration of Methotrexate can be increased when it is combined with Piroxicam.	#B1CFE5	0.370006530615265	1
Theophylline	Terbinafine	0.085	-1.432	Moderate	2 (1/1)	The metabolism of Theophylline can be decreased when combined with Terbinafine.	#B1CFE5	0.370006530615265	1
Metoprolol	Lidocaine	0.103	-2.147	Moderate	5 (2/3)	The serum concentration of Metoprolol can be increased when it is combined with Lidocaine.	#ABCBE2	0.925016326538163	1
Ranolazine	Digoxin	0.257	-6.203	Moderate	16 (3/13)	The serum concentration of Digoxin can be increased when it is combined with Ranolazine.	#88B0D3	2.96005224492212	1
Pyridostigmine	Dexamethasone	0.045	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Dexamethasone is combined with Pyridostigmine.	#B32020	0.185003265307633	1
Trimethoprim	Methotrexate	0.098	-3.818	Major	11 (3/8)	The risk or severity of adverse effects can be increased when Trimethoprim is combined with Methotrexate.	#9DC0DC	2.03503591838396	1
Cimetidine	Fentanyl	0.292	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Spironolactone	Benazepril	0.23	-2.863	Major	3 (1/2)	The risk or severity of adverse effects can be increased when Spironolactone is combined with Benazepril.	#A5C6DF	0.555009795922898	1
Warfarin	Ofloxacin	0.026	-1.432	Major	2 (1/1)		#B1CFE5	0.370006530615265	1
Perphenazine	Levofloxacin	0.195	-2.147	Moderate	5 (2/3)		#ABCBE2	0.925016326538163	1
Warfarin	Metronidazole	0.182	-7.158	Major	18 (3/15)	The serum concentration of Warfarin can be increased when it is combined with Metronidazole.	#80ABCF	3.33005877553739	1
Warfarin	Minocycline	0.353	Inf	Moderate	1 (1/0)	Minocycline may increase the anticoagulant activities of Warfarin.	#B32020	0.185003265307633	1
Fluvoxamine	Rasagiline	0.229	-2.863	Major	3 (1/2)	The serum concentration of Rasagiline can be increased when it is combined with Fluvoxamine.	#A5C6DF	0.555009795922898	1
Doxycycline	Iron	0.27	-1.909	Moderate	7 (3/4)	Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#ACCCE3	1.29502285715343	1
Tizanidine	Perindopril	0.362	-4.295	Major	4 (1/3)	The risk or severity of hypotension can be increased when Tizanidine is combined with Perindopril.	#99BDDA	0.740013061230531	1
Meloxicam	Lithium cation	0.5	Inf	Major	1 (1/0)	The serum concentration of Lithium can be increased when it is combined with Meloxicam.	#B32020	0.185003265307633	1
Phenytoin	Tacrolimus	0.12	-1.432	Major	2 (1/1)	The serum concentration of Tacrolimus can be decreased when it is combined with Phenytoin.	#B1CFE5	0.370006530615265	1
Ranolazine	Clarithromycin	0.214	-3.579	Major	7 (2/5)	The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.	#9FC1DD	1.29502285715343	1
Indomethacin	Nadolol	0.25	Inf	Moderate	1 (1/0)	Indomethacin may decrease the antihypertensive activities of Nadolol.	#B32020	0.185003265307633	1
Digoxin	Prazosin	0.275	-1.432	None	2 (1/1)		#B1CFE5	0.370006530615265	1
Haloperidol	Glycopyrronium	0.288	-13.6	Moderate	21 (2/19)	The serum concentration of Haloperidol can be decreased when it is combined with Glycopyrronium.	#4880B7	3.88506857146029	1
Terbutaline	Nadolol	0.275	-1.432	Major	2 (1/1)		#B1CFE5	0.370006530615265	1
Diazepam	Josamycin	0.325	2.096	None	4 (3/1)		#F5B2B2	0.740013061230531	1
Alprazolam	Telithromycin	0.144	-2.863	Moderate	3 (1/2)	The serum concentration of Alprazolam can be increased when it is combined with Telithromycin.	#A5C6DF	0.555009795922898	1
Erythromycin	Colchicine	0.542	1.397	Major	3 (2/1)	The serum concentration of Colchicine can be increased when it is combined with Erythromycin.	#F7B9B9	0.555009795922898	1
Nortriptyline	Terbutaline	0.021	Inf	Moderate	1 (1/0)	The risk or severity of adverse effects can be increased when Nortriptyline is combined with Terbutaline.	#B32020	0.185003265307633	1
Erythromycin	Itraconazole	0.833	Inf	Major	2 (2/0)	The metabolism of Erythromycin can be decreased when combined with Itraconazole.	#B32020	0.370006530615265	1
Ziprasidone	Amiodarone	0.065	-1.432	Major	2 (1/1)	The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Amiodarone.	#B1CFE5	0.370006530615265	1
Verapamil	Lithium cation	0.625	-4.295	Moderate	4 (1/3)	Verapamil may increase the neurotoxic activities of Lithium.	#99BDDA	0.740013061230531	1
Verapamil	Nadolol	0.288	-1.432	Major	2 (1/1)	Verapamil may increase the hypotensive activities of Nadolol.	#B1CFE5	0.370006530615265	1
Erythromycin	Rifampicin	1	Inf	Moderate	1 (1/0)	The metabolism of Erythromycin can be increased when combined with Rifampicin.	#B32020	0.185003265307633	1
Erythromycin	Sotalol	0.077	Inf	Major	1 (1/0)	Erythromycin may increase the QTc-prolonging activities of Sotalol.	#B32020	0.185003265307633	1
Disulfiram	Acenocoumarol	0.147	-5.726	None	5 (1/4)	The serum concentration of Acenocoumarol can be increased when it is combined with Disulfiram.	#8CB4D5	0.925016326538163	1
Terbutaline	Rasagiline	0.095	-5.01	Moderate	9 (2/7)	The risk or severity of adverse effects can be increased when Rasagiline is combined with Terbutaline.	#93B8D7	1.66502938776869	1
Warfarin	Leflunomide	0.067	Inf	Moderate	1 (1/0)	Leflunomide may increase the anticoagulant activities of Warfarin.	#B32020	0.185003265307633	1
Chlorthalidone	Lithium cation	0.143	Inf	Major	1 (1/0)	Chlorthalidone may decrease the excretion rate of Lithium which could result in a higher serum level.	#B32020	0.185003265307633	1
Primidone	Dexamethasone	0.144	-2.863	Moderate	3 (1/2)	The serum concentration of Dexamethasone can be decreased when it is combined with Primidone.	#A5C6DF	0.555009795922898	1
Warfarin	Rifampicin	0.117	-2.863	Major	3 (1/2)	The metabolism of Warfarin can be increased when combined with Rifampicin.	#A5C6DF	0.555009795922898	1
Midazolam	Itraconazole	0.401	-2.863	Major	3 (1/2)	The serum concentration of Midazolam can be increased when it is combined with Itraconazole.	#A5C6DF	0.555009795922898	1
Erythromycin	Ranolazine	0.114	-4.295	Major	4 (1/3)	The serum concentration of Ranolazine can be increased when it is combined with Erythromycin.	#99BDDA	0.740013061230531	1
Alprazolam	Cimetidine	0.239	-2.863	Moderate	3 (1/2)		#A5C6DF	0.555009795922898	1
Donepezil	Perphenazine	0.338	-1.432	Moderate	2 (1/1)		#B1CFE5	0.370006530615265	1
Amitriptyline	Ketoconazole	0.067	Inf	Moderate	1 (1/0)	The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.	#B32020	0.185003265307633	1
Esomeprazole	Ketoconazole	0.061	-2.863	Moderate	3 (1/2)	The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.	#A5C6DF	0.555009795922898	1
Carbamazepine	Oxybutynin	0.215	-2.863	None	3 (1/2)	The metabolism of Oxybutynin can be increased when combined with Carbamazepine.	#A5C6DF	0.555009795922898	1
Primidone	Nifedipine	0.267	-8.589	Major	7 (1/6)	The serum concentration of Nifedipine can be decreased when it is combined with Primidone.	#73A0C9	1.29502285715343	1
Erythromycin	Cilostazol	0.131	-7.158	Major	6 (1/5)	The serum concentration of Cilostazol can be increased when it is combined with Erythromycin.	#80ABCF	1.1100195918458	1
Minocycline	Cloxacillin	0.6	-5.726	Moderate	5 (1/4)	The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Minocycline.	#8CB4D5	0.925016326538163	1
Lidocaine	Nadolol	0.5	Inf	Moderate	1 (1/0)	The serum concentration of Lidocaine can be increased when it is combined with Nadolol.	#B32020	0.185003265307633	1
Ranolazine	Verapamil	0.478	-1.432	Major	2 (1/1)	The serum concentration of Ranolazine can be increased when it is combined with Verapamil.	#B1CFE5	0.370006530615265	1
Theophylline	Acyclovir	0.186	-10.021	Minor	8 (1/7)		#6697C4	1.48002612246106	1
Cimetidine	Acenocoumarol	0.131	-4.295	None	4 (1/3)	Cimetidine may increase the anticoagulant activities of Acenocoumarol.	#99BDDA	0.740013061230531	1
Atenolol	Ampicillin	0.272	-1.432	Moderate	2 (1/1)	The bioavailability of Atenolol can be decreased when combined with Ampicillin.	#B1CFE5	0.370006530615265	1
Lithium cation	Etoricoxib	0.098	-1.432	None	2 (1/1)	The serum concentration of Lithium can be increased when it is combined with Etoricoxib.	#B1CFE5	0.370006530615265	1
Fluconazole	Cilostazol	0.314	-8.589	Major	7 (1/6)	The serum concentration of Cilostazol can be increased when it is combined with Fluconazole.	#73A0C9	1.29502285715343	1
Galantamine	Glycopyrronium	0.348	-18.61	None	14 (1/13)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Galantamine.	#1E61A5	2.59004571430686	1
Prednisone	Estradiol	1	Inf	Moderate	1 (1/0)	The serum concentration of Prednisone can be increased when it is combined with Estradiol.	#B32020	0.185003265307633	1
Dihydroergotamine	Isosorbide mononitrate	0.167	Inf	Moderate	1 (1/0)	The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.	#B32020	0.185003265307633	1
Rifampicin	Etoricoxib	0.201	-2.863	None	3 (1/2)	The metabolism of Etoricoxib can be increased when combined with Rifampicin.	#A5C6DF	0.555009795922898	1
Erythromycin	Tacrolimus	0.22	-4.295	Major	4 (1/3)	The serum concentration of Tacrolimus can be increased when it is combined with Erythromycin.	#99BDDA	0.740013061230531	1
Minocycline	Iron	0.399	-4.295	Moderate	4 (1/3)	Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.	#99BDDA	0.740013061230531	1
Glyburide	Rifampicin	0.23	-4.295	Moderate	4 (1/3)	The serum concentration of Glyburide can be decreased when it is combined with Rifampicin.	#99BDDA	0.740013061230531	1
Piroxicam	Carvedilol	0.152	-4.295	Moderate	4 (1/3)	Piroxicam may decrease the antihypertensive activities of Carvedilol.	#99BDDA	0.740013061230531	1
Tenoxicam	Acenocoumarol	0.084	-1.432	None	2 (1/1)	Tenoxicam may increase the anticoagulant activities of Acenocoumarol.	#B1CFE5	0.370006530615265	1
Cyclosporine	Diclofenac	0.058	-5.726	Moderate	5 (1/4)	Diclofenac may increase the nephrotoxic activities of Cyclosporine.	#8CB4D5	0.925016326538163	1
Galantamine	Cyclobenzaprine	0.033	Inf	Moderate	1 (1/0)		#B32020	0.185003265307633	1
Warfarin	Meloxicam	0.141	-4.295	Major	4 (1/3)	Meloxicam may increase the anticoagulant activities of Warfarin.	#99BDDA	0.740013061230531	1
Clonidine	Labetalol	0.056	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Labetalol.	#1E61A5	0.185003265307633	1
Ziprasidone	Pimozide	0.7	-Inf	Major	1 (0/1)	The serum concentration of Pimozide can be increased when it is combined with Ziprasidone.	#1E61A5	0.185003265307633	1
Trospium	Trifluoperazine	0.5	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Cimetidine	Triazolam	0.714	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Galantamine	Trimipramine	0.2	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Fluconazole	Chlordiazepoxide	0.333	-Inf	None	1 (0/1)	The metabolism of Chlordiazepoxide can be decreased when combined with Fluconazole.	#1E61A5	0.185003265307633	1
Trospium	Oxybutynin	0.097	-Inf	Moderate	6 (0/6)	The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.	#1E61A5	1.1100195918458	1
Cyclosporine	Roxithromycin	0.029	-Inf	None	1 (0/1)	The metabolism of Roxithromycin can be decreased when combined with Cyclosporine.	#1E61A5	0.185003265307633	1
Trospium	Trihexyphenidyl	0.3	-Inf	Moderate	2 (0/2)	The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Trospium.	#1E61A5	0.370006530615265	1
Ziprasidone	Carbamazepine	0.269	-Inf	Minor	3 (0/3)	The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.	#1E61A5	0.555009795922898	1
Fluvoxamine	Nortriptyline	0.562	-Inf	Major	2 (0/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Nortriptyline.	#1E61A5	0.370006530615265	1
Rifabutin	Clarithromycin	0.625	-Inf	Moderate	2 (0/2)	The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.	#1E61A5	0.370006530615265	1
Trospium	Flavoxate	0.077	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Rosiglitazone	Ketoconazole	0.101	-Inf	Moderate	2 (0/2)	The metabolism of Rosiglitazone can be decreased when combined with Ketoconazole.	#1E61A5	0.370006530615265	1
Warfarin	Isotretinoin	0.098	-Inf	Moderate	2 (0/2)		#1E61A5	0.370006530615265	1
Testosterone	Acenocoumarol	0.353	-Inf	None	23 (0/23)	Testosterone may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	4.25507510207555	1
Glycopyrronium	Rivastigmine	0.225	-Inf	None	24 (0/24)	The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Rivastigmine.	#1E61A5	4.44007836738318	1
Clozapine	Bromazepam	0.25	-Inf	None	1 (0/1)	The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.	#1E61A5	0.185003265307633	1
Carbamazepine	Dextropropoxyphene	0.143	-Inf	None	1 (0/1)	The metabolism of Dextropropoxyphene can be increased when combined with Carbamazepine.	#1E61A5	0.185003265307633	1
Diltiazem	Buspirone	0.1	-Inf	Moderate	1 (0/1)	The metabolism of Buspirone can be decreased when combined with Diltiazem.	#1E61A5	0.185003265307633	1
Pramipexole	Cimetidine	0.08	-Inf	Moderate	2 (0/2)	The serum concentration of Pramipexole can be increased when it is combined with Cimetidine.	#1E61A5	0.370006530615265	1
Carbamazepine	Aripiprazole	0.459	-Inf	Moderate	3 (0/3)	The serum concentration of Aripiprazole can be decreased when it is combined with Carbamazepine.	#1E61A5	0.555009795922898	1
Methadone	Carbamazepine	0.231	-Inf	Major	1 (0/1)	The metabolism of Methadone can be increased when combined with Carbamazepine.	#1E61A5	0.185003265307633	1
Halazepam	Ketoconazole	0.143	-Inf	None	1 (0/1)		#1E61A5	0.185003265307633	1
Cyclosporine	Bupropion	0.6	-Inf	Moderate	1 (0/1)	The metabolism of Bupropion can be decreased when combined with Cyclosporine.	#1E61A5	0.185003265307633	1
Imipramine	Ketoconazole	0.024	-Inf	Moderate	1 (0/1)	The metabolism of Imipramine can be decreased when combined with Ketoconazole.	#1E61A5	0.185003265307633	1
Phenytoin	Prednisolone	0.062	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisolone can be decreased when it is combined with Phenytoin.	#1E61A5	0.185003265307633	1
Griseofulvin	Acenocoumarol	0.084	-Inf	None	5 (0/5)	The serum concentration of Acenocoumarol can be decreased when it is combined with Griseofulvin.	#1E61A5	0.925016326538163	1
Cimetidine	Midazolam	0.333	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Hydrocortisone	Primidone	0.218	-Inf	Moderate	7 (0/7)	The serum concentration of Hydrocortisone can be decreased when it is combined with Primidone.	#1E61A5	1.29502285715343	1
Cimetidine	Clomipramine	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Clomipramine can be decreased when combined with Cimetidine.	#1E61A5	0.185003265307633	1
Cefoxitin	Acenocoumarol	0.062	-Inf	None	1 (0/1)	Cefoxitin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.185003265307633	1
Ergotamine	Nadolol	0.364	-Inf	Moderate	1 (0/1)	Ergotamine may increase the atrioventricular blocking (AV block) activities of Nadolol.	#1E61A5	0.185003265307633	1
Nortriptyline	Pseudoephedrine	0.158	-Inf	None	2 (0/2)	Nortriptyline may decrease the antihypertensive activities of Pseudoephedrine.	#1E61A5	0.370006530615265	1
Warfarin	Mefenamic acid	0.067	-Inf	Major	1 (0/1)	Mefenamic acid may increase the anticoagulant activities of Warfarin.	#1E61A5	0.185003265307633	1
Digoxin	Oxytetracycline	0.125	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Tacrolimus	Danazol	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Tacrolimus can be increased when it is combined with Danazol.	#1E61A5	0.185003265307633	1
Ergotamine	Isosorbide dinitrate	0.053	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Lovastatin	Niacin	0.267	-Inf	Major	1 (0/1)	The risk or severity of rhabdomyolysis can be increased when Niacin is combined with Lovastatin.	#1E61A5	0.185003265307633	1
Fluvoxamine	Rizatriptan	0.059	-Inf	Major	1 (0/1)	The metabolism of Rizatriptan can be decreased when combined with Fluvoxamine.	#1E61A5	0.185003265307633	1
Naratriptan	Sertraline	0.077	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Naratriptan is combined with Sertraline.	#1E61A5	0.185003265307633	1
Quinapril	Lithium cation	0.081	-Inf	Moderate	2 (0/2)	The serum concentration of Lithium can be increased when it is combined with Quinapril.	#1E61A5	0.370006530615265	1
Eletriptan	Escitalopram	0.484	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Eletriptan is combined with Escitalopram.	#1E61A5	0.185003265307633	1
Digoxin	Telithromycin	0.217	-Inf	Moderate	3 (0/3)	The metabolism of Digoxin can be decreased when combined with Telithromycin.	#1E61A5	0.555009795922898	1
Carbamazepine	Doxepin	0.25	-Inf	Moderate	1 (0/1)	The metabolism of Doxepin can be increased when combined with Carbamazepine.	#1E61A5	0.185003265307633	1
Cyclosporine	Fluvastatin	0.572	-Inf	Moderate	2 (0/2)	The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.	#1E61A5	0.370006530615265	1
Citalopram	Naratriptan	0.125	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Citalopram is combined with Naratriptan.	#1E61A5	0.185003265307633	1
Acetylsalicylic acid	Heparin	0.073	-Inf	Moderate	2 (0/2)	Acetylsalicylic acid may increase the anticoagulant activities of Heparin.	#1E61A5	0.370006530615265	1
Cimetidine	Itraconazole	0.167	-Inf	Moderate	1 (0/1)	The serum concentration of Itraconazole can be decreased when it is combined with Cimetidine.	#1E61A5	0.185003265307633	1
Alfuzosin	Itraconazole	0.071	-Inf	Major	8 (0/8)	The serum concentration of Alfuzosin can be increased when it is combined with Itraconazole.	#1E61A5	1.48002612246106	1
Cyclosporine	Primidone	0.278	-Inf	Moderate	1 (0/1)	The metabolism of Cyclosporine can be increased when combined with Primidone.	#1E61A5	0.185003265307633	1
Eletriptan	Paroxetine	0.743	-Inf	Major	1 (0/1)	The metabolism of Eletriptan can be decreased when combined with Paroxetine.	#1E61A5	0.185003265307633	1
Fludrocortisone	Rifampicin	0.059	-Inf	Moderate	1 (0/1)	The serum concentration of Fludrocortisone can be decreased when it is combined with Rifampicin.	#1E61A5	0.185003265307633	1
Trospium	Levocabastine	0.2	-Inf	None	1 (0/1)		#1E61A5	0.185003265307633	1
Fluvoxamine	Oxycodone	0.402	-Inf	Moderate	2 (0/2)	The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Oxycodone.	#1E61A5	0.370006530615265	1
Cyclosporine	Sulfamethoxazole	0.044	-Inf	Major	2 (0/2)	Sulfamethoxazole may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.370006530615265	1
Furosemide	Streptomycin	0.111	-Inf	Major	1 (0/1)	The serum concentration of Streptomycin can be increased when it is combined with Furosemide.	#1E61A5	0.185003265307633	1
Theophylline	Cimetidine	0.5	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be decreased when combined with Cimetidine.	#1E61A5	0.185003265307633	1
Chlorpropamide	Glucosamine	0.2	-Inf	None	1 (0/1)		#1E61A5	0.185003265307633	1
Tacrolimus	Felodipine	0.107	-Inf	Moderate	2 (0/2)	The serum concentration of Tacrolimus can be increased when it is combined with Felodipine.	#1E61A5	0.370006530615265	1
Imipramine	Terbinafine	0.074	-Inf	Moderate	1 (0/1)	The metabolism of Imipramine can be decreased when combined with Terbinafine.	#1E61A5	0.185003265307633	1
Doxycycline	Carbamazepine	0.401	-Inf	Moderate	3 (0/3)	The serum concentration of Doxycycline can be decreased when it is combined with Carbamazepine.	#1E61A5	0.555009795922898	1
Midazolam	Josamycin	0.111	-Inf	None	1 (0/1)	The serum concentration of Midazolam can be increased when it is combined with Josamycin.	#1E61A5	0.185003265307633	1
Cilostazol	Itraconazole	0.194	-Inf	Major	4 (0/4)	The serum concentration of Cilostazol can be increased when it is combined with Itraconazole.	#1E61A5	0.740013061230531	1
Disulfiram	Metronidazole	0.067	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Disulfiram is combined with Metronidazole.	#1E61A5	0.185003265307633	1
Telithromycin	Acenocoumarol	0.113	-Inf	None	4 (0/4)	The metabolism of Acenocoumarol can be decreased when combined with Telithromycin.	#1E61A5	0.740013061230531	1
Cyclosporine	Clindamycin	0.038	-Inf	Moderate	2 (0/2)	The metabolism of Clindamycin can be decreased when combined with Cyclosporine.	#1E61A5	0.370006530615265	1
Clozapine	Diazepam	0.025	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Diazepam is combined with Clozapine.	#1E61A5	0.185003265307633	1
Cyclosporine	Indomethacin	0.042	-Inf	Moderate	2 (0/2)	Indomethacin may increase the nephrotoxic activities of Cyclosporine.	#1E61A5	0.370006530615265	1
Labetalol	Terbutaline	0.037	-Inf	Major	1 (0/1)	The risk or severity of adverse effects can be increased when Labetalol is combined with Terbutaline.	#1E61A5	0.185003265307633	1
Prednisone	Ethinylestradiol	0.042	-Inf	Moderate	1 (0/1)	The serum concentration of Prednisone can be increased when it is combined with Ethinyl Estradiol.	#1E61A5	0.185003265307633	1
Cyclosporine	Colchicine	0.154	-Inf	Major	2 (0/2)	The serum concentration of Colchicine can be increased when it is combined with Cyclosporine.	#1E61A5	0.370006530615265	1
Indomethacin	Labetalol	0.125	-Inf	Moderate	1 (0/1)	Indomethacin may decrease the antihypertensive activities of Labetalol.	#1E61A5	0.185003265307633	1
Clonidine	Carvedilol	0.926	-Inf	Major	1 (0/1)	Clonidine may increase the atrioventricular blocking (AV block) activities of Carvedilol.	#1E61A5	0.185003265307633	1
Prazosin	Propranolol	0.111	-Inf	Moderate	1 (0/1)	Propranolol may increase the orthostatic hypotensive activities of Prazosin.	#1E61A5	0.185003265307633	1
Theophylline	Rifampicin	0.399	-Inf	Moderate	2 (0/2)	The metabolism of Theophylline can be increased when combined with Rifampicin.	#1E61A5	0.370006530615265	1
Glimepiride	Rifampicin	0.1	-Inf	Moderate	3 (0/3)	The serum concentration of Glimepiride can be decreased when it is combined with Rifampicin.	#1E61A5	0.555009795922898	1
Tetracycline	Iron	0.122	-Inf	Moderate	2 (0/2)		#1E61A5	0.370006530615265	1
Trospium	Biperiden	0.05	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Biperiden is combined with Trospium.	#1E61A5	0.185003265307633	1
Rivastigmine	Flavoxate	0.15	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Phenytoin	Capecitabine	0.047	-Inf	Moderate	1 (0/1)	The serum concentration of Phenytoin can be increased when it is combined with Capecitabine.	#1E61A5	0.185003265307633	1
Cimetidine	Propranolol	0.286	-Inf	Moderate	1 (0/1)	The metabolism of Propranolol can be decreased when combined with Cimetidine.	#1E61A5	0.185003265307633	1
Carbamazepine	Ketoconazole	0.182	-Inf	Moderate	1 (0/1)	The metabolism of Ketoconazole can be increased when combined with Carbamazepine.	#1E61A5	0.185003265307633	1
Lamotrigine	Rifampicin	0.03	-Inf	Moderate	1 (0/1)	The metabolism of Lamotrigine can be increased when combined with Rifampicin.	#1E61A5	0.185003265307633	1
Primidone	Metronidazole	0.077	-Inf	Moderate	2 (0/2)	The serum concentration of Metronidazole can be decreased when it is combined with Primidone.	#1E61A5	0.370006530615265	1
Itraconazole	Josamycin	0.2	-Inf	None	1 (0/1)		#1E61A5	0.185003265307633	1
Ranolazine	Itraconazole	0.117	-Inf	Major	2 (0/2)	The serum concentration of Ranolazine can be increased when it is combined with Itraconazole.	#1E61A5	0.370006530615265	1
Metoprolol	Primidone	0.481	-Inf	Moderate	1 (0/1)	The serum concentration of Metoprolol can be decreased when it is combined with Primidone.	#1E61A5	0.185003265307633	1
Cimetidine	Rivastigmine	0.231	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Trospium	Azelastine	0.091	-Inf	None	1 (0/1)		#1E61A5	0.185003265307633	1
Chlorpropamide	Carvedilol	0.833	-Inf	Moderate	1 (0/1)	Carvedilol may increase the hypoglycemic activities of Chlorpropamide.	#1E61A5	0.185003265307633	1
Fluorouracil	Warfarin	0.034	-Inf	Major	2 (0/2)	The serum concentration of Warfarin can be increased when it is combined with Fluorouracil.	#1E61A5	0.370006530615265	1
Epinephrine	Rasagiline	0.04	-Inf	Moderate	1 (0/1)	Rasagiline may increase the hypertensive activities of Epinephrine.	#1E61A5	0.185003265307633	1
Colestipol	Hydrocortisone	0.5	-Inf	Moderate	1 (0/1)	Colestipol can cause a decrease in the absorption of Hydrocortisone resulting in a reduced serum concentration and potentially a decrease in efficacy.	#1E61A5	0.185003265307633	1
Triazolam	Clarithromycin	0.071	-Inf	Moderate	1 (0/1)	The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.	#1E61A5	0.185003265307633	1
Tetracycline	Insulin aspart	0.034	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Prazosin	Carvedilol	0.783	-Inf	Moderate	1 (0/1)	Prazosin may increase the antihypertensive activities of Carvedilol.	#1E61A5	0.185003265307633	1
Eplerenone	Lithium cation	0.2	-Inf	Moderate	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Eplerenone.	#1E61A5	0.185003265307633	1
Telithromycin	Amiodarone	0.167	-Inf	Major	1 (0/1)	Telithromycin may increase the QTc-prolonging activities of Amiodarone.	#1E61A5	0.185003265307633	1
Pseudoephedrine	Rasagiline	0.051	-Inf	Moderate	2 (0/2)	Rasagiline may increase the hypertensive activities of Pseudoephedrine.	#1E61A5	0.370006530615265	1
Torasemide	Amikacin	0.032	-Inf	Major	1 (0/1)	The serum concentration of Amikacin can be increased when it is combined with Torasemide.	#1E61A5	0.185003265307633	1
Digoxin	Bumetanide	0.059	-Inf	Moderate	1 (0/1)	The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.	#1E61A5	0.185003265307633	1
Indomethacin	Lithium cation	0.053	-Inf	Major	1 (0/1)	The serum concentration of Lithium can be increased when it is combined with Indomethacin.	#1E61A5	0.185003265307633	1
Testosterone	Warfarin	0.125	-Inf	Major	1 (0/1)	Testosterone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.185003265307633	1
Theophylline	Primidone	1	-Inf	Moderate	1 (0/1)	The metabolism of Theophylline can be increased when combined with Primidone.	#1E61A5	0.185003265307633	1
Fluorouracil	Metronidazole	1	-Inf	Moderate	1 (0/1)	The serum concentration of Fluorouracil can be increased when it is combined with Metronidazole.	#1E61A5	0.185003265307633	1
Alfuzosin	Ketoconazole	0.038	-Inf	Major	1 (0/1)	The serum concentration of Alfuzosin can be increased when it is combined with Ketoconazole.	#1E61A5	0.185003265307633	1
Trospium	Glycopyrronium	0.2	-Inf	Moderate	1 (0/1)	Trospium may increase the anticholinergic activities of Glycopyrronium.	#1E61A5	0.185003265307633	1
Flutamide	Warfarin	0.091	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Benzylpenicillin	Acenocoumarol	0.083	-Inf	None	1 (0/1)	Benzylpenicillin may increase the anticoagulant activities of Acenocoumarol.	#1E61A5	0.185003265307633	1
Torasemide	Tobramycin	0.071	-Inf	Major	1 (0/1)	The serum concentration of Tobramycin can be increased when it is combined with Torasemide.	#1E61A5	0.185003265307633	1
Betamethasone	Warfarin	0.083	-Inf	Moderate	1 (0/1)	Betamethasone may increase the anticoagulant activities of Warfarin.	#1E61A5	0.185003265307633	1
Digoxin	Tetracycline	0.1	-Inf	Moderate	1 (0/1)		#1E61A5	0.185003265307633	1
Metoprolol	Hydralazine	0.087	-Inf	Minor	1 (0/1)	Hydralazine may increase the hypotensive activities of Metoprolol.	#1E61A5	0.185003265307633	1
Mercaptopurine	Acenocoumarol	0.115	-Inf	None	1 (0/1)	Mercaptopurine may decrease the anticoagulant activities of Acenocoumarol.	#1E61A5	0.185003265307633	1
